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Abstract 
A number of approaches which aim to achieve amplification free nucleic acids detection 
are reported. The first approach uses dual function platinum nanoparticles to detect 
DNA. These particles physically separate DNA capture and electrocatalytic detection, 
which allows for significant enhancement for the sensitivity of DNA detection. 
Platinum nanoparticles were grown in the defect sites of an alkane thiol monolayer. 
These particles could then be functionalised with a capture DNA strand, and 
subsequently released from the surface by sonication. Using this method attomolar 
limits of detection were achieved.    
A molecular beacon for the detection and quantification of miR-132 is also reported.  
The stem-loop structure comprises a sequence complementary to miR-132, modified 
with a 6-FAM dye and dabcyl quencher on either end. In the absence of the target, self-
binding occurs bringing the luminophore and quencher into close proximity 
significantly decreasing the emission intensity. In the presence of miR-132, the signal is 
greatly enhanced, with a linear increase in intensity from a molar ratio of 0.25 to 2.00 of 
target. The structure could also efficiently differentiates between target and mismatched 
nucleic acid sequences. In the presence of a single base mismatch, the intensity is 
approximately a factor of 2 lower than a fully complementary target reflecting its lower 
association constant. 
The molecular beacon was then introduced into neuroblastoma cells by electroporation, 
allowing the miR-132 to be imaged within live cells. miR-132 appears to be localised 
within the nucleus of the cells where its concentration is of the order of 1µM.  
Transfection of the cells with an anti-miR-132, resulted in a decrease in the average 
emission intensity of 18%, however due to high variability in miR-132 between 
individual cells, confirmation of a statically significant difference was not possible. 
A displacement assay for the detection of miR-132, a biomarker of neuroblastoma, was 
also investigated. In this work, a capture strand of DNA complimentary to miR-132 was 
bound to a surface. A probe strand of DNA partially complimentary to this capture was 
attached to a large microsphere functionalised with Cy5 dye for visualisation of the 
particle. These microspheres where then bound to the surface by hybridization. This 
caused quenching of the dye excited state by the gold. When the fully complimentary 
miRNA target was added, it displaced the probe strand, and attached microsphere. This 
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resulted in a “switching on” of dye emission from the particles. This has the potential 
for single molecule miRNA detection, with a single binding event can generate a large 
detectable signal.  
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1.1  Introduction 
Micro ribonucleic acid (miRNA) has been shown to have an essential role in a wide 
variety of biological pathways.
1
 As such, cells which have become cancerous tend to 
have a differential expression of miRNA compared to healthy cells. Analysis of the 
miRNA expression of a wide number of cancer types has found miRNA deregulation in 
the majority of cases.
2
  
Recently, detection of miRNA expression has been identified as an attractive method of 
determining disease state for a wide range of cancers.
3
 Live-cell imaging has the 
potential to allow for real-time analysis of this miRNA expression profile that can 
enable recognition of the molecular subtype of cancer, which can inform the treatment 
strategy.
4
 For example neuroblastoma, the most common extracranial solid tumour 
found in children, has significantly differential progression, with some patients 
recovering with no treatment, whereas for others the prognosis is poor, even with 
aggressive treatment.
5
  
Early detection has been linked to improved survival rates for a number of cancers.
6-8
 
The miRNA biomarkers associated with early stage cancerous cells tend to be present at 
very low concentrations (fM), which makes detection challenging.
9
  
Currently, the state of the art detection method is Polymerase Chain Reaction (PCR) 
whereby a miRNA of interest is amplified to detectable limits.
8,10
 While this method has 
exceptional sensitivity, with detection of a few as 10 miRNA copies possible,
11
 it 
requires highly purified samples and highly skilled personnel
12
. This is acceptable in the 
context of centralised laboratories, but has the effect of significant increasing the cost 
and time for detection.  In order for wide-scale screening of miRNA expression to 
occur, the detection strategy needs to be both inexpensive and simple to perform. This 
research aims to achieve amplification-free selective and sensitive nucleic acid 
detection. 
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1.2  Nucleic Acids 
DNA contains all of the information needed to build a cell, to become tissues and form 
organs. This information is stored as genes, with each gene responsible for a trait of the 
organism
13
. The DNA must be protected from damage to ensure the integrity of this 
data.
14
 For this reason the DNA is contained in the nucleus of the cell, where transport 
is tightly controlled.
15
 To convey the information contained in the DNA to the rest of 
the cell, the DNA is transcribed into ribonucleic acid (RNA).
16
 
DNA and RNA share a number of structural similarities, with both being linear 
polymers, made up of individual building blocks called nucleotides or bases.
17
 RNAs 
tend to be shorter than DNA, usually in the range of hundreds to thousands of bases, 
whereas DNA is longer and can run to millions of nucleotides in length.
18
 RNA and 
DNA are composed of four nucleotides
19
. These nucleotides are bound to a backbone, 
which is composed of a 5 carbon sugar phosphorylated at carbon 5 and containing a 
hydroxyl group at carbon 3. This gives DNA and RNA directionality, and by 
convention DNA is read from the 5’ end to the 3’ end.20 A phosphodiester bond links 
the individual bases together, from the 3’ end of one base to the 5’ end of another.21 
The backbone of DNA contains a sugar known as 2-deoxyribose, which is a pentose 
sugar containing an oxygen bound to two hydroxyl groups. RNA, however, contains the 
sugar Ribose, which contains a forth hydroxyl group on C3. This additional hydroxyl 
makes RNA more reactive than DNA, and allows the cell to identify RNA.
22
 Another 
property of this hydroxyl group is that RNA can be cleaved into individual nucleotides 
in a basic solution.
23
 
 
 
 
Figure 1.1: Backbone sugars of nucleic acids, with DNA (left) and RNA (right). 
RNA and DNA have a total of 5 nucleotides. These are Guanine (G) and Adenine (A), 
which contain a six membered ring fused to a five membered ring, and Thymine (T), 
  2-deoxyribose                      Ribose 
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Cytosine (C) and Uracil (U) which contain a single 5 membered ring. A, G and C are 
found in both DNA and RNA, with T being found only in DNA and U only being found 
in RNA. Thymine is the non-methylated form of Uracil. 
24
 
 
 
Figure 1.2: Structure of nucleic acid nucleotides. 
 
1.2.1  Base Pairing 
In 1953 Watson and Crick discovered that DNA had a double helix structure.
19
 This was 
a major breakthrough for our understanding of the nature of DNA and of the way in 
which it functions to store genetic information. They found that DNA is composed of 
two strands of nucleotides which bind together to form a double helix. This means each 
cell has two complete copies of the information needed to operate that cell. If one of 
these strands becomes damaged, then this can be identified by its comparison, which 
allows the damaged cell to enter programed cell death, to prevent these mutations from 
causing harm to the organism.
25,26
 
The two strands are antiparallel, with one strand going from 5’ to 3’ and the other going 
from 3’ to 5’.20 Base pairing holds the two strands tightly together. A is paired to T by 
two hydrogen bonds, and G is bound to C by three hydrogen bonds. 
27
 The GC pairing 
is stronger, with a higher binding energy due to interactions with the secondary 
   Adenine              Guanine 
  Cytosine     Thymine    Uracil 
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structure of double stranded DNA which contributes significantly to the strength of the 
double helix, with hydrophobic interactions, van der Waals forces, and stacking.
28
  
 
 
 
 
 
 
 
 
Figure 1.3: The double helix structure of DNA, adapted from: National Human Genome 
Research Institute “Talking Glossary of Genetic Terms”29 (B) The base pairing of DNA 
adapted from “DNA II” Vision learning Vol. BIO-3.30 
In order for the information stored within the DNA to be accessible, the DNA helix 
must be capable of unwinding and separating. This process is called denaturation or 
melting, and can be achieved in the lab by increasing the temperature of a solution 
containing DNA.
31
 As the temperature increases, so does the kinetic energy of the 
DNA. At a certain point, the kinetic energy of the DNA is sufficient to break the 
hydrogen bonds holding the strands together. This is known as the melting temperature 
of the DNA and can be used as a measure of strength of base pairing between two 
strands.
32
  
This melting point is determined by a number of factors. As previously discussed the 
strength of the GC bond is stronger than the AT bond and so a higher GC content will 
result in a more stable helix requiring a higher melting temperature.
33
 The pH of the 
solution can also have a major impact on the melting temperature. At a low pH, the 
bases can become protonated, resulting in a positive charge causing repulsion between 
the two strands.
34
 
 
 
(A) (B) 
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1.2.2  Messenger RNA 
A number of different types of RNA are transcribed in the nucleus and contribute to the 
correct functioning of the cell. The types of RNA can be broken down in to two broad 
categories; protein-coding
35
 and non-protein coding
36
. Messenger RNA (mRNA) is the 
primary coding RNA. Its function is to transfer information from the DNA to the 
ribosome of the cell.
37
  During mRNA synthesis, the part of the DNA that contains the 
relevant information is copied into RNA by a polymerization reaction mediated by 
RNA polymerase.
38
  The RNA is encoded from 5’ to 3’, with the 3’ hydroxyl group 
being attacked by the nucleophilic phosphate group. RNA is synthesized at a rate of 
approximately 1000 nucleotides per minute at normal physiological conditions.
39
  
Messenger RNA is coded so that three nucleotides carry the information for one amino 
acid, called a codon.
17
 
The RNA produced is known as premature-mRNA (pre-mRNA) and is identical to the 
template strand of DNA, with the exception of T which is replaced by U.
40
 The RNA is 
then processed in the nucleus to produce mature mRNA, see Figure 1.4. At the 5’ end, 
the cap is modified with a guanine nucleotide which allows the ribosome and transport 
proteins to recognize the mRNA.
41
 The un-translated regions (UTR) are the areas at 
either end of the coding sequences which do not contribute to protein synthesis. These 
regions play an important role in the post transcriptional regulation of mRNA, allowing 
the cell to fine tune the expression of proteins by altering the expression of miRNA.
42
 
The coding sequence contains the codons for the synthesis of the protein, and is flanked 
by a start and stop codon which tells the ribosome when to begin and finish translation 
of the messenger RNA.  
The majority of RNA produced and present in a cell does not code for the production of 
a protein. These RNAs are known as non-coding RNA.
43,44,44
  
 
 
Figure 1.4: Schematic for the structure of a typical messenger RNA 
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1.3  Micro RNA 
Micro RNAs (miRNAs) are a class of small RNA molecules, approximately 16 to 29 
nucleotides long, which regulate gene expression at the post-transcriptional level.
45 
The 
primary function of miRNA is to down regulate the synthesis of proteins by protein-
coding genes.
46
 This is achieved by the degradation or inhibition of mRNA. miRNAs 
have also been implicated in the activation of targeted mRNA translation. In this way, 
miRNAs are capable of switching between upregulation and downregulation of 
proteins, depending on the cell cycle.
47
 This makes measurement of miRNA expression 
an important indicator of cellular function, which allows for the detection of cells with 
abhorrent expression, for example in cancerous tissue.   
miRNAs in circulating blood is an attractive target for disease detection, potentially 
allowing for non-invasive screening for a range of illnesses including cancer and a 
number of infections.
9
 Detection of miRNA has applications in early disease detection 
and theranostics, however this requires highly sensitive detection strategies. 
 
Figure 1.5: Adapted from National Institutes of Health. National Human Genome 
Research Institute. “Talking Glossary of Genetic Terms” 48 
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1.3.1  Biogenesis  
Micro RNAs are produced in the nucleus of the cell by transcription from genes. This 
transcription is performed by RNA polymerase II (Pol II)
49
 which can bind to a 
promoter region on the DNA to transcribe the tail region. The initial RNA strand 
produced is several hundred bases long, is known as primary-microRNA (pri-miRNA), 
and can contain the elements for a number of miRNAs.
50
  The 5’ end is capped with a 
distinctive nucleotide, and the 3’ end contains a number of adenosines, and is known as 
the “poly(A)” tail. 
 
Figure 1.6:  Formation of mature miRNA. Adapted from: Small RNAs tell big stories in 
Whistler, Nature Cell Biology.
51
  
 
Processing of the pri-miRNA is performed by a protein called DiGeorge Syndrome 
Critical Region 8 Gene (DGCR8) which combines with the enzyme Drosha to form the 
“microprocessor complex”52. Drosha is a protein which can cleave DNA. The pri-
mRNA is then cleaved by the microprocessor complex to produce a 60 to 70 base strand 
with a hairpin structure called precursor microRNA (pre-miRNA). The hairpin formed 
has a two base overhang at the 3’ end.  
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The pre-miRNAs are transported out of the nucleus by a transport protein called 
Exportin-5, which identifies the two base overhang.
53
 Once in the cytoplasm, the pre-
miRNA hairpin is cleaved from the enzyme Dicer to form a miRNA/miRNA duplex 
approximately 22 bases in length.
54
 These two strands of mature miRNA produced are 
imperfectly hybridized. Generally, only one of these strands is biologically active, while 
the other is degraded.
55
 
Since the pre-miRNA produced in the nucleus contains the same sequence as the mature 
form, detection strategies which rely on nucleic acid recognition can also detect this 
species. While this can lead to an increase in the apparent expression of the miRNA 
detected, the quantity of pre-miRNA present tends to be proportional to the mature 
miRNA present in the cell.
56
  
1.3.2  Mechanism of Action 
These mature miRNA are then integrated into a ribonucleoprotein effector complex to 
form the “RNA-induced silencing complex” (RISC).57 This complex uses the miRNA 
strand to identify its target, usually messenger RNA, based on complementarity between 
the miRNA and mRNA. The messenger RNA is then down regulated by either 
degradation or by preventing the mRNA from being transcribed.  If the miRNA is 
perfectly complimentary to its target, the mRNA will be cleaved by the enzyme 
Argonaute2. If the miRNA is imperfectly complimentary, the translation of the mRNA 
is suppressed.
58
 
 
Figure 1.7: Diagram showing the formation of the RNA induced silencing complex, and 
the subsequent silencing of the mRNA.
59
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1.4  Micro RNA as a Cancer Biomarker  
Recently, the role of miRNA as potential biomarkers has been investigated. An ideal 
biomarker should meet a number of criteria; it should allow identification of a particular 
disease or condition, provide information on the stage of the illness, be detectable in 
clinical samples or via non-invasive methods and allow monitoring on clinical response 
to an intervention.
60
 miRNA have the potential to meet each of these requirements.    
The essential role of miRNA in a variety of biological pathways is well known.
1
 
Cancerous cells show a differential expression of miRNA when compared to cells that 
are healthy. miRNA deregulation has been identified as occurring in the majority of 
cases examined for miRNA expression covering a wide range of types of cancer.
2
 This 
deregulation occurs for oncomirs, which are miRNAs which suppress the genes 
responsible for cell differentiation and apoptosis,
61
 and tumour suppressor miRNA 
which are downregulated in cancer.
3
 Together, these up and down regulated miRNA 
form an expression profile which is unique to the cancer subtype. This profile can then 
be used to diagnosis the illness and to inform treatment.  
Expression profiling of ovarian cancer tumours found that compared to normal ovarian 
cells, miR-100 was downregulated in 76 % of tumours. Significantly, miR-214 and 
miR-200a were found to be upregulated in high-grade and late-stage tumours. 
Furthermore, tumours with higher expression of miR-214 were found to be resistant to 
cisplatin.
62
 This expression profile highlights the ability of miRNAs to aid in the 
identification, staging and to inform the treatment of cancer.  
 
Figure 1.8: Expression of miR-199, miR-200a, miR-214 and miR-100 in primary 
ovarian tumours (left) compared to normal ovarian tissue (right). 
62
 
 13 
 
A study by Wu at al. 
63
identified a panel of four miRNA biomarkers to determine the 
risk of metastasis in clear cell renal cell carcinoma (ccRCC). The miRNA identified 
were miR-10b, miR-139-5p, miR130b and miR-199b-5p. Using a qPCR based assay 
this miRNA panel proved capable for the determination of metastasis risk and 
prognosis, with 76 % sensitivity and 100 % selectivity. This is particularly significant 
since no other means of predicting metastases in ccRCC is currently available.   
While these studies focused on clinical tumour samples, research into circulating 
miRNA as a biomarker is also on-going.
60
 Stable miRNAs have been detected in a 
number of bodily fluids, including blood and saliva.
64
 This is attractive for minimally 
invasive detection of cancer. miRNAs are vulnerable to RNase degradation in the 
extracellular environment.
65
 Blood has been shown to contain RNases
66
, so the presence 
of stable circulating miRNA suggests a protection mechanism for these miRNA. Some 
studies have shown that encapsulation with proteins or lipid membranes may act to 
shield miRNAs from degradation.
67,68
       
A study by Kerin et al.
69
 investigated miRNA biomarkers for the early detection of 
breast cancer. A panel of 7 miRNA were identified which were differentially expressed 
in the whole blood of patients with breast cancer compared to a health control. Two 
miRNA in particular, miR-195 and let-7a were found to be significantly higher on 
average, with a 19.25 fold increase for miR-195. Detection of an elevated level of 
miR-195 proved capable of predicting individuals with cancer at a rate of 100 % 
specificity and 85.5 % sensitivity.  
 
Figure 1.9: Difference in miR-195 expression in blood of breast cancer patients(right) 
compared to a health control (left), with line showing a concentration which achieves 
100% specificity and 85.5% sensitivity.
69
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Tewari et al.
70
 studied the expression of miRNAs in human plasma from patients with 
prostate cancer. A panel of four miRNA which are upregulated were identified,        
miR-141, miR-16, miR-24 and miR-19b. Significantly, detection of elevated miR-141 
could identify an individual with cancer at 60 % sensitivity and 100 % specificity. The 
concentration which corresponded to detection of cancer in this work was 
approximately 25 fM. 
 
Figure 1.10: Detection of mioR-141 in the serum of 25 healthy controls (left) and 25 
patients with metastatic prostate cancer (right) with line showing a concentration which 
achieves 100% specificity and 60%% sensitivity. 
70
 
 
While significant research is on-going to identify miRNA panels for the detection and 
prognosis of various cancer subtypes
60
, the ultra-low concentrations of the miRNA 
biomarkers involved require highly sensitive methods for effective detection. As 
illustrated in Figure 1.10, the concentrations of miRNA in blood are extremely low, in 
the attomolar range. The importance of multiplexed detection strategies is highlighted in 
these studies. For the early detection of cancer, widespread screening would be 
required, which can be facilitated by point of care detection. To achieve these goals, the 
detection strategy must be inexpensive, rapid and simple
71
 while it must also be 
compatible with multiplexed detection of multiple miRNAs, and achieve detection in 
the attomolar range. In the studies previously discussed, PCR was used for the 
determination of miRNA expression level. While PCR is highly sensitive and capable of 
multiplexed detection, the cost and time associated with a measurement make 
implementation of wide-scale screening difficult to implement.
12
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1.5  miRNA Detection 
1.5.1  Northern Blot Analysis  
The earliest attempts to quantify miRNAs were by northern blotting. This procedure 
starts with the extraction of RNA from the sample of interest. The miRNA are then 
separated on the basis of size using gel electrophoresis, and transferred to a nylon 
membrane by a capillary blotting system. The RNA can then be covalently attached to 
the membrane by a variety of methods. Traditionally, this was done by UV light or heat. 
A labelled nucleic acid probe is then added to the system, which hybridizes specifically 
to the miRNA of interest. The nylon sheet is then washed to remove the non-specifically 
bound probe, and the bound probe can be detected by X-ray film.
72
  
 
Figure 1.11: Basic procedure for carrying out a northern blot analysis. Adapted from: 
Developmental Biology, 2014, 10
th
 Edition 
73
  
 
This method was originally designed for use in mRNA detection, and so a number of 
alterations have been made to improve detection sensitivity.
74
 Cross linking by UV light 
or heat can cause damage to miRNA, and is thus generally unsuitable. Recently,   1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) has been used to crosslink 
miRNAs to the nylon membrane, and this has improved sensitivity by 25 to 50 fold. The 
nucleic acid probes traditionally used were DNA based, however for miRNA detection, 
this results in poor sensitivity and long hybridization times. The use of locked nucleic 
acids (LNA) results in significant improvement and using these improved methods, 
miRNA has been detected as low as 0.05 fmol.
75
 
Overall, this method benefits from simplicity and ease of use, however it does require 
significant time to setup, run and detect the miRNA of interest. It also requires a number 
of steps, from RNA purification to gel electrophoresis, EDC binding and addition of 
probe. 
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1.5.2  qRT-PCR 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is a method of 
miRNA detection based on the specific amplification of the miRNA of interest.
76
 PCR 
is a process which amplifies DNA in a highly specific manner.  The first step in qRT-
PCR is to synthesise “copy” DNA (cDNA) from the extracted RNA.  This is done using 
reverse transcriptase (RT)
77
. In a typical experiment, two different reverse transcriptions 
are carried out. Using random primers all of the RNA in a sample is reverse transcribed 
to cDNA, and this cDNA is used to amplify an endogenous control (housekeeping 
gene).
78
 The second type utilises microRNA-specific RT which, unlike the first RT, 
only reverse transcribes a single miRNA. This primer binds to the miRNA of interest 
and allows the reverse transcriptase enzyme to identify the miRNA and to generate 
cDNA.  This process is destructive, with the miRNA being disassembled as the DNA is 
assembled (Figure1.11).
79
  The resulting cDNA can be used in subsequent PCR 
reactions. 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Scheme for reverse transcription from RNA to cDNA in PCR. 
 
In real time PCR, results are obtained from an early phase of the PCR run. This early 
phase of amplification is known as the exponential phase and is very specific.
80
 A 
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nucleotide sequence called a TaqMan probe is used in addition to two primers, 
deoxynucleotides and a DNA polymerase enzyme.
81
 The probe is tagged with a 
florescent molecule, known as a Reporter, and an excited state acceptor molecule called 
a Quencher.
82
 When the DNA polymerase synthesising the new DNA reaches the 
annealed probe, it cleaves the probe. This increases the distance between the Quencher 
and the Reporter, allowing the fluorescent signal from the Reporter to increase. The 
increase in signal is proportional to the amplification of the target, see Figure 1.12.
83
 
 
Figure 1.13: Diagram showing generation of fluorescent signal during quantitative 
PCR. 
 
In each cycle, the amount of target miRNA is doubled.  After a certain number of 
cycles, the florescence will become intense enough to be detected and this cycle number 
is known as the Ct value.
84
 The more miRNA present in the original sample, the more 
quickly this will happen i.e. the lower the Ct value. Using this Ct value the relative 
quantification of a target miRNA can be calculated.  The endogenous control is used to 
normalise samples.
85
 qRT-PCR is capable of detecting a very low concentration of 
miRNA, in some cases a copy number of 10 or less.
11
 Unfortunately, PCR currently 
requires highly purified samples. This significantly increased the time for a detection, 
and requires highly skilled technicians.
12
  This makes PCR unsuitable for a point of care 
setting.  
Fluorescent Reporter 
Quencher 
DNA Polymerase 
Primer 
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1.5.3  Optical Detection Methods 
Optical detection of miRNA has the potential to be considerably faster than northern 
blotting or PCR, but can have issues with sensitivity.
86
 In a simple miRNA microarray, 
a strand of nucleic acid which is complimentary to the target of interest is covalently 
bound to a surface, this is commonly referred to as the “capture” strand.87 The extracted 
RNA, containing the miRNA target, is then labelled with a fluorescent label and 
exposed to the surface. The target miRNA binds to the capture strand, and the 
remaining RNA is rinsed from the surface. The miRNA concentration can then be 
determined using a fluorescence reader to measure the intensity.
88
  
 
Figure 1.14: Diagram of a nucleic acid microarray with labelled miRNA target. 
 
Biological Labelling 
Labelling of the miRNA can be done in a number of different ways. Direct labelling is 
the modification of the miRNA with a dye and has been widely applied in many 
settings.
89
 One such method is Guanine labelling, whereby the miRNA is modified at 
the N7 position of guanine moieties with a fluorophore. This has the advantage of 
allowing the attachment of multiple dyes to a single miRNA, which improves the signal 
intensity. However, it means that the sensitivity is directly determined by the Guanine 
content of miRNA, and this can vary greatly between different miRNA.
90
  
Capture Nucleic Acid 
Target miRNA                                labelled target 
label attached 
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Another direct labelling method uses T4 RNA ligase which couples to the 3’ terminal of 
miRNA to attach a dye molecule.
91
  It was discovered that this method is only suitable 
for RNA in the 18-25 nucleotide size range. Further investigation showed that this 
method requires the OH moiety present on the 3’ terminal of mature miRNA. This 
provides significant benefits, as labelling of other RNA in an extracted sample 
represents a considerable source of background signal. This specificity removes the 
need to separate the miRNA from other RNA present, improving detection time. One 
disadvantage of this method is that only a single dye is attached to each miRNA, which 
severely reduces the limit of detection. The sensitivity of this method has been shown to 
be superior to northern blotting, but considerably less effective that qRT-PCR.
92
 
Another method of direct labelling involves the use of Poly(A) polymerase (PAP) 
enzyme, which causes the addition of a polynucleotide tail, 20-50 nucleotides long, on 
the 3’ terminal. This poly(A) tail can then be modified using any NHS-ester dye. An 
advantage of this method is that multiple dye molecules can be attached to each 
miRNA, which improves sensitivity, and unlike guanine labelling, the sequence of 
miRNA being examined has been shown to have no impact on this labelling. The limit 
of detection for this method was determined as 0.14 fmol using miR-124.
93
 
Chemical labelling  
miRNA labelling using chemical methods allows for much more diversity than 
biological means. One such method involves the oxidation of the 3’ hydroxyl groups 
using sodium periodate to form a reactive di-aldehyde. This was then reacted with 
Biotin-X-hydrazide in a condensation reaction to yield biotinylated miRNA, which 
could then be precipitated using ethanol. A quantum dot was then attached to the biotin 
specifically using streptavidin. Quantum dots have very high quantum efficiency, and so 
maximise the detection sensitivity. This method also has the benefit of consistency 
between different miRNA. While this particular reaction yielded a modest limit of 
detection of 0.4 fM, this procedure allowed for the attachment of more sophisticated 
detection moieties.
94
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1.5.3.1  Indirect Labelling 
Direct labelling suffers from the need to modify the target miRNA before detection, 
which presents several challenges, such as different labelling efficiencies for different 
miRNAs, and increased background signal due to the presence of other miRNA which 
are labelled due to non-specific adsorption.
95
 Indirect detection can overcome many of 
these shortcomings. In an indirect microarray, a capture strand which is complimentary 
to approximately half the target is covalently attached to the surface, the target is then 
added, without the need for prior sample separation.
87
 The surface is rinsed to remove 
non-specifically bound RNA, and a second nucleic acid strand, complementary to the 
free portion of the target is introduced- a sandwich assay. This “probe” strand can be 
modified in advance with a wide variety of dyes, complexes and other detection 
moieties. This system allows for a much greater degree of control over the detection 
strategy, as the probe strand can be produced with a binding site such as an amine or 
thiol for easy modification.
88
 
 
 
Figure 1.15: Diagram of a nucleic acid microarray with labelled probe strand. 
 
One such system was created using Locked nucleic acids, which has the advantage of 
improved binding efficiency and improved differentiation from mismatched sequences. 
This is important when using shorter capture strands.
96
 The capture and probe strands 
were 10 -12 nucleoids in length, with five sets designed to target five different miRNA. 
The target miRNA were attached to a surface via a capture LNA strand, a biotin 
functionalised probe strand was then introduced, and Cy3 dye labelled streptavidin was 
added. Using this system, a limit of detection of 1 Amole or 10 fM was achieved. By 
adjusting the temperature during the capture and probe hybridisation, this system was 
also capable of discriminating a single mismatched base.
97
 
 
Capture Nucleic Acid 
Target added 
Labelled probe 
added 
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1.5.4  Electrochemical Detection 
Electrochemical detection of miRNA has a number of benefits over optical methods. 
The signal produced for a single electrochemical event can be significantly higher than 
optical methods can achieve, a light source is not required and the instrumentation is 
significantly more robust. A study by Marija et al used nanopores to sensitively detect 
miRNA in a solution. 
98
 In this research, a strand of RNA complimentary to the miRNA 
target was added to the solution to form a stable duplex. A protein, p19, which 
specifically binds only to double stranded RNA, was linked to a magnetic nanoparticle. 
This complex was added to the solution where it is bound to the target duplex, and 
could then be removed from the solution by the application of a magnetic field. This 
achieved a significant enrichment by a factor of 100,000-fold of the target duplex. The 
duplex was then separated from the p19 and detected using a nanopore. This nanopore 
is 3-nm in diameter and less than 10 nm thick. It is capable of detecting single 
molecules of miRNA by measuring ion conductance though the pore. As the Target 
miRNA duplex moves through the membrane, the flow of ions though the channel is 
reduced, which causes a decrease in the observed current. The transit time of the analyte 
though the pore is dependent on its nature, with DNA transiting in 20 µs, whereas RNA 
takes 50 µs. Discrimination is also possible by examining the current profile of the 
molecule, with RNA producing a greater current differential.  
 
Figure 1.16: Detection strategy for the detection of miRNA. Step (I), DNA 
complimentary to miRNA target added. (II)Enrichment of miRNA target using a protein, 
P19, which selectively binds to duplexed nucleic acid. Protein attached to a magnetic 
nanoparticle to allow for separation. (III) miRNA:probe duplex is released from 
protein. (IV) Detection of duplex by decrease in ion conductance when passing through 
nanopore.
98
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Overall, this method allows for the detection of a single molecule of miRNA, however 
its specificity is based solely on the attachment of the p19 protein, which detects all 
miRNA duplexes present in the solution. In addition, this pre-processing step is labour 
intensive, and greatly increases the detection time. This method is also unsuitable for 
multiplexed detection, as the discrimination at the point of detection is reasonably 
insensitive.
98
 
Some of the limitations of the nanopore approach have been solved by Gu et al.
99
 In this 
study, the target miRNA is identified using a polycationic peptide-peptide nucleic acid 
probe, which contains a region completely complimentary to the target. Peptide nucleic 
acids (PNA) are synthetic polymers which are similar to DNA and RNA. They have the 
benefit of higher binding affinity for the target, forming more stable PNA/miRNA 
duplexes. PNAs are also stable over a greater range of pH and temperature and are more 
resistant to breakdown by nucleases and proteases.
100
 
A membrane of similar size is used, which can detect the presence of duplexed miRNA, 
but not single stranded miRNA. A potential is applied across the membrane which 
attracts the positively charged PNA/Target duplex into the pore, while repulsing other 
negatively charged single stranded miRNA. As before, when the duplex enters the pore, 
the ions flowing through are blocked, causing a decrease in the current.  
 
 
Figure 1.17:  Detection of miRNA using a positivity charged PNA probe strand. After 
hybridisation to miRNA target, detection occurs by drop in current when duplex transits 
through nanopore. 
99
 
 
 23 
 
The limit of detection for the miRNA Let-7b was measured as 50 pM using this system, 
although data suggests that this might be improved with better data analysis techniques 
to remove non-specific signals. This method has a number of advantages over earlier 
approaches. The use of a PNA probe adds target sequence - dependent specificity to the 
capture probe, and improves the selectivity of the assay due to the high binding affinity 
of PNA for the perfectly matched target. The potential differential also ensures that only 
positively charged species will pass through the pore.  
Another method which has been shown to have excellent capabilities in detection is 
based on a neutralizer displacement. In this assay, a capture strand is bound to a nano-
structured microelectrode surface. A secondary strand, the neutralizer, which is partially 
complimentary to the capture, is manufactured with a PNA conjugate and cationic 
amino acids. When the target is introduced, it displaces the positively charged 
neutralizer. This binding event can then be detected in two ways, the neutralizer 
displacement causes a significant change in the charge at the capture strand, and the 
neutralizer is now free in solution to be detected.
101
 
 
Figure 1.18: detection of nucleic acid by displacement of a partially complementary, 
positively charged strand.
101
 
 
In this experiment, the primary detection was performed at the electrode surface by 
measuring the current associated with loss of the neutralizer strand. After the addition of 
the capture strand, the current was high, and this was reduced after the addition of the 
neutralizer. When the target DNA was added at 1 pM, the current increased by more 
than 300%. Further investigation established that, the limit of detection was 100 aM for 
a 20-mer DNA target. The ability of this system to detect RNA was also examined 
where it achieved good sensitivity. While miRNA was not directly detected in this 
study, the ability to detect short DNA sequences suggests that this method would be 
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suitable, although a slight decrease in the sensitivity would be expected due to the 
weaker binding efficiency of RNA. This could potentially be overcome however by 
using LNA based capture strands.  
 
An assay based on direct electrical detection has been developed by Fan et al.
102
 In this 
work, a capture strand was immobilised between a nano-gapped array. The array 
contained 150 -200 fingers, with each being 700 mn wide and 200 µm long. The capture 
strand was composed of PNA to improve binding efficiency and to reduce non-specific 
interactions. The target miRNA was added to the array, forming a duplex with the PNA 
capture. The duplex was then incubated at pH 4.0 with aniline, hydrogen peroxide and a 
protein, HPR. The acidic pH caused the aniline molecules to become protonated, and 
they were then attracted to the negatively charged miRNA/PNA duplex. This resulted in 
a local increase in acidity which promoted the polymerization of the aniline to form 
nanowires. The sample was then doped with HCl vapour to improve the conductivity of 
the aniline.  
 
Figure 1.19: Detection of miRNA by capturing with probe PNA in a nano-gapped array, 
followed by growth of a conductive polymer.
102
 
 
Using this method the limit of detection was determined as 5 fM. To check the 
selectivity of this method, a miRNA with single base mismatch to the target was 
examined, and showed only 5 % signal strength when compared to the target. One 
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major benefit of this system is its suitability for multiplexed analysis, as each finger can 
be labelled with a different miRNA capture, and the same procedure can then be applied 
to analyse multiple miRNA simultaneously. This method is highly complicated, 
requiring a number of steps to achieve detection, which limits the practicality of this 
system for point of care miRNA detection. 
Another platform technology based on the bridging of an electrode was developed by 
Swager et al.
103
 for the detection of DNA. In this work, a capture strand of DNA 
complimentary to 15 bases of the target nucleic acid was synthesised. This capture 
strand was then modified on each end with a carbon nanotube (CNT) by covalent 
attachment. These nanowires were then suspended in a non-conductive nanogap 
between two gold electrodes to form DNA-CNT network. When the DNA target was 
added, it hybridised to the capture DNA. A probe strand, modified with the enzyme 
horseradish peroxidase, was added which bound to the target DNA. This enzyme could 
then be stimulated to catalyse the reduction of a conductive silver layer, which bridged 
the non-conductive gap between the two CNTs. This caused a significant increase in the 
conductivity, which acted as the analytical signal.  
 
 
Figure 1.20: Conductivity-based DNA detection method utilizing capture DNA 
covalently attached to two SWCNT. After hybridisation with target DNA, a HRP 
labelled probe strand is added, which catalyses the reduction of silver to increase the 
conductivity between the SWCNT.
103
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The detection limit of this platform was approximately 10 fM for DNA. This method is 
suitable for miRNA detection, however a decrease in sensitivity would be expected if a 
DNA capture sequence was used due to the lower binding affinity for DNA/DNA 
hybrids compared to DNA/miRNA. This technology is not suited to a multiplexed assay 
presently, and the time required from sample input to measurement may make use of 
this device in a point of care system challenging.  
miRNA detection using a photoelectrochemical system was developed by Dai et al.
104
 
In this work, single walled carbon nanotubes (SWCNT) are combined with DNA 
modified with CdS Quantum Dots. The DNA is complimentary to the miRNA target, 
and remains attached to the SWCNTs based on π-π interactions. The mixture is 
deposited onto an electrode and light applied to the surface. The quantum dots then 
generate a measurable photocurrent. DNase I is then added, which breaks down the 
accessible DNA, while leaving the DNA bound to the SWCNTs unaffected. When the 
miRNA target is added, hybridisation to the DNA increases the separation between the 
DNA and SWCNTs, resulting in breakdown of the DNA by DNase I. This causes 
quantum dots to be released into solution, causing a measurable drop in the 
photocurrent at the electrode. 
Using this method, a limit of detection of 34 fM was achieved, with a linear detection 
range from 50 fM to 100 pM. This method benefits from simplicity of use, and has 
potential for use in a point of care setting, since the modified electrode surface can be 
produced in advance.  
 
Figure 1.21: Photoelectrochemical detection of miRNA based on displacement of QDs 
from a SWCNT modified electrode. An electrode is modified with SWCNT, and QD 
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labelled capture DNA is added, giving rise to a measurable photocurrent. DNase I 
breaks down accessable DNA. Addition of target causes hybridisation to capture DNA, 
resulting in DNase I degredation, loss of QD from surface, and a reduction in 
photocurrent.    
104
 
 
1.5.5  Live Cell miRNA Detection 
1.5.5.1  Genetic Modification 
Live cell imaging of miRNA allows for the visualisation and analysis of miRNA 
expression levels and alterations. This is important for disease detection and for the 
elucidation of intercellular processes by studying the dynamics of miRNA 
expression.
105
  
The first live-cell imaging of miRNAs was performed using green fluorescent protein 
(GFP). In a study by Naldini et al.,
106
 cells were transfected with GFP plasmids labelled 
with DNA complimentary to the miRNA of interest. In the presence of the target 
miRNA, binding to this DNA resulted in downregulation of GFP production. The level 
of the miRNA target could then be elucidated by the difference in intensity between cell 
lines with differential miRNA expression. This system was capable of detecting a 
number of endogenous miRNA. Significantly, when miR142-3p levels in hematopoietic 
and non-hematopoietic cell lines were examined, a greater than 100-fold deference in 
green FP expression was measured.  
A more advanced version of this method was developed by Inoue et al.
107
. In this work, 
miR-133, which is upregulated during myogenic differentiation, was examined in 
mouse embryos. Cells were transfected with genes for GFP and red fluorescent protein 
(RFP). As in the previous work, the GFP gene was modified with a capture DNA strand 
which caused down regulation of protein production upon hybridisation to the miRNA 
target, in this case miR-133. The RFP was unmodified, and so its expression was 
independent of mIR-133 concentration. The expression level of miR-133 could then be 
calculated based on the differential emission intensity between GFP and RFP. This 
system was capable of detecting the increase in miR-133 expression during 
differentiation towards muscle cells, see Figure 1.22. 
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Figure 1.22: Two colour measurement of miR-133. Downregulation of green 
fluorescent protein caused by miR-133. Red fluorescent protein acts as endogenous 
control.
107
  
 
While this method was somewhat successful for the detection of miRNA in live cells, it 
suffers from a number of issues. The poor penetration of the exciting light by tissue 
significantly reduces the signal to noise ratio.
108
 The autofluorescence of cells further 
obscures the available signal, resulting is significant background.
109
 This limits 
usefulness for this technique for monitoring miRNA for disease detection. 
Another approach which has been examined for the in vivo detection of miRNA is 
bioluminescence imaging. This involves the use of photo-active enzymes that emit light 
when a specific substrate is available, known as luciferases.
110
 Bioluminescence 
imaging benefits from a lack of background bioluminescence signal since no external 
excitation source is required.
111
 A wide range of luciferases are also available at a 
variety of different wavelengths, including Firefly luciferase (Fluc) which emits at 
560 nm
112
 and Gaussia luciferase (Gluc) with emission at 480 nm
113
. The higher 
wavelength Fluc is useful for imaging applications due to increased tissue penetration; 
however the Gluc produces a considerably stronger light emission.
114
  
In a study by Lee at al. 
115
, a Fluc plasmid was combined with a promoter for pre-miR-
23a, which caused an upregulation of Fluc upon pre-miR-23a binding. A second 
luciferase probe using a Gluc plasmid was modified with a capture strand for mature 
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miR-23a was also prepared. This probe causes downregulation of Gluc production upon 
miR-23a binding. This dual probe system was used to monitor premature and mature 
miR-23a in HeLa, 293 cells and P19 cells. Implantation of these cells into nude mice 
showed differences in miR-23a concentration in 239 and P19 cells, see Figure 1.23.  
 
Figure 1.23: Nude mice implanted with 239 and P19 cells transfected with Fluc, which 
is upregulated in the presence of pre-miR-23a, and Gluc, which is downregulated upon 
binding to mature miR-23a.
115
 
 
While the use of luciferases overcomes many of the issues with fluorescent proteins, 
including decreasing the background signal due to autofluorescence and improved 
tissue penetration for higher wavelength luciferases, a number of issues remain. The use 
of plasmids for the detection of miRNAs requires genetic modification of the host cells. 
This makes analysis of the results questionable, since genetic modification may cause 
changes in the endogenous miRNA concentration. Additionally, these systems rely on 
the synthesis of the reporter by the cell, meaning the results are strongly dependent on 
cellular metabolism. A decrease in the observed signal may be due to target miRNA 
binding, or as a result of apoptosis. These issues make implementation of these genetic 
techniques in a clinical setting problematic.    
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1.5.5.2  Molecular Beacons 
In a molecular beacon (MB) a strand of nucleic acid which is complementary to the 
miRNA target is produced. The strand has an additional 4 to 7 bases at one end, with 
self-complementarity to its opposite end.
116,117
 The nucleic acid is modified on one end 
with a dye and on the other with a quencher molecule. In the absence of the miRNA 
target, self-binding occurs, which brings the dye and quencher molecules into close 
proximity. This allows for transfer of the excited state via FRET. When the miRNA 
target is added, the MB opens up, due to the high affinity for the target. This separates 
the dye and quencher “switching on” emission. This system has the benefit of very low 
background signal in the absence of miRNA target, since ideally the dye should be 
completely quenched.
118
 This approach allows for a significant degree of control over 
the sensitivity and selectivity of the detection.  
 
Figure 1.24: Scheme of molecular beacon unwinding when bound to target nucleic acid 
119
 
Another benefit of MBs is the speed of detection. Since the probe is complimentary to 
the entire 22 – 25 bases of a miRNA, the binding affinity of the target to the molecular 
beacon is high, with chemical equilibrium being established in minutes.
120
 This is a 
significant advantage over the genetic methods previously discussed. 
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1.5.5.2.1  Design Considerations 
One issue with plasmid based monitoring of miRNA expression is the limited 
penetration of light into tissue. Dyes with longer emission wavelengths are capable of 
improving this penetration. MBs allow for the addition of a number of dyes, with the 
only limiting factor being the brightness of a dye and availability of a quencher with 
high efficiency FRET. The dabcyl quencher is widely used for quenching of fluorescent 
molecules due to its broad absorbance typically giving extensive spectral overlap.
121-123
 
This allows for quenching of a wide range of dyes such as 6-FAM (em. 520 nm), HEX 
(em.533 nm) and Cyanine 3 (em. 565 nm).
124
 Black hole quenchers (BHQ) are also 
available a range of absorptions, for example BHQ3 with maximum absorbance at 
672 nm
125
 allows for higher wavelength dyes such as Texas Red (em. 615 nm) and 
Cyanine 5 (em. 667 nm) to be integrated into a MB.
124
  
The length of the self- complimentary region (stem) of the molecular beacon allows for 
a significant degree of control over the sensitivity and selectivity of the beacon. If the 
stem is short, the MB will open more readily, which improves the sensitivity of 
detection, at the cost of selectivity. Alternatively, a longer stem sequence allows for 
greater discrimination from mismatched sequences, but lower sensitivity.
126,127
   
Another issue when MBs are used for live cell imaging is protection from nucleases. 
MBs constructed from DNA are vulnerable to degradation by DNases.
128
 This allows 
for an increase in the separation between the dye and quencher, resulting in a 
fluorescent response in the absence of the miRNA target. A number of strategies have 
been employed to protect MBs for these cellular nucleases. One example is Locked 
Nucleic Acids (LNA), whereby an RNA nucleotide is modified with an addition bridge 
between the 2’ oxygen and 4’ carbon.96 LNA has been shown to be resistant to 
nucleases, and has the additional advantage of improved binding affinity compared to 
DNA or RNA.  2’-O-methyl-RNA129 and Peptide nucleic acids130 are also available. 
Delivery of MBs through the cell membrane can be problematic due to the large size 
and negative charge, which limits passive diffusion.
30
 A number of methods have been 
developed to overcome this issue. Electroporation involves the application of an electric 
field to the cell membrane.
131
 This increases the permeability of the membrane by the 
formation of pores, which allow diffusion of the molecular beacon into the cell. This 
method is high efficient for the delivery of MBs but often has poor cell viability.
132
 
Lipofection is another method for the introduction of nucleic acids to cell. In this 
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approach, the molecular beacon is placed in a solution containing phospholipids, which 
spontaneously forms vesicles, encapsulating the MB.
133
 These vesicles then merge with 
the cell membrane, delivering the MB into the cell. This method is capable of high 
efficient transfection with excellent cellular viability but is generally unsuitable for in-
vivo detection.
134
  
The modification of MBs with Cell penetrating peptides (CPPs) has also been 
successful. These CPPs facilitate the uptake of the MB through the cell membrane.
135
 
This method has significant potential for the uptake of MBs without the need for 
additional reagents, and is potentially suitable for in vivo detection, however the exact 
mechanisms for this process are poorly understood at present.
136
  
One of the first attempts to quantify cellular miRNA using molecular beacons was 
performed by Kim et al.
137
  In this work, C2C12 cells were transfected with a MB 
containing 6-FAM and BHQ1 for the detection of miR-26a, and a second MB for 
miR-206 with Texas red and BHQ2. Skeletal muscle differentiation of the C2C12 cells 
showed steadily increasing cellular concentration of miR-026a and miR-206, see Figure 
1.25, with good agreement between PCR results and fluorescent intensity. Significantly, 
transfection of HeLa cells with synthetic miR-26a and miR-206 resulted in a 
corresponding increase in fluorescence from 0.01 to 0.1 nmol.   
 
 
Figure 1.25: Detection of miR-206 (Red) and miR-26a (Green) in differentiating C2C12 
cells over 6 days. Overlaid with nucleus staining (blue) with 4′,6-diamidino-2-
phenylindole.
137
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A study by Chen et al.
138
 investigated the concentration of miR-155 in lung cancer cells. 
In this work, a MB for miR-155 was prepared with Cyanine5 and BHQ3 in a 
combination of LNA and DNA. The MB was additionally functionalised with chitosan, 
which conferred a positive charge to the MB to improve permeability. In this 
experiment three lung cancer cell lines, with known high expression of miR-155, were 
examined. The cells were treated with either the MB with a commercially available lipid 
based transfection (siPORT) or the chitosan modified MB, see Figure 1.26. The 
chitosan modified MB showed higher fluorescence in each of the cell lines tested, 
which suggests improved uptake of the MB compared to the lipofection. Significantly, 
when cells were transfected with a randomised MB, no significant signal was received, 
which suggests good stability and selectivity for the beacon. Analysis for the relative 
fluorescence signal from each of the cell lines showed good agreement with qRT-PCR 
results. 
 
Figure 1.26: Detection of miR-155 in three lung cancer cell lines. Delivery of MB with 
chitosan (top) and lipid based transfection siPORT (bottom).
138
 
 
One issue in the determination of cellular miRNA concentration using MBs is 
transfection efficiency. As seen in Figure 1.26, the intensity measured is highly 
dependent on the intercellular concentration of the MB. For electroporation, pores form 
in the membrane, which can remain open for up to 9 minutes, so the concentration of 
MB in the cell should equilibrate with the solution. 
139
 However, for lipid based 
transfection or cell penetrating moieties, the transfection efficiency can be difficult to 
 34 
 
determine, making accurate miRNA measurement of concentration problematic. A 
recent study by Kim et al.
140
 seeks to address this issue using a dual colour molecular 
beacon. In this work a strand of DNA complimentary to miR-9 was produced, modified 
on one end with Cyanine3 and Cyanine5.5 on the opposite end. A second short 
sequence with partial complementarity modified with a black hole quencher was also 
produced. The two strands were combined in solution, causing binding of the shorter 
sequence, and subsequent quenching of the Cyanine3 by BHQ1. In the absence of the 
target miRNA, a signal is received for the Cyanine5.5, but not Cyanine3. When the 
target was added, the shorter strand was displaced, switching on fluorescence of 
Cyanine3. This allowed for the concentration of the molecular beacon during live cell 
imaging to be determined independently of the miR-9 concentration. 
 
 
 
Figure 1.27: Dual colour molecular beacon, showing (top) design of the MB, and 
(bottom) miR-9 concentration dependent fluorescence of Cyanine3, and miR-9 
concentration independent intensity of Cyanine5.5.
140
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Overall, molecular beacons are a highly efficient method for determination of 
intercellular miRNA concentration. The “switching on” of fluorescence upon target 
recognition provides a low background, allowing detection at considerably lower 
concentrations than genetic methods which rely on down regulation of fluorescence.  
Modified nucleic acids aid in resistance to cellular nucleases, and longer wavelength 
dyes have improved the overall performance by enhancing tissue penetration. 
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1.6  Scope of Thesis  
The objective of this work is to achieve the ultrasensitive detection of miRNA, without 
amplification, in solution phase and in live cells. For solution phase detection, a method 
which is compatible with the development of a point of care diagnostic device was a 
major objective. To address this issue, two different approaches were investigated for 
the amplification free detection of miRNA, i.e., electrocatalytic platinum nanoparticles, 
and a displacement assay. For the live cell imaging of miRNA, the primary goal was to 
examine the concentration and localisation of a miRNA associated within 
neuroblastoma cells. To achieve this goal, a molecular beacon for the detection of miR-
132 was designed and fully characterised.  
Following a review of the relevant literature in Chapter 1, Chapter 2 details the 
production of regioselective platinum nanoparticles which are used for the detection of 
short DNA strands. The current state of the art for the detection of DNA and miRNA is 
PCR, whereby the nucleic acid of interest is amplified up to detectable limit. While this 
method provides highly sensitive detection, with a limit of detection of approximately 
10 copies, the equipment and highly skilled personnel make this technology unsuitable 
for a point of care setting.  Amplification free electrocatalytic nucleic acid detection has 
the potential to achieve the detection of nucleic acids at clinically relevant 
concentrations (fM), while also providing rapid detection which is suitable for 
integration into a point of care device.  
In order to attach platinum nanoparticles to a detection assembly, the PtNPs must be 
modified. This modification is usually to the entire surface of the PtNP. This reduces 
the catalytic properties of these particles by reducing the surface area of platinum 
available for reaction. PtNPs that are functionalised with probe strand DNA only in 
particular regions, “regioselectively modified”, and have the potential to overcome this 
issue by allowing one side of the nanoparticles to attach to the detection assembly, and 
leaving another side clean for electrocatalysis.  
The next objective of this work was the development of a molecular beacon (MB) for 
the detection of miR-132 in live cells. The environmental conditions within live cells 
vary greatly, e.g., with respect to pH, polarity etc., and so the photophysical properties 
of the dye, 6-FAM, and the quencher, dabcyl, which were integrated into the MB were 
examined in Chapter 3. In Chapter 4, the ability of the MB for the detection of miR-132 
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in solution phase was examined. This allowed for the binding kinetics of the MB to be 
studied, which allows for better interpretation of results from live cells. The ability of 
the MB to detect the presence of miR-132 isolated from a cellular source was also 
examined.  
In Chapter 5, the MB was used for the detection miR-132 in live cells. As previously 
mentioned, negatively charged nucleic acids are incapable of diffusing through the cell 
membrane unassisted, and so methods for introducing the molecular beacon to the cells 
were examined.  The intensity of the MB emission within individual cells was then used 
to examine the localisation of miR-132 in live cells, and to determine the total  
concentration in the cell. By imaging a large number of cells, the distribution of miR-
132 concentration variation between individual cells was determined. The cellular 
concentration of miR-132 was also modulated using synthetic miRNA, and the impact 
on the observed intensity was examined. 
In Chapter 6, an in vitro assay for the detection of mIR-132 is described based on the 
displacement of microspheres modified with probe strand DNA that are initially bound 
to a sensor surface. The objective of this work was to produce an assay, fully 
compatible with a microfluidic based system, which would allow rapid and highly 
sensitive detection of miRNA. A microsphere was modified with a probe DNA strand, 
which was complimentary to 11 of 22 bases of a capture DNA strand. This capture 
strand was complimentary to the full 22 bases of the miR-132 target. Hybridisation of 
the capture and target allowed capture of the microspheres to a gold surface, which 
could be released upon the addition of the miR-132 target.  Conclusion and future 
recommendations arising from this thesis are given in Chapter 7. 
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2.1  Introduction 
Micro RNAs (miRNA) are a class of short nucleic acids which post-transcriptionally 
modify the expression of genes by downregulating the production of proteins.
1
 miRNA 
are essential in a wide variety of biological pathways.
2
 Cells which have become 
cancerous tend to have differential expression of miRNA when compared to health 
cells.
3
 This differential expression allows for the user of miRNA as a biomarker for 
cancer. Ideally, a biomarker should be capable of identifying a condition, provide 
information on the stage of the illness, be available via minimally invasive tests, and 
inform the treatment of the conditions.
4
 miRNAs have the potential to fulfil each of 
these requirements. 
Detection of short nucleic acid sequences is important in the diagnosis of a number of 
diseases, such as cancer
1-3
 and a number of infections
4-6
. Early detection has been linked 
to improved survival rates for a number of cancers
7-9
. While at present a number of 
highly sensitive methods exist for the detection of short nucleic acid strands, many of 
these methods are not currently suitable for a point of care setting. In order to achieve 
the full potential of short nucleic acids as biomarkers, wide scale screening is necessary. 
Currently, the state of the art detection strategy is polymerase chain reaction (PCR) 
which amplifies the nucleic acid target in the sample up to detectable limits.
9,10
 This 
method is highly sensitive and capable of measuring a very small initial concentration.
11
 
Unfortunately, PCR requires highly purified samples, which is time consuming and 
requires highly skilled technicians.
12
 These factors make PCR unsuitable for a point of 
care setting. Amplification free detection of nucleic acid sequences has the potential to 
provide rapid, reagent free detection, well suited to point of care measurement.  
Optical methods are available, which are considerably faster than PCR, however these 
methods tend to have issues with sensitivity.
86
 A simple optical detection methods is a 
sandwich assay, whereby a strand of capture DNA is immobilised to a surface. This 
strand is complimentary to half of the nucleic acid target. The capture strand binds to 
the target of interest. A second probe strand of DNA is then hybridised to the free end 
of the target.
87
 This probe strand can be modified with a number of detection strategies 
including dyes and quantum dots.  
Electrochemical detection of nucleic acids has a number of benefits over PCR or optical 
methods. A single electrochemical even can produce a significant signal. This allows for 
 51 
 
the direct detection of the nucleic acid of interest, without amplification. This has the 
potential to significantly improve detection times since pre-processing of the sample is 
reduced. The instrumentation used for electrochemical detection is also significantly 
more robust, and has been successfully into a number of point of care devices, for 
example blood glucose monitoring.
17
 
This work outlines a platform technology, which should be capable of detecting any 
short nucleic acid sequence with high sensitivity, not by increasing or amplifying the 
concentration of the target but by dramatically amplifying the current response 
associated with small numbers of binding events.  
The objective of this work was to develop a high sensitivity detection strategy based on 
using electrocatalytic platinum nanoparticles (PtNPs) as labels in a DNA sandwich 
assay so as to determine the concentration of a nucleic acid target in solution. PtNPs 
have a number of attractive properties for analytical devices including electrocatalysis 
which can allow for high sensitivity detection.
13
 Electrocatalysis of water or hydrogen 
peroxide is highly efficient, and has been integrated into a number of analytical 
devices.
14-16
  Platinum is also highly stable, with no oxidation in air, or reaction with 
water acids or bases.
17
 However, for efficient electrocatalysis, clean surfaces that are 
free of organic adsorbates are the most efficient.  Simultaneously satisfying the needs of 
molecular recognition and electrocatalytic detection is challenging but one productive 
strategy is to physically separate the two functions in different regions of each 
nanoparticle.
18,19
 Therefore, regio selective PtNPs were prepared, which separate the 
detection and attachment of the nanoparticle into two distinct regions.  
As illustrated in Figure 2.1, regio selective PtNPs were prepared by functionalising a 
polycrystalline gold (Au) surface with an alkane thiol monolayer.
20
 By controlling the 
concentration of the alkane thiol and the deposition time, imperfect monolayers can be 
formed in which the monolayers contain nanoscale defects. 
21
 Platinum was then 
electrodeposited into these defects to produce a mushroom shaped PtNP. The top 
surface of these PtNPs could then be functionalized with a thiol terminated DNA probe 
strand that is complementary to half of the DNA target. The PtNPs were then released 
into suspension by sonication, resulting in regio selective PtNPs, with the DNA attached 
to the top surface, and with the underlying surface clean for electrocatalytic detection.    
These PtNPs could then be used as part of a sandwich assay, whereby a capture strand 
of DNA complementary to half the DNA target was attached to a Au surface. The target 
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was allowed to hybridize to one end of the capture, and then the probe modified PtNP 
was hybridized to the free end of this capture. The presence of the PtNP could then be 
detected electrocatalytically and the number of bound particles depends on the target 
concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 53 
 
                 Electrode 1               Electrode 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Scheme for the production of regio selective PtNPs. Showing (A) deposition 
of defective alkane thiol, (B) electrodeposition of PtNPs, (C) modification of PtNPs with 
probe DNA, and (D) release of PtNPs into solution by sonication. Detection of target 
DNA by (I) modification with capture DNA, (II) hybridization with target DNA,(III) 
immersion into suspension of probe functionalised PtNPs and (IV) electrocatalytic 
detection.  
(A) 
(B) 
(C) 
(D) 
(I) 
(II) 
(III) 
(IV) 
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2.2  Experimental 
2.2.1  Materials 
Dodecanethiol was purchased from Sigma Aldrich. For DNA hybridization a buffer 
(1 M NaCl-TE) was prepared with 1.0 M NaCl, 10 mM Tris-HCl and 1 mM EDTA, and 
was adjusted to pH 7.0 with 1.0 M NaOH. 
DNA was purchased from Eurogentec at ≥98 % purity. The target chosen was for the 
detection of Staphylococcus aureus bacteria, which causes mastitis. The following 
sequences were ordered:  
Capture:  5’- CGG-CAG-TGT-TTA-TCA -3’ – SH 
Target:5’- TGA-TAA-ACA-CTG-CCG-TTT-GAA-GTC-TGT-TTA-GAA-GAA-
ACT-TA-3’ 
Probe:  SH-5’- TA-AGT-TTC-TTC-TAA-ACA-GAC- -3’  
 
2.2.2  SEM Imaging 
Scanning Electron Microscopy (SEM) was used to examine the surface morphology for 
the electrodeposition of PtNPs. Images were taken with a Hitachi S3000N scanning 
electron microscope with an accelerating voltage of 20 kV. Gold coated silicon wafer, 
99.999 % Au, 100 nm thick, was purchased from Sigma Aldrich and used for all 
images.  
 
2.2.3  Electrochemical Set-Up 
Measurements were performed using a CH Instruments Model 660. A three-electrode 
electrochemical cell was used for electrochemical measurements. The working electrode 
was a 2 mm radius planar Au disk, the reference electrode was silver/silver chloride 
(Ag/AgCl in 3 M KCl), and the counter electrode was a Pt wire. Solutions were 
deoxygenated before use with nitrogen. Experiments were carried out at room 
temperature (~20  °C). All glassware was cleaned in an acidic solution comprised of 
three parts H2O, one part HNO3. 
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The working electrode was mechanically polished before experimentation to produce a 
smooth surface. Polishing was carried out using 0.3 µm alumina on a felt pad for 
approximately 10 to 20 minutes in a figure of eight motion. After polishing, the 
electrode was rinsed with water and ethanol and sonicated for at least five minutes. The 
working electrodes were cycled in a 0.1 M solution of H2SO4 between -0.2 and +1.5 V 
at a scan rate of 100 mVs
-1
 to electrochemically clean the electrode and to calculate the 
surface area, see Figure 2.2. The reduction of the Au oxidation peak, at approximately 
+0.8 V, was used to calculate the surface area of the electrode surface using Equation 
2.2. The geometric area of the electrode is 0.0314 cm
2
 for a planar 2 mm radius using 
Equation 2.1. The surface roughness could then be calculated as shown in Equation 2.3. 
All electrodes required to be at surface roughness of 1.6 or below to ensure consistency 
between experiments and an Au surface which was free from defects and absorbates.  
Equation 2.1: Geometric Area 
 
Equation 2.2: Electrochemical Area 
 
                      
 
Equation 2.3: Roughness Factor 
    
 
Figure 2.2: Cyclic voltammogram of a 2 mm diameter Au disk electrode in 0.1 M H2SO4 
at a scan rate of 100 mVs
-1
. The reference electrode was Ag/AgCl in 3 M KCl. 
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2.2.4  Monolayer Deposition 
Gold disk electrodes were cleaned as previously described and immersed in a 1mM 
solution of dodecanethiol in ethanol for 1 to 12 hours. Electrodes were then rinsed with 
ethanol and dried under nitrogen. The monolayer deposition was monitored by CV in 
H2SO4 to calculate the available Au surface area.  
2.2.5  DNA Immobilisation 
After electrodeposition of PtNPs within the defects of the monolayers, the electrodes 
were immersed in a 10 µM solution of thiolated probe DNA in 1 M NaCl-TE buffer for 
2 hours. Electrodes were then rinsed in deionised water to remove loosely attached 
oligos. The functionalised PtNPs were then removed by sonication in 0.01 M H2SO4.  
Working electrodes were cleaned and polished as previously described and immersed in 
a 10 µM solution of thiolated capture strand DNA in 1 M NaCl-TE buffer for 2 hours. 
The electrodes were then rinsed with 1 M NaCl-TE buffer to remove loosely attached 
oligos.  
Capture DNA functionalised electrodes were then immersed in a solution of target DNA 
at concentrations between 1 aM and 1 µM in 1 M NaCl-TE buffer at 37 °C for 90 
minutes to hybridize. The electrodes were then rinsed with 1 M NaCl-TE buffer to 
remove loosely attached oligos.  
The electrodes, functionalised with capture DNA and target strands, were then 
immersed in the PtNPs functionalised with probe for 2 hours at 37 °C. The electrodes 
were then rinsed with 1 M NaCl-TE buffer. 
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2.3  Results and Discussion 
2.3.1  Monolayer Deposition  
A monolayer with nanoscale defects is required in order to electrodeposit and regio 
selectively modify PtNPs. These defect sites act as nucleation sites for the growth of 
Pt.
22,23
 When a Au surface is exposed to an alkane thiol, at first a highly disordered 
monolayer is formed.
24
 Over time, this monolayer becomes more ordered, eventually 
becoming defect free.
21
 The time for the monolayer to fully assemble depends on a 
number of factors, including the chain length of the alkane thiol
25
, the concentration in 
solution
26
 and the temperature of deposition
27
. Disorder in monolayers can take the form 
of missing rows
28
, vacancy islands of low density monolayer
29
, and defects where the 
monolayer is absent or disordered
30
.  At shorter deposition times, a monolayer is formed 
with some highly ordered areas, and other areas with missing rows, islands and defect 
sites. As the deposition time is increased, the order of the monolayer increases by filling 
these islands and missing rows, and by decreasing the size of defect sites. For the 
production of regioselective PtNPs, a monolayer where these islands and missing rows 
are filled, but where nanoscale defects remain was required. In this experiment a 1 mM 
solution of dodecanethiol in ethanol was examined for suitability.  
The area of the Au electrode can be determined using voltammetry in acid by measuring 
the charge associated with forming and then reducing the Au oxide. The microscopic 
area can be determined since reduction of an oxide monolayer
31
 corresponds to 390 µC 
cm
-2
 of charge passed. The surface roughness factor can then be calculated as the ratio 
of the microscopic area to the geometric area.
32
 The electrochemical area (EA) of the 
clean Au electrode was first calculated, working electrodes where then placed in the 
dodecanethiol solution for between 1 and 12 hours. The EA of the Au was then 
measured again. The results for this experiment are shown in Figure 2.3.  
After 1 hour in the monolayer solution 73.3±22.7 % of the Au EA was available. As the 
time of deposition is increased the surface area decreases and after 4 hours only 
12.7±4.6 % of the area was accessible. As the monolayer deposition time is further 
increased, the EA continues to decrease. At the 12 hour time point, the EA is 0.4±0.7 % 
of the initial Au area. These results suggest that from 1 to 4 hours the monolayer is 
highly disordered, with a large number of sizable defects and islands. From 4 to 9 hours 
the reduction in Au surface area is much lower, which is consistent with increasing 
 58 
 
order via the filling of missing rows, islands and reducing defect size. From 9 to 12 
hours the available surface area approaches 0, which suggest the monolayer is 
essentially defect free.  
 
 
Figure 2.3: Percentage of initial electrochemical surface area of Au for 2 mm Au 
electrodes after immersion in a 1 mM solution of dodecanethiol in ethanol between 1 
and 12 hours. Electrochemical area calculated by cyclic voltammetry in 0.1 M H2SO4 at 
a scan rate of 100 mVs
-1
. 3 repeats were performed for each experiment. The reference 
electrode was Ag/AgCl in 3 M KCl. 
0
20
40
60
80
100
0 2 4 6 8 10 12 14
%
 o
f 
In
it
ia
l A
u
 A
re
a
 
Deposition Time (Hours) 
 59 
 
 
Figure 2.4: Mass of Pt deposited onto 2mm gold electrodes after immersion in a 1 mM 
solution of dodecanethiol in ethanol between 1 and 12 hours. Applied potential of -
0.25V for 180 seconds in 1mM H2PtCl6 in 0.5M H2SO4. 
 
Figure 2.5: Mass of 2 mm Auplatinum deposited versus percentage of initial 
electrochemical surface area of gold for 2mm gold electrodes after immersion in a 1 
mM solution of dodecanethiol in ethanol between 1 and 12 hours. Applied potential of -
0.25 V for 180 seconds in 1 mM H2PtCl6 in 0.5 M H2SO4. The reference electrode was 
Ag/AgCl in 3 M KCl. 3 repeats were performed for each experiment. 
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To further probe the effect of the monolayer assembly time, Pt was electrodeposited 
onto each of the electrodes. The mass of Pt deposited was then calculated based on the 
charge passed during the deposition assuming that the electrodeposition process is 
100 % efficient. The results for this experiment are shown in Figure 2.4. As the surface 
area available decreases, the mass of Pt also decreases.  
The 1 hour monolayer shows significant Pt deposition of 65.6±6.0 µg. However after 4 
hours this drops significantly to 1.6±0.2 µg. This corresponds to the EA with 26.7 % 
coverage after 1 hour, increasing to 87.3 % coverage after 4 hours. As the monolayer 
deposition time is further increased, the mass of Pt deposited continues to drop. At 7 
hours the mass of Pt deposited is 0.9±1.0 µg, At deposition times of greater than 7 hours 
the mass of Pt drops further, reaching 0.5±4.2 µg at 12 hours. For the EA, after 7 hours, 
93 % of the surface was covered and this increased to 99.6 % at 12 hours. If the Pt was 
only deposited onto the Au surface, then a smaller mass of Pt deposited on the 12 hour 
monolayer would be expected. This data suggests that at 7 hours and above, the 
available Au area is quickly covered, with further deposition occurring onto the Pt. This 
is promising for the goal of producing PtNPs at the defect sites. 
Figure 2.5 shows a comparison of the Pt deposited versus the available EA. The mass of 
Pt decreases exponentially with decreasing available Au area. If the Pt was deposited 
only onto Au, a linear correlation would be expected. This exponential provides further 
evidence of the preferential deposition of Pt onto pre-existing Pt. When the monolayer 
is highly disordered, the available Au is quickly coated by a layer of Pt. As more Pt is 
deposited, the area available for deposition increases as the Pt grows in three 
dimensions. For highly ordered monolayers, only small defect sites are available. Even 
after 180 seconds, the mass of Pt deposited is very low, which provides a very small 
area for the further growth of Pt.   
Based on these results it was decided that 8 hours would provide an ordered monolayer 
with nanoscale defects. This should give an EA of 1.5±0.5x10
-3 
cm
2
 which corresponds 
to 96 % coverage of the Au surface. Figure 2.6 shows an SEM image before and after 
the deposition of an 8 hour monolayer. Before deposition the Au appears dark due to the 
high conductivity of the surface. After monolayer deposition the majority of the surface 
appears to be considerably lighter most likely due to charging by the electron beam due 
to the non-conducting monolayer. The majority of the surface appeared to be covered, 
with a number of darker defect sites also visible. This dark colour indicated that the 
monomer is highly disordered in these areas, which allows the surface charging to 
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dissipate. While a number of large defect sites are visible, with diameters within the 
0.17 to 0.3 µm range, a large number of smaller, nanoscale defects, should also be 
present. However, it is important to note that SEM is not an ideal technique for 
characterising defects in monolayers and provides limited insights. 
 
Figure 2.6: Scanning electron microscope image of Au wafer, (A) before, and (B) after, 
immersion in a 1 mM solution of dodecanethiol in ethanol for 8 hours.  
 
(A) 
(B) 
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Figure 2.7 shows CVs of each of the steps in the detection assembly. (A) shows a clean, 
unmodified 2mm Au electrode. It is characterised by an Au oxide peak at +0.87 V, with 
an Au surface area of 0.036 cm
2
 (surface roughness factor of 1.14). After the electrode 
is templated with dodecanethiol for 8 hours (B), the Au oxide peak is significantly 
reduced in size and corresponds to an area of 0.002 cm
2
. This is consistent with 
coverage of the Au surface with the alkanethiol monolayer, which blocks access to the 
underlying Au.
33
 The CV’s for Figure 2.7 (C) and (D) are discussed in sections 2.3.2 
and 2.3.3 respectively.  
Figure 2.8 shows voltammograms for the each of the steps in the production and release 
of the PtNPs. These have been recorded over a potential region where there are no 
faradaic reactions and the response is dominated by capacitance. The bare Au electrode 
initially shows a capacitance of 64.0 µFcm
-2
, which is consistent with a clean electrode 
that is free of organic adsorbates.
34
  Following monolayer deposition for 8 hours, the 
capacitance decreases to 5.5 µFcm
-2
 which is consistent with the formation of a low 
dielectric constant film.  The low absolute value is consistent with a close packed film 
perhaps with a small number of widely separated defects.  
Since a monolayer with appropriate defects had been identified, the next objective was 
to determine the optimal potential for the deposition of Pt into these defect sites. 
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Figure 2.7: Cyclic voltammograms in 0.1 M H2SO4 of: (A) 2 mm unmodified Au 
electrode, (B) after deposition of a defective C12 monolayer, (C) following 
electrodeposition of PtNPs into the monolayer defects (D) after the PtNPs have been 
desorbed via sonication. The reference electrode was Ag/AgCl in 3 M KCl. 
 
E / Volts 
10 µA  
(A) 
(B) 
(C) 
(D) 40 µA 
12 µA 
 64 
 
 
Figure 2.8: Cyclic voltammograms in 0.1 M H2SO4 of 2 mm unmodified Au electrode, 
after deposition of a defective C12 monolayer, following electrodeposition of PtNPs into 
the monolayer defects, and after the PtNPs have been desorbed via sonication. The 
reference electrode was Ag/AgCl in 3 M KCl. 
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2.3.2  Platinum Deposition Potential 
The next objective was to determine the optimum potential for the deposition of PtNPs 
into these defects. Figure 2.9 shows a CV of a clean Au electrode in 0.5 M H2SO4 and in 
1mM hydrogen hexachlorideplatinate (IV) hydrate (H2PtCl6) in 0.5 M H2SO4. The Pt 
solution is characterised by an increase in the oxidation current at +0.26 V, and a 
hydrogen production peak at -0.3 V. The reduction of Pt reaches a maximum at -0.25 V, 
with smaller current present until +0.1 V. Based on this CV it was decided to examine 
the voltammetric deposition of Pt from +0.2 V to -0.3 V. Electrodes were prepared with 
an 8 hour dodecanethiol monolayer and immersed in a 1 mM H2PtCl6 in 0.5 M H2SO4. 
A fixed potential was then applied for 180 seconds.  
A typical current-time transient is shown in Figure 2.10. The current-time transient was 
then integrated to calculate the total charge passed. This charge was then used to 
calculate the mass of Pt deposited using Equation 2.4. This current-time transient shows 
a sharp rise in the charge passed initially, for approximately 30 seconds. This is 
consistent with rapid nucleation due to the large over potential at an applied potential of 
-0.25 V. The rate of increase of the charge then decreases, suggesting that at this point 
the electrodeposition is characterised by radial diffusion towards this particle.
35
 
 
                
Equation 2.4 Mass of Pt deposited 
                
 
Where F is faradays constant (96485 Cmol
-1
), Q is the total charge, MW is the 
molecular weight of Pt (195.09 gmol
-1
) and n is the number of electrons (4).  
As expected from the voltammetry, -0.25 V gave the largest quantity of Pt deposited, 
see Figure 2.11, at 6.14±0.48 µg, which corresponds to 4.01±0.31 mgcm
-2
 based on the 
area available after the deposition of an 8 hour monolayer.  More negative potentials 
also resulted in a large amount of deposited Pt, with -0.3 V giving 5.71±0.90 µg and      
-0.35 V depositing 4.22±0.30 µg. While a more negative current should result in a 
larger volume of Pt deposited, vigorous hydrogen evolution at these potentials most 
likely impairs the growth of the PtNPs. At potentials more positive than -0.25 V the 
amount of Pt deposited dropped sharply, with only 0.91±0.31 µg deposited at -0.2 V, 
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which corresponds to 0.59±0.21 mgcm
-2
, and 0.32±0.08 mgcm
-2
 at a potential of 0.0 V. 
This decrease is consistent with an exponential decrease in driving force as the potential 
is increased  
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Figure 2.9: Cyclic voltammogram from -0.3 V to 1.6 V of a 2 mm Au electrode in 1 mM 
H2PtCl6 in 0.5 M H2SO4. The reference electrode was Ag/AgCl in 3 M KCl. 
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Figure 2.10: Current-time transient for growth of PtNPs in monolayer defects on a 
2 mm Au electrode prepared in a 1 mM solution of dodecanethiol in ethanol for 8 hours. 
The applied potential was -0.25 V. The solution contains 1 mM H2PtCl6 dissolved in 
0.5 M H2SO4. Inset showing integrated curve of charge passed vs. time. The reference 
electrode was Ag/AgCl in 3 M KCl. 
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Figure 2.11: Mass of Pt deposited onto 2 mm Au electrodes after immersion in a 1 mM 
solution of dodecanethiol in ethanol for 8 hours. Applied potential between +0.2 V and 
-0.35 V for 180 seconds in 1 mM H2PtCl6 in 0.5 M H2SO4. 3 repeats were performed for 
each experiment. The reference electrode was Ag/AgCl in 3 M KCl. 
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Figure 2.12 shows SEM images following deposition at potentials from +0.2 V 
to -0.3 V. At each of the potentials, a number of PtNPs are visible with good dispersion 
throughout the area imaged. The average size of the PtNPs is shown in Figure 2.13, 
with the surface coverage in Table 2.1. 
At 0.2 V PtNPs with a diameter of 119±26 nm are formed with high surface coverage, 
25±9 %. The growth of these particles is consistent with rapid nucleation of the surface, 
followed by diffusion controlled growth. This gives rise to a large number of evenly 
sized PtNPs. 
As the applied potential becomes more negative at 0.1 V, the size of the particles 
increases to 246±71 nm, however the surface coverage also drops significantly to 
12.2±7.0 %. Consistent with the increased driving force, these results suggest that 
PtNPs rapidly nucleate, grow and coalesce giving rise to fewer, larger particles.   
At a potential of 0.0 V, the particle size is 128±76 nm, and the surface coverage is 
12.7±2.8 %. The smaller particle size and higher standard deviation is unexpected since 
the higher driving force would be expected to yield larger particles while instantaneous 
nucleation ought to lead to more uniform particles.  This behaviour most likely arises 
due to the ability of the PtNPs to catalyse water reduction in this acidic electrolyte. 
Specifically, gas evolution is likely to slow the nanoparticle growth due to competition 
between water reduction and nanoparticle growth as well as non-diffusional mass 
transport.  The increase in the standard deviation is consistent with this process since 
smaller PtNPs tend to be more catalytic than larger ones, i.e., the influence of water 
reduction on the growth rate depends on the absolute size of the particles leading to a 
greater standard deviation.  
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At -0.1 V the particles’ diameter is 179±77 nm. The surface coverage increases 
significantly to 30.1±6.4 %, the highest value for the whole potential range investigated. 
The larger particle size suggests that the larger driving force for electrodeposition exerts 
a greater influence than gas evolution on the final particle size. The relative standard 
deviation for these particles is quite high at approximately 43 %. The mass of Pt was 
higher again at this potential at 0.74±0.07 µg.  
From a potential of -0.20 V to -0.35 V the coverage is in the range of 12±0.6 % to 
6.9±2.8 %. However, the charge passed was significant and would correspond to 
6.14±0.48 µg at -0.25 V and 5.71±0.9 µg at -0.30 V if the coulometric efficiency was 
100 %. Analysis of the particle size for this potential range shows large variation, with    
-0.2 V showing small particles at 94±47 nm, whereas -0.25 V is at 641±473 nm, -0.30 V 
at 422±378.12 nm and -0.35 V at 1.5±1.3 nm. Under these conditions, the PtNPs 
efficiently reduce water causing bubble formation and a very large relative standard 
deviation for the diameter of the particles. 
As previously discussed, the rate of nanoparticle nucleation and growth depends on the 
applied potential and on transport of the Pt ions towards the growing PtNPs. If the 
applied overpotential is sufficiently negative and the solution is quiescent, once a 
nucleation site is formed, the growth and eventual size of the particles depends on the 
diffusion rate through the solution. However, at these more negative potentials, the 
PtNPs formed are highly efficient at the reduction of water to produce hydrogen. This 
hydrogen evolution acts to mix the solution, which ought to lead to a greater Pt
2+
 flux 
than is possible from diffusion alone giving rise to large PtNPs particles. However, gas 
evolution can also mechanically dislodge the PtNPs especially where their radius is 
small since these are the most catalytically active but have the smallest area of contact 
with the electrode and leads to a very low surface coverages of less than 7 %. This 
suggests that the majority of the PtNPs formed were removed from the surface. This 
explains the very small PtNPs at -0.35 V at 13±9 nm, the Pt detected by SEM is likely 
the “tails” of the PtNPs left behind on the surface after removal of the primary NP. 
For -0.3 V and -0.25 V the large relative standard deviation in the size suggests the loss 
of a large number of PtNPs also, with some very large particles remaining, but the 
majority being lost from the surface.  
Based on these results it was decided that a potential of +0.1 V would be the most 
suitable. The particles produced, are large at 246±71 nm, with reasonably consistent 
size and a good surface coverage of 12±2.8 %. 
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Figure 2.7(C) shows a CV of PtNPs which were deposited into the monolayer with an 
applied potential of +0.1 V. After deposition of the monolayer, the available Au area is 
significantly reduced by 95 % to an area of 0.002 cm
2
. When Pt is electrodeposited, the 
Au oxide peak becomes undetectable, suggesting coverage of the defect sites in the 
monolayer with Pt. A Pt oxide peak also becomes visible at +0.38 V, with an 
electrochemical surface area of 0.132 cm
2
. This large EA for Pt is consistent with the 
growth of PtNPs in the monolayer defect sites.
36
 The CV also shows hydrogen 
adsorption/desorption and hydrogen evolution at -0.3 V.   
After the deposition of Pt into the defective monolayer, the EA of Pt was calculated 
from the Pt oxide reduction peak as 0.132 cm
2
. Using the SEM images shown in Figure 
2.14, and assuming that all of the PtNPs are hemispheres, the total area would be 
0.024 cm
2
. This shows that the actual area of Pt is approximately 20 % of that 
calculated by CV. This result may suggest that the particles may have a rough surface 
but given the assumptions made and the likely errors involved in estimating the 
quantities involved, this level of agreement is acceptable. To achieve an accurate 
measurement of the mass of platinum, methods such as inductively coupled plasma 
mass spectroscopy (ICP-MS) or atomic force microscopy (AFM) would yield 
considerably more accurate results. 
Voltammograms which were recorded over a potential range where the response is 
dominated by capacitance are shown in Figure 2.8. After the deposition of an 8 hour 
monolayer onto the working electrode the capacitance was 5.5 µFcm
-2
, based on the EA 
of a bare electrode of 0.036 cm
2
. When Pt was electrodeposited at +0.1 V the 
capacitance increased significantly to 221.6µFcm
-2
. This suggests the growth of a large 
number of PtNPs on the surface of the electrode. This value is larger than the 
64.0 µFcm
-2
 capacitance received for the clean Au electrode, and is consistent with the 
increase in electrochemical surface area seen in Figure 2.7. 
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Figure 2.12: Scanning electron microscopy of Pt deposited onto an Au wafer after 
immersion in a 1 mM solution of dodecanethiol in ethanol for 8 hours. Applied potential 
between +0.2 V and -0.35 V (A to I) for 180 seconds in 1 mM H2PtCl6 in 0.5 M H2SO4. 
The reference electrode was Ag/AgCl in 3 M KCl. 
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Figure 2.13: Average nanoparticle diameter from scanning electron microscopy of Pt 
deposited onto Au wafer after immersion in a 1 mM solution of dodecanethiol in ethanol 
for 8 hours. Number of particles measured between 41 and 814. Applied potential 
between +0.2 V and -0.35 V for 180 seconds in 1 mM H2PtCl6 in 0.5 M H2SO4. 3 
repeats were performed for each experiment. The reference electrode was Ag/AgCl in 
3 M KCl. 
 
Table 2.1: Summary of results for nanoparticle diameter and surface coverage from 
SEM and mass of Pt deposited from charge passed during deposition. 3 repeats were 
performed for each experiment. 
Potential (V) Pt Deposited (µg) Diameter (nm)  % Surface Coverage 
0.20 0.12±0.15 119±26 25.8±8.9 
0.10 0.14±0.33 246±71 12.2±7.0 
0.00 0.49±0.12 128±76 12.7±2.8 
-0.10 0.74±0.07 179±77 30.1±6.4 
-0.20 0.91±0.32 94±47 1.2±0.6 
-0.25 6.14±0.48 641±473 6.9±2.8 
-0.30 5.71±0.90 422±378 1.2±0.6 
-0.35 4.22±0.30 13±9 1.5±1.3 
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2.3.3  Nanoparticle Desorption 
The next objective was to desorb the PtNPs from the electrode surface while preserving 
the functionality of the adsorbed probe strand DNA. Sonication is frequently used to 
break up aggregates
37
, mix nanomaterials
38
, and other solution phase processing of 
PtNPs
39-42
. It has also been shown to effectively remove nanosphere masks and surface 
confined PtNPs 
43,44
. For these reasons, sonication represented an attractive method for 
the release of the electrodeposited PtNPs.   
As seen in Figure 2.14, after electrodeposition a large number of PtNPs were visible on 
the surface of the electrode. (B) shows the electrode after 1 hour of sonication in 0.01 M 
H2SO4. The majority of the PtNPs have been removed from the surface, with only traces 
of Pt visible. It is believed that these traces occur as a result of PtNPs that fail to fully 
desorb from the surface. This image suggests that sonication is highly efficient at 
removal of the PtNPs.  
The PtNPs which were removed by sonication were then drop cast onto an Au wafer 
and imaged by SEM, see Figure 2.14 (C). In order to minimise dying induced 
aggregation effects, the nanoparticle suspension is sufficiently dilute so that a fully 
dispersed nanoparticle array can be obtained.  Significantly, the particles are well 
separated with no major clustering visible. The size of the PtNPs is 80±12 nm, 
compared to 123±35 nm before sonication, this decrease in the apparent size may be 
due to preferential settling of larger PtNPs causing smaller particles pre-concentrate in 
the desorbed suspension and the standard deviation decreases to 14.6 % compared to 
28.7 % before sonication. 
The CV of the working electrode after sonication is shown in Figure 2.7(D). The large 
Pt peak at +0.38 V present after the deposition of Pt is significantly reduced from 
0.132 cm
2
 to 0.004 cm
2
.This suggests that the majority of the PtNPs have been 
successfully removed from the surface. A Au oxide peak is also visible at +0.87 V with 
a surface area of 0.003 cm
2
. This is a somewhat higher available area than after the 
deposition of the monolayer of 0.002 cm
2
, which suggests that the sonication procedure 
may remove a small amount of the monolayer in addition to the PtNPs.  
Figure 2.8 shows voltammograms where the response is dominated by the interfacial 
capacitance. Based on the EA of the bare Au electrode, after electrodeposition of Pt the 
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capacitance was 221.6 µFcm
-2
.  When the particles are removed by sonication, the 
capacitance decreased to 23.7 µFcm
-2
. This value is significantly higher than the 
monolayer only value of 5.5 µFcm
-2
, which provides further evidence of the loss of 
some monolayer coverage for this step. 
Since PtNPs that were suitable for DNA detection had been successfully produced, the 
next objective was to measure the ability of the assay to determine the concentration of 
DNA in solution, i.e., to confirm that the particles retained their molecular recognition 
functionality. 
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Figure 2.14: SEM images of (A) PtNPs electrodeposited onto an Au wafer after 
immersion in a 1 mM solution of dodecanethiol in ethanol for 8 hours using applied 
potential of +0.1 V for 180 seconds in 1 mM H2PtCl6 in 0.5 M H2SO4. (B) after the 
PtNPs have been desorbed via sonication.  (C) desorbed PtNPs drop cast film onto Au 
wafer. The reference electrode was Ag/AgCl in 3 M KCl. 
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2.3.4  DNA Detection 
The detection of DNA relies on the attachment of a thiolated capture strand to a clean 
Au electrode.
45
 This capture strand then selectively hybridises with a section of the 
target and finally the probe strand labelled electrocatalytic PtNPs hybridise with the 
remaining section of the target in a sandwich assay format.  The surface density of the 
capture strands on the electrode
46
 and the surface area of the Au have a significant 
impact on the number of target binding sites available on the surface
47
. In order to 
maintain a consistent number of attached particles, the surface roughness was monitored 
by CV, and the deposition time of 2 hours was rigorously maintained.  
After the electrode was modified with the capture surface, it was then immersed in a 
solution containing the target nucleic acid sequence. DNA hybridization is both highly 
temperature and time dependent. As the temperature approaches the melting 
temperature of the DNA/DNA duplex, the binding rate increases
20
 but at the melting 
temperature, 50 % of the duplex will spontaneously disassociate.
48
 The melting 
temperature of the target / capture hybrid was calculated as 39.2 °C.
49,50
 A temperature 
of 37 °C was chosen as this allows for rapid hybridisation, and good discrimination 
against mismatched DNA.  
Following hybridisation of the capture and target, the electrode was then immersed in a 
suspension of the PtNPs functionalised on one side with the probe strand. While it is 
difficult to determine the concentration of the PtNPs, it is sufficiently high so that all 
targets captured on the electrode can be labelled. The hybridization was carried out at 
37 °C for 3 hours. The fully assembled detection assay was measured by CV. Figure 
2.15 shows the CV obtained for a clean Au electrode functionalised with capture strand 
DNA, bound to target DNA, and then to the nanoparticle via the probe strand. Well-
defined peaks are visible in the -0.05 V to -0.3 V range for hydrogen 
adsorption/desorption. This provides clear evidence for the expected DNA detection 
assembly. Control experiments, where the nanoparticle was not functionalised with the 
probe, or where no capture were present showed no hydrogen adsorption/desorption 
which suggests this signal is not due to non-specific absorption of the PtNPs onto the 
Au surface. Voltammetry of the assembly surface was expected to be a destructive 
process, and so electrodes used for these CV’s were not used in the detection of DNA.  
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Figure 2.15: Cyclic voltammogram of a 2 mm radius Au disc electrode after 
modification with capture strand DNA and hybridization with the target and 
nanoparticle labelled probe sequence where the target strand concentration is 1 μM.  
The supporting electrolyte is 0.01 M H2SO4 and the scan rate is 100 mV s
−1
. The 
reference electrode was Ag/AgCl in 3 M KCl. 
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2.3.5  Detection of DNA by Hydrogen Peroxide Electrocatalysis 
PtNPs have previously been shown to catalyse the reduction of hydrogen peroxide.
14,51
 
To analyse the ability of the sensor to detect the DNA target, electrodes were modified 
with capture DNA, and then immersed in a target containing solution between 1 µM and 
1 am. The capture/target duplex was then hybridised with probe functionalised PtNPs. 
The completed sensor was then placed in a 0.01 M H2SO4 solution, and a fixed potential 
of -0.25 V was applied. The current was measured for 10 minutes to allow the system to 
equilibrate. Hydrogen peroxide was then added to give a final concentration of 200 µM. 
The difference in current before and after the addition of hydrogen peroxide, Δi, was 
taken as the analytical signal. A representative example is shown in Figure 2.16. The 
large increase in the measured current is after the addition of hydrogen peroxide.  
 
Figure 2.16: Current-time response for the detection of 10 nM target DNA in 0.01 M 
H2SO4. H2O2 added at 10 minutes to give a concentration of 200 µM. The applied 
potential was -0.25 V. The reference electrode was Ag/AgCl in 3 M KCl. 
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Figure 2.17 shows the dependence of i as the target concentration is systematically 
varied from 1 aM to 1 µM.  The change in current is proportional to the log 
concentration of DNA, and an acceptable linear response was achieved from 10 pM to 
1 µM.  
Ideally, the addition of hydrogen peroxide would be unnecessary, since PtNPs are 
capable of reducing water. This would allow for the use of a reagent free detection 
strategy since water in the sample, e.g., blood, could be used to generate the current 
response. Analysis of the signal received before addition of peroxide resulted in a 
correlation between concentration of the DNA target and the signal received, however 
the variability was significant As previously discussed, when working electrodes are 
cleaned, a surface roughness in the range of 1 to 1.3 is desired. Gold is also capable of 
the reduction of hydrogen peroxide
52
, and of oxygen in solution
53
. 
If electrodes with such large variation in the available surface area were used, then this 
would result in a significantly higher level of error for a given detection. However, in 
this experiment, the change in current after the addition of hydrogen peroxide was used 
as the analytical signal, which had the added benefit of controlling for differences in the 
Au surface area available, since the magnitude of the current before peroxide addition is 
not used directly. One possible approach that could be applied here, would be to block 
the Au surface with a closely packed monolayer after modification with capture DNA 
and target DNA hybridization. This may reduce the background signal, making single 
point detection with water feasible.  
As a control experiment, PtNPs were uniformly functionalised with capture DNA, and 
the assay was performed again. The response for these particles is shown in Figure 2.17. 
A good linear response is again observed from 10 pM to 1 µM, however the sensitivity 
is significantly lower at 4.9 x 10
-2 
µA
-1
. This poorer sensitivity is thought to arise from 
the lower electrocatalytic properties of the particles, since peroxide must pass through 
the DNA monolayer before reaching the Pt surface and being reduced. This difference is 
sensitivity suggests that the regioselective particles were successfully produced, i.e. part 
of the nanoparticle is unmodified, which improves the catalytic properties of the 
particle, giving rise to a higher current.  
As an additional control experiment, the assay was performed in the absence of Pt, 
using an unlabelled probe strand. The signal for this control was less than 2 % of that 
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observed in the presence of PtNPs. Based on a signal to noise ratio of 3:1, the limit of 
detection (LOD) for this assay is approximately 0.1 aM. 
Figure 2.17: Calibration plots for the electrochemical detection of Staph. aureus 
mastitis DNA on a 2 mm diameter bare electrode following hybridization with probe 
DNA immobilized regio selectively on PtNPs (♦) and where the probe is unlabelled 
(▲).  A control experiment showing the response of the electrode with uniform PtNPs 
functionalized with a homogenous full DNA monolayer is also illustrated (■)3 repeats 
were performed for each experiment. The reference electrode was Ag/AgCl in 3 M KCl. 
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2.4  Conclusions 
The objective of this chapter was the detection of short nucleic acids, suitable for a point 
of care setting. To achieve this, regio selectively modified PtNPs were produced and 
used in the subsequent detection of DNA at low concentrations. PtNPs were produced 
by the electrodeposition of Pt into defects within an alkanethiol monolayer. For the 
growth of nanoparticles, a monolayer with nanoscale defects was required. A range of 
monolayer deposition times from 1 to 12 hours was examined using a solution 1mM 
dodecanethiol. From 1 to 4 hours a highly defective monolayer was formed, as the 
deposition time was further increased, the available surface are decreased in a manner 
consistent with increasing order of the monolayer. After 7 hours, the available surface 
are approached zero. By depositing platinum into defects from 1 to 12 hours it was 
found that an 8 hour monolayer deposition time with in ethanol gave a monolayer with 
nanoscale defects that acted as a suitable template. 
The optimal deposition potential for the PtNPs was also investigated. Based on the CV 
of the Pt solution, the potential used during the electrodeposition step was varied 
between +0.2 V and -0.35 V. At lower potentials, a large amount of platinum was 
deposited onto the electrode, however SEM images shoed that the vast majority of the 
platinum was lost from the surface due to hydrogen gas production which mechanically 
removed the PtNPs. At higher potentials, the reduced driving force allowed for 
controlled growth of nanoparticles. A deposition potential of +0.1 V was chosen as 
optimal based on the particle size, monodispersity and yield.  The diameter of these 
particles was 246±71 nm. 
Removal of the particles from the working electrode was then investigated. Sonication 
was investigated based on previous reports of nanoparticles processing and nanoscale 
mixing using this technique. SEM images of the Au electrode after sonication showed 
that the vast majority of the PtNPs were successfully removed. Images of the drop cast, 
desorbed particles showed the particles were still intact, however the size dropped to 
79±12 nm suggesting that some preferential enrichment of the smaller particles 
occurred. This is believed to be due to preferential settling of larger PtNPs in solution, 
which decreases the average size of the available PtNPs. 
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After the successful production and release of the PtNPs, the detection of DNA was 
examined. PtNPs were modified with probe DNA with complimentarily to one end of 
the DNA target and released into solution. A clean Au electrode was modified with 
capture DNA complimentary to the opposing end of the DNA target. This capture DNA 
strand was then hybridized with the DNA target at 37 ºC, and immersed in the PtNP 
solution. After hybridization of the probe to the target DNA, the presence of Pt was 
confirmed by CV in dilute sulphuric acid. A distinctive Pt oxidation was apparent at 
+0.3 V, with peaks in the -0.05 V to -0.3 V range for hydrogen adsorption/desorption. 
This cyclic voltammetry was believed to be destructive, so electrodes used for CV were 
not subsequently used for the detection of DNA.   
Detection of target DNA was then performed by application of a fixed potential of          
-0.25 V in H2SO4. The system was allowed to equilibrate, and then H2O2 was added to 
give a concentration of 200 µM. The difference in current before and after the addition 
of hydrogen peroxide was taken as the analytical signal. Detection was possible at as 
low as 1 aM, with a linear response from 10 pM to 1 µM. Based on a signal to noise 
ratio of 3:1, the LOD for this assay is 0.1 aM. This extremely low concentration 
highlights the sensitivity of this approach.  
To analyse whether the regio selective PtNPs were more effective that uniformly 
decorated PtNPs, a second calibration was carried out. The sensitivity of the regio 
selective PtNPs was significantly higher with 8.8 x 10
-2
 µA
-1
, compared with 4.9 x 10
-2
 
µA
-1
 for uniformly decorated particles. This provides good evidence for the successful 
production of regioselective PtNPs, where one area of the particles is clean, allows for 
efficient electrocatalysis. 
This work contained in the chapter has been published in Electrochimica Acta, and has 
been included at the end of this thesis.  
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CHAPTER 3 
Photophysical Characterisation of 6-FAM and 
Dabcyl for Detection of miR-132 Using a 
Molecular Beacon 
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3.1  Introduction 
Live cell imaging of miRNAs allows for the analysis and visualisation of miRNA 
expression levels within cells. This can potentially aid in the identification of cancerous 
cells, and provide information on the specific cancer subtype. This type of analysis is 
particularly important as it can provide rapid results with very small volumes of cells, 
which minimises the impact to the patient.  
Molecular beacons (MB) are a method of examining cellular miRNA concentration 
based on the strong recognition of complimentary nucleic acids.
1,2
 In a MB, a strand of 
nucleic acid complimentary to the target of interest is produced. This strand is produced 
with a four to six base overhang with complementarity to bases on the opposing end of 
the strand. The strand is also modified with a dye molecule and a quencher. When the 
target is absent, self-binding of the MB occurs. This brings the dye and quencher 
molecules into close proximity. Forster resonance energy transfer (FRET) then allows 
transfer of the excited state from the dye to the quencher which “switches off” emission 
of the dye. This method benefits low background, since the dye should be non-emissive 
in the absence of the target. By varying the length of the self-complimentary region of 
the MB, the sensitivity and selectivity can be adjusted.
3
   
In order to accurately determine the localisation and concentration of miRNA in live 
cells, the environmental impacts on the dye and quencher molecules must be fully 
characterised. Within a live cell, the pH can vary greatly. With the intercellular fluid of 
the cell is generally in the region of pH 7.2, some areas of the cell can be significantly 
different. Lysosomes can have a pH as low as 4.7
4
, whereas the mitochondria are pH 
8.0
5
.  
As illustrated in Figure 3.1, the main objective of this work was to determine the extent 
of localisation and concentration of miR-132 in live cells. To achieve this goal a MB 
was constructed using 6-carboxyfluorescein (6-FAM), a targeting strand of nucleic acid 
and a dabcyl quencher molecule. Solution phase testing of the dye was carried out to 
fully characterise the impact of environmental factors on the properties of the dye, for 
example the emission intensity. 
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Figure 3.1: Cartoon of the cell containing MB for the detection of miR-132. 
 
 
 
Figure 3.2: Structure of 6-FAM (left), and Dabcyl (right). 
 
Figure 3.2 shows the structure of the fluorescein dye and dabcyl quencher. It is 
important to note that while the structures above were incorporated into the final MB, 
they were modified by attachment to the nucleic acid (NA) strand. The 6-FAM contains 
only a single carboxylic acid group in the MB, and the Dabcyl contains no free 
carboxylic acid group in the final MB.  
The 6-FAM dye was found to have significant sensitivity to changes in the polarity of 
the solvent and the pH environment, both causing significant changes to the intensity of 
the dye. The concentration dependent self-quenching of the dye and the ability of the 
dabcyl quencher were investigated. The introduction of the 6-FAM dye to a 
neuroblastoma cell line was also investigated. Passive uptake of the dye was not 
observed, even with the addition of permeabilizing agents. The efficiency of 
electroporation of the dye into the cells was investigated as well as its effect on the cell 
viability.  
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3.2  Experimental 
3.2.1  Materials 
6-Carboxylfluorisin (6-FAM) was purchased from Sigma Aldrich at ≥97 % purity as 
determined by HPLC. 4-([4-(Dimethylamino)phenyl]-azo)-benzoic acid (Dabycl) was 
purchased from Sigma Aldrich at ≥90 % purity as determined by HPLC. Phosphate 
buffered saline (PBS) was prepared at a phosphate buffer concentration of 0.01 M and a 
sodium chloride concentration of 0.154 M using PBS tablets (Sigma Aldrich) in RNase 
free water. 
Nucleic acids were synthesised by Exiqon at 85 % purity. 
Molecular Beacon: 5’-6FAM+CGA+CCA+TGG+CTG+TAG+ACT+GTT+AGT+CG-
DAB-3’ (DNA/ LNA where the + is a Locked Nucleic Acid) In the absence of target, 
the 5’ 6-Carboxyfluorescein (6FAM) was held in close proximity to the 3’ Dabcyl, 4-
((4-(dimethylamino)phenyl)azo)benzoic acid (DAB) 
 
3.2.2  Emission Spectroscopy 
Emission spectrums were obtained using a Jasco V-670. Emission and excitation slits 
were typically 20 nm. Solvents used were 1 % DMSO in PBS unless otherwise stated. 
 
3.2.3  Time Correlated Single Photon Counting 
Lifetime results were determined using a PicoQuant Fluotime 100 TCSPC system with 
excitation at 450 nm. In each case, an instrument response function (IRF) was collected 
using ludox AM 30 colloidal silica solution (Sigma Aldrich), and the lifetime was fitted 
by using an exponential model with reconvolution, whereby the IRF contribution to the 
signal is subtracted. Data was fitted to a single exponential providing it gave a good 
quality fit, i.e. a 2 value of below 1.2 and no systematic residual. Where this was not 
possible, two exponentials were fitted to the data.  
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The model used for performing multi exponential reconvolution fits was: 
 
 
Where  Ai = Amplitude of the i 
th
 component in counts at time 0. 
 τi =  Lifetime of the i 
th
 component 
 
3.2.4  Cell Culture   
The adherent human neuroblastoma cell line, SK-N-AS, was obtained from the 
American Type Culture Collection (ATCC). The cells were cultured in Minimum 
Essential Media, with 10 % foetal bovine serum, 0.5 % L-glutamine and 0.5 % non-
essential amino acids, with 100 µg/mL Gentamicin at 37 ˚C and 5 % CO2. 
The cells were split at three day intervals, and seeded at a ratio of 1:3. Prior to splitting, 
the cells were rinsed with 5 mL of PBS. 1mL of trypsin was added over a five minute 
period. Approximately 5 mL of cell culture media was then added to neutralise the 
trypsin. 2 mL of this solution was then added to a new cell culture flask with 8 mL of 
media. The mixture was gently mixed by pipetting and replaced in the incubator. 
3.2.5  Imaging 
Cellular imaging was performed using a Zeiss LSM 510 confocal microscope, which 
was used for dye visualisation, with an argon ion laser at 458 nm and with an LP560 nm 
filter at 6 % for 6-FAM. For DRAQ-7 a HeNe laser at 633 nm with an LP650 nm filter 
at 100 % was used. A 63 x oil emersion objective lens (NA 1.4) was used, with a further 
4 x zoom obtained using the scanning software. Experiments were run for periods of up 
to 60 minutes. 
 
 
Equation 3.1: Lifetime fitting 
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3.2.6  Electroporation 
Prior to experiments with the MB, the ability to deliver the 6-FAM dye into live cells by 
electroporation was investigated. A technical bulletin from Bio-Rad “Transfection of 
Neuroblastoma Cell Lines Using the Gene Pulser MCcell Electroporation System” was 
used as a starting point for the method development. The parameters initially used were 
a cell density of 3 x 10
6
 cells per mL, square wave pulse of 200 V peak amplitude and 
20 ms pulse width. An electroporation cuvette (Sigma Aldrich) with a 0.2 cm gap was 
used for all experiments. 
Electroporation experiments were performed using the Bio-Rad GenePulser Xcell. Cells 
were incubated for 48 hours, which achieved approximately 75 % confluency. Cells 
were then rinsed with PBS three times to remove the media, and trypsinised for 10 
minutes. Cells were then resuspended in 1 mL of media, and counted using a 
haemocytometer. Cells were diluted to achieve a cell density of 3 x 10
6
 cells per mL. 
400 µL of this suspension was loaded into an electroporation cuvette. 6-FAM was 
added to achieve a concentration of 50 µM. The cuvette was then placed in the Bio-Rad 
GenePulser Xcell and electroporated as previously described. The cells were then 
immediately transferred to a cell culture dish, post electroporation, and media was 
added to bring the final volume to 2 mL. The cells were then incubated for 24 hours. 
This allowed the cells which survived the procedure to attach to the surface. Cells were 
then imaged by confocal microscopy to determine viability.   
 
 
 
 
 
 
 
 
 
 97 
 
3.3  Results and Discussion 
3.3.1  6-Carboxyfluorescein 
The photophysics of 6-carboxyfluorescein (6-FAM) were investigated to determine its 
suitability for use as part of a MB biosensor. It contains a fluorescein molecule with an 
additional carboxylic acid group. This COOH provides the attachment point for a 
targeting moiety, i.e., a nucleic acid sequence. Fluorescein has an exceptional quantum 
yield of 95 %
6
, reasonable photostability
7
, and has high compatibility with the 488 nm 
argon laser line
8
. Fluorescein derivatives have been used extensively for the detection of 
nucleic acids.
9,10,11,12
 
Figure 3.3 shows the absorption and emission spectra for 10 µM 6-FAM in 1 % DMSO 
and PBS. The maximum absorbance was found at 491 nm, which closely matches the 
literature value of 492 nm in 0.1 N NaOH
13
.  A shoulder is visible at approximately 
460 nm, this may be due to the protonation state of the dye which is discussed later. 
 
Figure 3.3: Absorbance and emission spectra of 10 µM 6-FAM in 1 % DMSO with PBS. 
Excitation at 395 nm with excitation and emission slits at 2.5 nm. 
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3.3.2  Solubility Effects 
In order to examine environmental impacts on 6-FAM, a solvent study was carried out. 
The dye is poorly soluble in water, and so ethanol (=24.5) and DMSO (=46.7) were 
investigated. The 6-FAM was highly soluble in both solvents. In ethanol, a strong 
colour was observed after the addition of the dye, whereas in DMSO the colour was less 
intense. Figure 3.4 shows the absorption spectra for 10 µM solutions in these two 
solvents. No absorbance is observed in DMSO at this concentration.  
 
Figure 3.4: Absorption spectra for 100 µM 6-FAM in DMSO and ethanol 10 µM 1 % 
DMSO in PBS and 1 % EtOH in PBS. 
 
However, since the purpose of further work was live cell imaging and RNA analysis, a 
pure organic solvent was not appropriate. It was found that by first dissolving the 6-
FAM in either DMSO or EtOH, and then diluting in water to give a 1 % organic solvent 
system, a stable solution was achieved. To maintain a controlled pH, PBS was used 
instead of pure water. When the dye in DMSO was added to water, a very strong colour 
was observed compared to the stock. Previous studies of fluorescein have shown that at 
concentrations of higher that 1 % in DMSO, significant quenching of the fluorescent 
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signal occurs due to rapid relaxation of the excited state due to H-bonding with the 
solvent.
14
  
Figure 3.4 shows the absorption spectra of a 1 % solution of 10 µM 6-FAM with 
DMSO or EtOH in PBS and reveals that the absorbance is significantly larger than in 
the pure solvent. The absorbance of the 1 % DMSO solution was greater than that 
displayed in the 1 % EtOH solution. In each case, the dye was fully dissolved with no 
particulate matter visible after centrifugation, so this effect is not due to incomplete 
dissolution.  These spectral changes in different solvent systems suggest that the dye is 
environmentally sensitive, which may be problematic for miRNA quantitation in live 
cells. Fluorescein has been show previously to be sensitive to the polarity of the solvent 
used, showing higher intensities in more polar solvents.
15
 The results obtained here are 
consistent with the previous reports, with the relatively non-polar DMSO displaying the 
smallest signal, the somewhat polar EtOH displaying a slightly higher signal, and polar 
water showing the highest signal.  
 
Figure 3.5: Emission spectra of 10 µM 6-FAM after excitation at 395 nm. 1 % DMSO 
and 1 % EtOH in PBS with 5 nm excitation and emission slits. 100 % DMSO and 100 % 
EtOH with 20 nm excitation and emission slits. 
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Figure 3.5 shows the emission spectra for these solutions. As seen in the absorption 
spectra, where DMSO had a negligible absorbance, the emission spectrum for this 
solution is also undetectable at this concentration.  The water containing solutions have 
significantly higher intensities, with a more than 10 fold enhancement from 100 % 
ethanol to 1 % ethanol which agrees with the increase in absorbance. The shape of the 
1 % DMSO and 1 % EtOH responses are similar, with a primary peak at approximately 
515 nm and a secondary shoulder peak around 550 nm.  The 100 % EtOH spectrum 
shows two peaks of similar intensity.  
 
 
Figure 3.6: Time correlated single photon counting lifetime for 10 µM 6-FAM in 1 % 
DMSO in PBS with single exponential decay fit (top) and residual plot (bottom). 
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Table 3.1: Showing the time correlated single photon counting lifetime for 10 µM            
6-FAM in DMSO, ethanol, 1 % DMSO in PBS and 1 % ethanol in PBS (n=3). 
 Lifetime (ns) 2 
100 % DMSO 2.5±0.4 1.02±0.07 
1 % DMSO 4.1±0.0 1.07±0.02 
100 %EtOH 4.3±0.3 1.22±0.12 
1 % EtOH 4.1±0.0 1.14±0.09 
 
Figure 3.6 shows a representative fit to the TCSPC data for the lifetime determination. 
In this case, a single exponential provided a high quality fit, with a high degree of 
agreement between the decay and fitted exponential. The residual plot shows an even 
distribution over the analysed range, suggesting that a single exponential is sufficient to 
describe this decay. Table 2.1 shows the lifetimes of 6-FAM in each of the solvent 
mixtures analysed. The 1 % DMSO, 1 % EtOH and 100 % EtOH show similar lifetimes 
of 4.2±0.2 ns. The 100 % DMSO is significantly shorter, at 2.5±0.4 ns, which is 
consistent with the lower emission intensity observed. 
Overall, the DMSO emission intensity and lifetime are significantly lower than in water 
containing solvent systems. One possible explanation for these results is that 
dimerisation of the dye in the ground state is mediated by the solvent, with DMSO 
promoting this self-association. Another possibility is that the excited state is coupled to 
the vibrational modes of the solvent causing more rapid destabilisation of the excited 
state. Based on previous reports
15
, the latter mechanism is considered more likely.  
This data also suggests that the dye has significant environmental sensitivity, with 
DMSO and ethanol causing significant changes in both the absorption and emission 
spectra. This may be an issue for cellular imaging, as the various environments of the 
cell can have significantly different properties. To further examine the environmental 
effects on the 6-FAM dye, the effects of pH on the dye were examined since different 
regions of the cells can have somewhat different pH values.   
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3.3.3  pH Study 
The pH within a cell can vary significantly, while the intercellular fluid is generally     
pH ~7.2
5
, some organelles can be significantly different, with mitochondria at pH 8.0
16
 
and lysosomes as low as 4.7
4
. Fluorescein is known to be pH sensitive, being used 
previously as a pH sensor
17,18,18
. Fluorescein contains a number of different pH 
dependent forms, see Figure 3.7, with only two of the forms contributing to a 
fluorescent signal
19
. The monoanion form emits near 450 nm while the dianion form 
emits at 495 nm. 6-FAM is structurally similar to fluorescein. 
 
Figure 3.7: pH dependent ionisation of fluorescein. 
 
Figure 3.8: Absorbance spectra for a range of pH adjusted samples of 10 µM 6-FAM in 
1 % DMSO and PBS, at a starting pH of 7.4, adjusted with NaOH and HCl. 
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Figure 3.9: Emission spectra for a range of pH adjusted samples of 10 µM 6-FAM in 
1 % DMSO and PBS, normalised for absorption at 450 nm. Excitation at 450 nm with 
excitation slit 2.5 nm and emission slit 5 nm, at a starting pH of 7.4, adjusted with 
NaOH and HCl. 
 
A solution of 10 µM 6-FAM with 1 % DMSO in PBS was prepared and the pH adjusted 
using HCl and NaOH solutions. The initial pH in PBS was 7.4, the pH was then 
adjusted up and down from this point, with fresh solutions used to collect data for the 
acidic and basic ranges. Figure 3.8 shows the absorbance spectra for this experiment. At 
pH 7.4 a primary peak is observed with max absorbance at 495 nm with a shoulder 
visible at approximately 460 nm. As the pH is increased, this shoulder becomes less 
pronounced, and the intensity of the primary peak is enhanced to 0.68 at pH 12.7. The 
acidic pH range causes much more significant changes to the absorption peak shape and 
intensity. At pH 5.2, the intensity of the primary absorption peak at 495 nm is 
significantly decreased from 0.56 at pH 7.4 to 0.26 at pH 5.2, and the shoulder peak at 
approximately 450 nm is enhanced from 0.2 to 0.25. As the pH is decreased further to 
pH 3.1, a peak at 440 nm becomes dominant, and the 495 nm peak continues to 
decrease in size. This 440 nm peak continues to increase in absorbance, up to a 
maximum of 0.35 at pH 1.6. 
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Fluorescein has an isosbestic point at 460 nm where the absorbance at all pH values is 
equal, however 6-FAM does not show a sharp isosbestic point. A number of the 
absorbance spectra converge at approximately 450 nm, however the spectra for pH 1.6, 
4.8 and 5.2 deviate significantly. To minimise the effect of pH induced changes, the 
emission spectra were recorded using excitation at 450 nm. The emission spectra were 
then numerically normalised based on the absorbance value at 450 nm to allow for an 
accurate comparison. 
Figure 3.9 shows the emission spectra for the pH range. The max intensity at pH 7.4 is 
at 513 nm, and a slight shoulder is seen at approximately 560 nm. As the pH is 
increased the maximum emission increases from 340 A.U. at pH 7.4 up to 380 A.U. at 
pH 9.4. As the pH is further increased no significant change to the peak shape or 
intensity is observed. This is in keeping with the absorption data, with little change 
observed in the 495 nm absorption peak as pH increases. This behaviour is strongly 
reminiscent of fluorescein.  
Conversion between 6-FAM in the monoanion and dianion form can be described as 
HA → A- + H+ 
Ka = [A
-
] [H
+
] 
           [HA] 
                                                             
where HA represents the monoanion form and A
-
 represents the dianion form. The pKa 
of 6-FAM is 6.45
20, 
which corresponds to a Ka of approximately 2.8 x 10
6
. At a pH of 
7.4, the [H
+
] is 2.5 x 10
7
 M. Based on Equation 3.2 it can be calculated that 
approximately 90 % of the dye is in the dianion form, with 10 % in the monoanion 
form. When the pH is further increased, the remaining monoanion is converted to 
dianion, and the maximum possible emission intensity is then observed. 
In the absorption spectrum, the acid range caused significant change to the peak shapes 
and intensities, and this is reflected in the emission spectra. When the pH is decreased 
from pH 7.4 to pH 5.2, the emission intensity drops from 340 to 96 A.U. The absorption 
spectra also show a similar change from 0.56 to 0.14 at 495 nm. The peak shape is also 
affected, with a shoulder peak at 560 nm then becoming visible. When the pH is 
decreased the emission intensity drops further from 98 A.U. at pH 5.2 to 56 A.U. at 
pH 2.5, and this is also reflected in the absorption spectra at 495 nm as a drop from 0.14 
to 0.02 occurs. 
Equation 3.2: Acid dissociation 
Equation 3.3: Association constant 
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These results again closely match fluorescein. As the pH is decreased, the monoanion 
becomes favoured over the dianion, causing both the absorption and emission peaks to 
change shape. As the pH is further lowered, the non-fluorescent forms of the dye 
become more prevalent, which causes a decrease in emission intensity.  
Table 3.2: Lifetime data based on 3 repeats for a range of pH adjusted samples of 
10 µM 6-FAM in 1 % DMSO and PBS, at a starting pH of 7.4, adjusted with NaOH and 
HCl. 
Sample 
 
Lifetime t1 
2
 
pH 1.6 2.3 ± 0.0 1.07 ± 0.08 
pH 2.6 2.6 ± 0.0 1.09 ± 0.05 
pH 3.1 2.8 ± 0.0 1.10 ± 0.06 
pH 4.8 3.3 ± 0.0 1.09 ± 0.06 
pH 5.2 3.3 ± 0.0 1.03 ± 0.05 
pH 7.4 4.1 ± 0.0 1.08 ± 0.06 
pH 8.4 4.0 ± 0.0 1.13 ± 0.02 
pH 9.4 4.0 ± 0.0 1.11 ± 0.00 
pH 10.8 4.2 ± 0.0 1.12 ± 0.02 
pH 11.9 4.1 ± 0.0 1.12 ± 0.01 
pH 12.7 4.2 ± 0.0 1.07 ± 0.06 
 
 
Figure 3.10: Lifetime data for a range of pH adjusted samples of 10 µM 6-FAM in 1 % 
DMSO and PBS, at a starting pH of 7.4, adjusted with NaOH and HCl. Lifetimes are 
reproducible to within 2 %. Error bars present but not visible.   
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Table 3.2 shows the TCSPC lifetime results for this pH range. All of these lifetimes 
could be fitted to a single exponential. At pH 7.4 the lifetime is 4.1±0.0 ns. As the pH is 
increased, this value remains unchanged. The acidic pH range caused a measurable drop 
in the lifetime of the dye, from 4.1±0.0 ns at pH 7.4, to 3.3±0.0 ns at pH 5.2. This 
reflects the significant peak changes seen in the absorption spectra with the monoanion 
becoming favoured over the dianion. As this pH is further decreased to 2.6, the lifetime 
drops to 2.6±0.0 ns. This pH induced change agrees with the absorption spectra, see 
Figure 3.8, which shows the monoanion form at 440 nm becoming the primary peak at 
pH 3.1 and below, with a significant reduction in the dianion peak at 495 nm.  
Overall, the TCSPC data suggests that the ionic state of the dye has a significant impact 
on the lifetime of the dye, with the dianion form having a longer lifetime of 
approximately 4.0 ns, and the monoanion form having a significantly shorter lifetime of 
approximately 2.6 ns. This again underlines the pH sensitivity of the dye.  
The pH sensitivity of the dye is potentially an issue for the detection of the miRNA 
target if it occurs in different regions of the cells due to variations occurring in cellular 
pH values. A second issue for consideration is the effect of dye concentration on the 
emission intensity. For example at high concentrations the small stokes shift could lead 
to trivial quenching and a lower emission intensity that would be interpreted incorrectly 
as arising from a low miR-132 concentration. 
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Concentration Study  
The effect of changes in concentration on the absorption and emission spectra were 
examined. Figure 3.11 shows the emission spectra for a range of concentrations from 
10 µM to 1000 µM. A linear enhancement in intensity is observed from 10 µM up to 
50 µM, after which the rate of increase in intensity begins to level off, as shown in 
Figure 3.12. This data agrees with previous work which has shown that 6-FAM self-
quenches via trivial quenching and dimerisation at higher concentrations
20
.    
Of note here is the shift in the peak maximum, which changes significantly with 
concentration, as shown in Table 2.3. At the 10 µM concentration, the position of 
maximum intensity is at 515 nm, and this value increases with the concentration up to 
536 nm at 1000 µM. It is possible that this change is caused by FRET, with the dye 
molecules which would emit at an apparently lower wavelength having a spectral 
overlap with the 6-FAM absorption spectra causing a shift in the apparent maximum 
emission position. This process becomes more likely to occur as the concentration 
increases. The shape of the emission spectrum also changes with a greatly diminished 
signal below 518 nm at 500 µM and 1000 µM. 
Figure 3.13 shows the absorption spectra for these samples. At concentrations above 
10 µM, the absorbance values measured were above 1, and therefore this data cannot be 
accurately analysed as this data violates the Beer-Lambert law.  
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Figure 3.11: Emission spectra of 6-FAM in 1 % DMSO with PBS from 10 µM to 
1000 µM after excitation at 395 nm with excitation slit at 2.5 nm and emission slit at 
2.5 nm.  
 
 
Figure 3.12: Max emission intensity versus concentration of 6-FAM in 1 % DMSO with 
PBS from 10 µM to 1000 µM. 
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Concentration ( µM) Max Emission (nm) 
100 536.0 
500 533.0 
100 525.1 
75 524.0 
50 521.9 
25 521.9 
10 515.0 
 
 
Figure 3.13: Absorbance spectra for 6-FAM with increasing concentration from 1 µM 
to 25 µM, in 1 % DMSO with PBS at pH 7.4. 
 
 
0
0.5
1
1.5
2
2.5
350 400 450 500 550 600 650
A
b
so
rb
an
ce
 
Wavelength (nm) 
25µM
10µM
1µM
Table 3.3: Effect of concentration on the position of max emission intensity with 
increasing 6-FAM concentration in 1 % DMSO with PBS from 10 µM to 1000 µM. 
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Table 3.4: Lifetimes of 6-FAM from 10 µM to 1000 µM for three repeats after excitation 
at 450 nm in 1 % DMSO with PBS at pH 7.4. 
Concentration ( µM) Lifetime (ns) 2 
10 4.1±0.0 1.08±0.00 
25 4.2±0.0 1.08±0.02 
50 4.4±0.0 1.17±0.05 
75 4.5±0.1 1.18±0.10 
100 4.7±0.1 1.09±0.08 
500 5.6±0.3 1.16±0.08 
1000 6.3±0.4 1.09±0.05 
 
 
 
Figure 3.14: Effect of increasing concentration on 6-FAM lifetime in 1 % DMSO with 
PBS from 10 µM to 1000 µM for three repeats. Where error bars are not visible they 
are comparable to the size of the symbols. 
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Figure 3.14 shows the TCSPC results for the concentration range examined. From 
10 µM to 100 µM the lifetime remains constant at approximately 4ns, which 
corresponds to the semi-linear enhancement seen in the emission spectra for this 
concentration range. At 500 µM the lifetime increases to 5.6±0.3 ns, and then to 
6.3±0.4 ns at 1000 µM.  
This increase in the observed lifetime at higher concentrations can arise from a number 
of possible mechanisms. Fluorescein has been shown previously to undergo aggregation 
at high concentration, which results in dimerisation.
20
 This process would explain the 
decrease seen in emission intensity at high concentration, but is not sufficient on its own 
to explain the changes in lifetime as static quenching should result in a non-fluorescent 
complex. Due to the small spectral overlap between the absorption and emission bands 
of 6-FAM, Förster energy transfer of the excited state could be occurring. This process 
has been shown previously
20
 to be significant at higher concentrations, however this 
would result in shorter lifetimes for 6-FAM. The cause of these longer lifetimes is not 
well understood.  
The concentration data shows that at a high concentration significant quenching of the 
dye occurs, however as the effect does not become significant until 100 µM, this can be 
easily avoided by keeping the concentration low. As the photophysical properties of the 
dye had been fully characterised, the next step was to examine the MB in the presence 
of the quencher. 
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3.3.4  Dabcyl 
Dabcyl is a dark quencher, i.e. it absorbs excitation energy from a dye molecule and 
releases this energy as heat
21
. Dabcyl has been widely used for the quenching of 
fluorescein derivatives based on its large spectral overlap.
22,23,23,24,24
 
The photophysics of dabcyl were investigated to examine its quenching properties. The 
dabcyl was insoluble in water, and in water containing solvent systems, so all 
experiments were performed in 100 % DMSO. The absorption spectra for 10 µM of the 
dabcyl in DMSO is shown in Figure 3.15. A broad absorption peak is observed with 
peak maximum at 480 nm. The overlap between dabcyl and a 10 µM 6-FAM solution in 
1 % DMSO is also shown. The graph shows a high degree of overlap which is desirable 
for fluorescence quenching. 
 
Figure 3.15: Absorbance spectra of 10 µM Dabcyl in DMSO (Black) and emission 
spectra of 10 µM 6-FAM with 1 % DMSO in PBS (Red). Excitation at 395 nm with 
excitation slit at 2.5 nm and emission slit at 2.5 nm. 
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Table 3.5: Calculated values for Förster energy transfer from the 6-FAM to the dabcyl. 
Forster Distance (Å) 82.66 
Rate of Electron Transfer (1/s) 7.78 x 10
13
 
Dexter Value (1/eV) 0.82 
J value (cm
6
) 2.82 x 10
-12
 
 
The distance between 6-FAM and dabcyl at which energy transfer is 50 % efficient (R0) 
can be represented as: 
 
Where  K
2
 = Orientation factor 
 ϕD = Fluorescence quantum yield 
 n = Refractive index  
 J = Spectral overlap integral   
 
The orientation factor was assumed to be 2/3 for rapidly rotating randomly orientated 
donor and acceptor molecules.
25
 The refractive index was 1.4, the average for DMSO 
(1.48)
26
 and water (1.33)
27
. The quantum yield was 0.74, as previously reported.
20
 The 
spectral overlap was calculated based on the spectra shown in Figure 3.15. Based on 
this calculation, the critical Förster energy distance was calculated as 82 Å. Therefore, 
efficient quenching is expected when the dye and quencher are in close proximity in the 
parent beacon. Based on the structure of the MB, a separation of <50 Å is expected. 
The quenching of 6-FAM by dabcyl can potentially occur by two mechanisms. One is 
static quenching, whereby direct collision of a 6-FAM molecule and the dabcyl results 
Equation 3.4: Critical Förster energy distance 
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in quenching. The maximum distance that an excited 6-FAM molecule can diffuse 
within its excited state lifetime is given by: 
d = (Dτ)1/2 
Where d = diffusion length 
 D = Diffusion coefficient of the solvent 
 τ = Fluorescent lifetime 
 
Assuming that the diffusion coefficient is approximately 5 x 10
-6
 cm
2
 s
-1, and τ = 2.1 x 
10
-9 
s, then the diffusion length is 1 x 10
-7 
cm, i.e. 10 Å. This distance is so small that 
the probability of a collision occurring is very low. The second mechanism is by energy 
transfer. As shown previously, the critical energy transfer distance is 82.6 Å. This 
considerably longer distance suggests that FRET is the primary means of fluorescence 
quenching by dabcyl.   
In order to experimentally examine the ability of the dabcyl to quench the 6-FAM, a 
quenching study was undertaken. As previously stated, dabcyl is insoluble in water 
containing solvent systems and so the experiment was performed in DMSO. In DMSO, 
the emission intensity of the 6-FAM is significantly reduced as shown previously, and 
so the concentrations were increased to 100 µM and the excitation wavelength was 
increased to 450 nm to provide adequate emission intensity. As illustrated in Figure 
3.16, in the absence of dabcyl, an emission maximum was observed at 528±0 nm with 
intensity of 135±4.4 A.U. As the concentration of dabcyl is increased, the position of 
maximum emission intensity increases, as shown in Figure 3.18. The peak shifts from 
528±0 nm in 5-FAM, to 565±1 nm at 50 µM dabcyl, and further to 596±1 nm in the 
presence of 500 µM dabcyl, see Figure 3.18. 
Equation 3.5: Diffusion length 
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Figure 3.16: Emission spectra for 100 µM 6-FAM in DMSO with varying 
concentrations of Dabcyl quencher from 1 µM to 1mM after excitation at 450 nm with 
excitation slit at 20 nm and emission slit at 20 nm. 
 
As seen in Figure 3.16, the intensity of the emission is also significantly reduced as the 
concentration of dabcyl is increased. In the absence of dabcyl the maximum emission is 
135.3±4.4 A.U. As dabcyl is added, the emission drops sharply, with 1 µM resulting in 
a drop to 87±3 % of the initial signal. The addition of 50 µM dabcyl results in a 
decrease in intensity to 49±2 %., and then further to 27±1 % with 200 µM of dabcyl. At 
1000 µM the emission intensity reduced to 12±2 % compared to 6-FAM alone. 
Overall these results are promising, as the 6-FAM seems to be highly quenched by the 
addition of dabcyl, with even low concentrations causing a significant reduction in 
signal intensity. Figure 3.17 shows a Stern Volmer plot of the quenching experiment. 
For collisional quenching, a straight line is expected. This is not observed here which 
suggests a more complicated quenching mechanism.  
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Figure 3.17: Stern Volmer plot of maximum emission intensity for 100 µM 6-FAM in 
DMSO with varying concentrations of dabcyl quencher from 1 µM to 1mM after 
excitation at 450 nm with excitation slit at 20 nm and emission slit at 20 nm 
 
 
Figure 3.18: Wavelength of maximum emission intensity for 100 µM 6-FAM in DMSO 
with varying concentrations of dabcyl quencher from 1 µM to 1 mM after excitation at 
450 nm with excitation slit at 20 nm and emission slit at 20 nm. 
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Figure 3.19 shows a representative TCSPC fit for 100 µM 6-FAM in DMSO.  The 
lifetime could not be fitted to a single exponential but is adequately described by two 
components, a lifetime of 2.2±0.0 ns, which accounted for 26 % of the signal, and a 
second lifetime of 0.7±0.0 ns which accounted for 74 % of the signal. The shorter 
lifetime is most likely due to instrumental noise, as it remains consistent throughout the 
experiment and is present in different samples recorded under these conditions. Due to 
the low intensity of the emission in 100 % DMSO, this background signal becomes a 
more significant contributor to the signal.  
 
 
Figure 3.19: Time correlated single photon counting lifetime for 100 µM 6-FAM in 
DMSO with fit (top) and residual plot (bottom). 
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The lifetime results for the 6-FAM as the concentration of dabcyl is systematically 
varied are shown in Table 2.2. For this range of concentrations, the two lifetimes remain 
consistent at 2.1±0.1 ns and 0.6±0.1 ns. 
The lifetime would be expected to decrease as the concentration of quencher is 
decreased for collisional quenching. This is not observed for the range of lifetimes, 
which suggest that static quenching may be the primary quenching mechanism under 
these conditions.  
Table 3.6: Lifetime results for 100 µM 6-FAM in DMSO with varying concentrations of 
dabcyl quencher from 1 µM to 1 mM after excitation at 450 nm. 
  τ1 (ns)  τ2 (ns)  
2
 
6-FAM 2.2±0.0 26.1±4.7 % 0.7±0.0 73.9±4.7 % 1.05±0.10 
1 µM Dabcyl 2.2±0.1 22.3±4.4 % 0.7±0.0 77.7±4.4 % 1.15±0.08 
10 µM Dabcyl 2.2±0.0 30.3±14.3 
% 
0.7±0.1 69.7±14.3 % 1.12±0.07 
50 µM Dabcyl 2.1±0.0 25.6±2.6 % 0.7±0.0 74.4±2.6 % 1.14±0.06 
100 µM Dabcyl 2.0±0.0 30.2±0.4 % 0.6±0.0 69.8±0.4 % 1.24±0.10 
200 µM Dabcyl 1.9±0.0 39.4±2.0 % 0.5±0.0 60.6±2.0 % 1.19±0.09 
500 µM Dabcyl 2.1±0.1 72.0±7.4 % 0.8±0.1 28.0±7.4 % 0.99±0.07 
1000 µM Dabcyl 2.0±0.1 81.2±4.7 % 0.5±0.1 18.8±4.7 % 1.05±0.09 
 
 
Figure 3.20: Percentage contribution of the 2.09±0.12 ns lifetime for 100 µM 6-FAM in 
DMSO with varying concentrations of dabcyl quencher from 1 µM to 1 mM after 
excitation at 450 nm. 
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3.3.5  Molecular Beacon 
 
Figure 3.21: Absorbance and emission spectra of a 10 µM solution of the 6-FAM-
dabycl MB in PBS. Excitation at 395 nm with excitation slit at 20 nm and emission slit 
at 20 nm. 
 
The solubility of the MB (MB) was investigated, and it was determined that the MB 
was soluble in aqueous solutions, which is most likely due to the presence of the 
negatively charged DNA. A 50 µM stock of the MB was prepared and the UV and 
emission spectra acquired. The UV spectra exhibits maximum absorbance at 495 nm 
which is indistinguishable from that found for 6-FAM, however the absorbance 
intensity was significantly lower, being 0.616 for the free 6-FAM dye, compared with 
0.084 for the same dye concentration bound within the hairpin. This lower absorbance is 
unexpected given that the MB also contains a dabcyl quencher that has wavelength of 
maximum absorbance of 480 nm, which should also be contributing to this absorbance 
signal. The reduced absorbance may be due to interaction with the nucleic acid or the 
loss of the carboxy functional group upon binding to the nucleic acid. The emission 
peak shape is similar for both the free 6-FAM dye and MB.  However the emission 
intensity is much lower in the MB due to the FRET energy transfer to the dabcyl 
quencher. Ideally no emission would be observed, which would signify complete 
quenching of the 6-FAM by the dabcyl. The presence of this signal could cause a 
significant deterioration in the signal to noise ratio when trying to detect the miRNA 
target. 
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Figure 3.22: Time correlated single photon counting lifetime for 10 µM MB in 1 % 
DMSO in PBS with fit (top) and residual plot (bottom). 
 
Figure 3.22 shows the TCSPC data for the MB. The lifetime could not be fitted to a 
single exponential and was discovered to contain 2 components: a lifetime of 3.5±0.2ns, 
which accounted for 77 % of the signal, and a second lifetime of 1.1±0.0 ns which 
accounted for 23 % of the signal. 6-FAM
20
 has a pKa of 6.45, and so at a pH 7.4 in PBS 
approximately 90 % will be in the protonated form and 10 % will be in deprotonated 
form. However, on the basis of the investigations of the free dye both of these 
conformations are expected give rise to a lifetime in the 3 ns to 4 ns range, as shown in 
Table 2.2, which does not account for the 1.1±0.0 ns signal. As discussed above, the 
shorter lifetime is considered to arise from the instrument, e.g., filter emission.  
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3.5±0.0 77 % 1.1±0.0 23 % 1.144 
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3.3.6  Live Cell Imaging 
3.3.6.1  Passive Uptake 
One significant objective was to determine the concentration of miR-132 within the 
cells using live cell imaging. The SK-N-AS cell line was chosen as a source of  miR-
132 as it has been shown to highly express this miRNA.
28
  However, getting the MB 
into the cells was a potential issue. As a starting point, the ability of 6-FAM dye to 
passively enter the cells was investigated. A simple passive uptake experiment was 
performed in which the cells were incubated overnight with a 50 µM solution of the 6-
FAM. After incubation, the cells were rinsed with fresh media, and were imaged using a 
confocal microscope, see Figure 3.23. No emission from the dye was detected under 
confocal imaging and the cells appeared to be healthy and unaffected by the addition of 
6-FAM to the media, with good attachment to the cell culture dish and normal 
morphology. 
 
Figure 3.23: Confocal fluorescence microscopy of SK-N-AS cells after incubation with 
50 µM 6-FAM, overnight, and after washing with fresh media. Excitation with argon 
ion laser at 458 nm and with an LP560 filter at 6 %. 
 
20µm 
 122 
 
As the dye was not taken up by the cells passively, the next attempted approach was the 
addition of solvents to the media to improve the permeability of the cells. DMSO has 
been shown to be non-toxic to cells at low concentrations
29,30,30
, and to improve the 
permeability of lipid membranes
31
. A control experiment was performed, containing 
only SK-N-AS cells with 1 % DMSO in the media and the cells appeared to be healthy 
after 24 hours of incubation, showing normal shape and good attachment to the surface.  
Cells were then incubated for 4 hours and 24 hours with 6-FAM in 1 % DMSO. The 
cells appeared to be healthy, with normal morphology and good attachment to the 
surface. The cells were imaged in the 6-FAM containing media, see Figure 3.24, as this 
provides contrast for the image. No signal was detected for 6-FAM within the cells, 
with a weak signal present in the media around the cells. This was the case for cells 
incubated for both 4 hours and 24 hours. 
The concentration of DMSO was then increased from 1 % in the media, to 2 %, see 
Figure 3.25. Again, the viability of the cells was high at more than 90 %, with the 
control cells appearing healthy and having normal morphology. When the cells were 
incubated with 50 µM 6-FAM for 4 hours and 24 hours, no signal was present within 
the cells. 
Ethanol has also been shown to increase the permeability of lipid membranes
32
, and so 
ability of ethanol to improve the uptake of 6-FAM was also investigated. A batch of 
SK-N-AS cells were incubated with 5 % ethanol for 24 hours. In this case the viability 
of the cells was significantly reduced to approximately 70 % compared to a control 
population. When cells were incubated with ethanol and 50 µM 6-FAM, no significant 
uptake was observed.  
Based on these experiments, the use of solvents to improve the uptake of 6-FAM was 
considered unsuccessful, and so alternative methods were then investigated.   
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Figure 3.24: Confocal fluorescence microscopy of SK-N-AS cells after 24 hours with 
50 µM 6-FAM in 1 % DMSO and media. Excitation with argon ion laser at 458 nm and 
with an LP560 filter at 6 %. 
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Figure 3.25: Confocal image of SK-N-AS cells after 24 hours with 50 µM 6-FAM in 
2 % DMSO and media. Excitation with argon ion laser at 458 nm and with an LP560 
filter at 6 %. 
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3.3.6.2  Electroporation   
Since both passive and solvent assisted uptake of the dye were unsuccessful, an 
alternate method of getting the dye into the cells was investigated. Electroporation is a 
highly efficient technique which allows for the introduction of nucleic acids and other 
charged species to a cell by increasing the permeability of the cell membrane. This is 
achieved by the application of an electrical field across the cell membrane which causes 
the formation of pores in cell membranes
33
, see Figure 3.26. This allows molecules 
usually excluded from the cell to diffuse in.
34
   
Figure 2.27 shows a cell which has been electroporated with 50 µM 6-FAM, imaged in 
the dye containing media. A signal of higher intensity was observed in the cell, which 
suggests successful transfection. The viability of the cells however was very poor, i.e. 
below 5 %. When the media was removed and placed on a glass slide, a large number of 
dead cells can be seen as shown in Figure 3.28. The cells were treated with a viability 
stain, DRAQ7, (in red) which is only taken up by cells with ruptured cell membranes. 
As can be seen, all of the cells in suspension were dead. However for the small number 
of cells that remained alive after electroporation, emission from the 6-FAM can be 
observed. Interestingly, the 6-FAM was highly excluded from the cell nucleus, but was 
present in the rest of the cell. There are two possible explanations for these images. It is 
possible that at a concentration of 50 µM, that the 6-FAM is toxic to the cell, and that 
the cells which were efficiently transfected died as a result. The other possibility is that 
the cells died as a result of the electroporation procedure, caused by the catastrophic 
failure of the cell membrane, and that this, in turn, allowed the dye to diffuse into the 
cells. The backscatter image shows a significant amount of cell debris, for cells 
damaged in the electroporation procedure. 
 
 
 
 
 
 Figure 3.26 Formation of pores in cell membrane during electroporation 
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Figure 3.27: Confocal image of SK-N-AS cells after electroporation with 50 µM 6-FAM 
in media. Excitation with argon ion laser at 458 nm and with an LP560 filter at 6 %. 
5µm 
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Figure 3.28: Confocal image of floating SK-N-AS cells after electroporation with 
50 µM 6-FAM (Green) in media and with 1 µM DRAQ7 (Red) viability dye. Excitation 
with argon ion laser at 458 nm and with an LP560 filter at 6 %. 
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3.4  Conclusions 
The goal of this chapter was to examine the environmental impacts of the cellular 
environment on the photophysics of the dye integrating into a MB for the detection of 
miR-132. This can inform the interpretation of results from live cells.  
In this work, the dye 6-carboxyfluoresin was examined for suitability as part of a MB. 
The dye was found to be insoluble in water, but could be added to aqueous media by 
first dissolving in DMSO or ethanol and then transferring to water. 1 % organic solvent 
was found to be sufficient to maintain stable solubility in water.  
The photophysics of the dye were examined using absorption and emission spectra, and 
the lifetime was examined using TCSPC. This lifetime was measured as 4.1±0.0 ns, 
which closely matches literature values for similar dyes. The effect of pH on the dye 
was also examined, and the absorbance data suggests significant changes to the dye as 
pH changes due to protonation and deprotonation of the dye. This results in different 
peaks at high and low pH, with both peaks contributing to the signal at intermediate 
levels of pH. This sensitivity of the dye to changes in pH may have an impact of the 
observed intensity of the MB in live cells. For example, in lysosomes where the pH is in 
the region of pH 4.7, it would be expected that the intensity of emission would decrease. 
No significant changes were observed at pH 7.4 and above. This is highly desirable for 
live cell imaging of cells, since the intercellular fluid, mitochondria, and nucleus are at 
or above pH 7.4. 
The concentration study of the dye found that at higher than 100 µM significant self-
quenching of the dye occurs. The emission was also affected, with a strong linear 
correlation with changes in concentration only from 10 µM to 100 µM, after which the 
emission intensity depends only weakly on the concentration.  Since no significant self-
quenching occurs at lower concentrations, future experiments with live cells can be 
performed at concentrations lower than 100 µM.  
Basic characterisation of the MB was also carried out, with the emission, absorption and 
lifetime matching 6-FAM in terms of the position of maximum intensity, however the 
absorption and emission intensity was considerably reduced for the MB, which may be 
due to the 6-FAMs interaction with the nucleic acid strand. This lower than expected 
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emission intensity is also consistent with the expected quenching of the dye by the dacyl 
quencher.   
The suitability of 6-FAM for use in live cell imaging was also examined. It was found 
that the dye does not passively enter the cells, and that the addition of solvents DMSO 
and ethanol displayed no improvement in this uptake. To overcome these issues, 
electroporation was investigated. This method was successful in delivering the 6-FAM 
to the cells, however it resulted in poor cell viability of approximately 5 %. Confocal 
fluorescence imaging reveals that the 6-FAM is highly excluded from the nucleus of the 
cell for both living and dead transfected cells.  
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 Solution Phase Detection of miR-132 
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4.1  Introduction 
 
 
Figure 4.1 Scheme of MB attaching to miRNA target  
The aim of this project was to detect the concentration and localisation of miR-132 in 
live neuroblastoma cells. In Chapter 3, the photophysics of the 6-FAM dye and dabcyl 
quencher were examined to characterise potential environmental impacts on the MB. An 
importation step in the process of live cell imaging was to fully understand the 
performance of the molecular beacon (MB) for the detection of the target in solution. 
The cellular environment contains a number of potential hazards for the detection of 
miRNA, including pH variation
1-3
 and enzymes which can degrade DNA
4-6
. Solution 
phase testing allows for the performance of the MB to be probed without these potential 
complications which will aid in the interpretation of results from live cell imaging. 
The emission of the dye in the absence of the target was examined also. This is 
important as the limit of detection of the MB is dependent on this background signal. 
This background can potentially be reduced by increasing the number of bases in the 
“stem” of the MB.  This has the effect of increasing the relative stability of the self-
bound form of the MB, which can result in a lower intensity signal. A second version of 
the MB was designed which aimed to improve the sensitivity of the assay by reducing 
the background emission in the absence of target. 
Dye Quencher 
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Initially, solution phase testing was performed using a synthetic analogue of the target 
which allowed the detectable concentration range to be determined. This allows for the 
binding of the MB for the target to be calculated, which gives valuable information on 
the rate and reversibility of binding.  
An important factor in the production of a MB for the detection of miRNA is 
specificity. A number of miRNA are present within cells which contain a number base 
matches with the target of interest. Detection of these sequences could lead to a higher 
signal, increasing the error associated the miRNA detection. To examine the specificity 
of the MB, a number of target sequences containing either one, two, or three 
mismatched bases were prepared. It is highly unlikely that miRNA are present within 
the cell with this high degree of similarity, so insensitivity to a single mismatch is 
indicative of a highly sensitive detection strategy.  
Thermal cycling of the molecular beacon is also examined. This allows for the most 
stable conformer to become the predominant from. This provides information on the 
stability of the molecular bacon at varying temperature.  
The ability of the MB to detect cellular miRNA target was then analysed using miRNA 
extracted from lysed neuroblastoma cells. This allowed the concentration of miR-132 
within a single SK-N-AS cell to be estimated. This is important for future work with 
live cells, since the signal received from the MB should correspond to that seen in lysed 
cells.  
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4.2  Experimental 
4.2.1  Materials 
For DNA hybridisation, phosphate buffered saline (PBS) was prepared at a phosphate 
buffer concentration of 0.01 M and a sodium chloride concentration of 0.154 M using 
PBS tablets (Sigma Aldrich) in RNase free water. 
Nucleic acids were synthesised by Exiqon at 85 % purity. 
MB: 5’-6FAM+CGA+CCA+TGG+CTG+TAG+ACT+GTT+AGT+CG-DAB-3’ 
(DNA/LNA where the + is a Locked Nucleic Acid) 
miR-132 Mimic: 5’- UAA-CAG-UCU-ACA-GCC-AUG-GUC-G-3’ (RNA) 
1BMM: 5’- UAACAGUCUACAGCCAUGGUCC-3’ (RNA) 
2BMM: 5’- UAACAGUCUACAGCCAUGGUUC-3’ (RNA) 
3BMM: 5’- UAACAGUCUACAGCCAUGGGUC-3’ (RNA) 
 
4.2.2  Emission Spectroscopy 
Emission spectra were obtained using a Jasco V-670. Emission and excitation slits were 
20 nm for all experiments. 
 
4.2.3  Time Correlated Single Photon Counting 
Lifetime results were calculated using the PicoQuant FluoFit Pro version 4.6.6. In each 
case, an instrument response function (IRF) was collected, and the lifetime was fitted 
using an exponential model using reconvolution, whereby the IRF contribution to the 
signal was subtracted. Data was fitted to a single exponential providing it gave a good 
quality fit, i.e. a 2 value of below 1.2 with no systematic residual. Where this was not 
possible, two exponentials were fitted to the data.  
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The model used for performing multi exponential reconvolution fits is: 
 
 
Where  Ai = Amplitude of the i 
th
 component in counts at time 0. 
 τi = Lifetime of the i 
th
 component 
 
4.2.4  RNA Extraction 
A liquid-liquid extraction was used to selectively extract RNA from the cells. Cells 
were lysed with one volume of QIAzol reagent (Qiagen). Two volumes of chloroform 
were then added. The mixture was centrifuged for 15 minutes at 12,000 g to form two 
clearly defined layers. The RNA is retained in the colourless aqueous layer, whereas the 
DNA is retained in the pink organic layer. The upper phase, containing the RNA, was 
removed, 1.5 volumes of ethanol were added, and the solution was mixed well. The 
solution was added to an “RNeasy Spin Column”. The column was then centrifuged at 
13,000 rpm for 30 seconds. The RNA is retained on the column. The column was then 
washed with buffer RWT (Qiagen) and a further three times with buffer RPE (Qiagen). 
This removes impurities held in the column, leaving only purified RNA retained on the 
column. The RNA was then eluted out with 100 µL of RNase free water. 
 
 
 
 
 
 
 
Equation 4.1: Lifetime fitting 
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4.3  Results and Discussion 
 
4.3.1  Concentration 
The ability of the MB to detect the target miRNA, miR-132, in solution was 
investigated to allow calculation of the binding affinity of the MB to the target, and to 
calculate the linear detection range. The concentration of beacon was held constant at 
1 µM, and the concentration of target was varied between 0.25 µM and 20 µM.  
4.3.1.1  Absorption 
Figure 4.2 shows the absorption spectra for the MB as the concentration of the miR-132 
target in solution is increased. The shape of the absorption spectrum changes as the 
concentration of the target was varied, e.g., from 0 µM to 1 µM. Two distinct peaks 
were observed at 480 nm and 506 nm, but the relative intensity of the 480 nm peak 
decreased at higher target concentrations. The 506 nm peak was consistent with 6-FAM 
dye alone obtained at low concentrations, which had a peak at approximately 513 nm. 
The secondary peak at 480 nm was believed to have arisen from the dabcyl quencher 
which had a maximum absorbance at 453 nm. As the concentration increased, the 
480 nm dabcyl peak remained constant, but the 506 nm peak increased, suggesting that 
opening of the MB was altering the absorption of the 6-FAM. If the excitation 
wavelength used was in the region of these peaks, then these changes in relative peak 
intensity would affect the expected linear dependence of the emission intensity on 
unfolded MB concentration. To avoid these issues, emission spectra were recorded 
using 395 nm excitation where the absorbance increases linearly with increasing 
concentration. While this did result in a lower overall signal intensity for the emission 
spectra, the brightness of the dye was still sufficient to provide an adequate signal.  
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Figure 4.2: Absorption spectra of 1 µM MB in PBS with varying concentration of 
miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 10 minutes.  
 
 
Figure 4.3: Emission spectra of 1 µM MB in PBS with varying concentration of 
miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 10 minutes. 
Emission and excitation slits were 20 nm, excitation at 395 nm. 
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4.3.1.2  Emission 
Figure 4.3 shows the emission intensity measured using 395 nm excitation. Following 
addition of the target, the emission increased rapidly but stopped increasing after less 
than 1 minute, indicating rapid opening of the stem-loop structure which is highly 
desirable for imaging applications.
7,8
 This suggests that the beacon : target hybrid has 
excellent binding efficiency, which  allows this method to provide very fast results, 
especially when compared with traditional techniques such as PCR
9,10
 or Northern 
blotting
11,12
. 
 As illustrated in Figure 4.3, the  time independent emission intensity increases linearly 
with increasing target concentrations up to 2 µM (mole ratio MB:target, 1:2) before 
saturation is observed for concentrations above 10 µM (mole ratio MB:target, 1:10). 
This behaviour is consistent with target binding and unfolding of the stem loop which 
increases the separation between dye and quencher resulting in a turn on of the 
emission. Above this concentration of 2 µM, there is insufficient self-bound beacon and 
the emission intensity no longer increases with an increasing concentration of the target. 
The observation of a background emission from the beacon in the absence of target 
significantly increases the LOD.
13,14 
 
Figure 4.4 Dependence of the emission intensity of a 1 µM solution of the MB in PBS on 
the concentration of the miR-132 target after a hybridization time of 10 minutes. 
Corrected to remove background emission in the absence of target.   The solid line is 
the least squares fit of Equation 4.2 to the experimental data. Emission and excitation 
slits were 20 nm excitation at 395 nm. 3 repeats were performed for each experiment. 
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Figure 4.4 shows the emission intensity at 520 nm as the concentration is increased. 
Binding at a single site can be described by the following equation
15
: 
]132[
]132[
]132[
][ max



 miRK
miR
miR
Hairpin
a

 
where max and Ka are the maximum specific binding and equilibrium association 
constants, respectively.  Figure 4.4 shows the best-fit obtained which yields an 
association constant of 6.5±0.4 x 10
5
 indicating that the equilibrium strongly favours the 
formation of the hybridized product with a corresponding Gibbs free energy 
of -33.1±0.2 kJmol
-1
, calculated using UNAFold software.  
 
Table 4.1 Lifetime results based on three repeats for 1 µM MB in PBS with varying 
concentration of miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 
10 minutes when the emission is time independent. 
 
 
 
 
 
 τ1 (ns)  % τ2 (ns)  % 
2
 
MB 3.6±0.0 43.1±1.1 1.1±0.0 56.9±1.27 1.27±0.08 
0.25 µM 3.4±0.0 57.5±2.8 1.1±0.0 42.5±1.16 1.16±0.03 
0.50 µM 3.3±0.0 68.6±0.6 1.1±0.0 31.4±1.16 1.16±0.11 
0.75 µM 3.3±0.0 70.7±1.7 1.1±0.0 29.3±1.14 1.14±0.02 
1.00 µM 3.3±0.0 73.9±1.5 1.1±0.0 26.1±1.12 1.12±0.08 
1.50 µM 3.3±0.0 76.3±1.7 1.1±0.0 23.7±1.11 1.11±0.06 
2.00 µM 3.3±0.0 79.0±1.2 1.1±0.0 21.0±1.18 1.18±0.06 
10.00 µM 3.3±0.0 81.5±1.4 1.1±0.0 18.5±1.15 1.15±0.04 
20.00 µM 3.3±0.0 83.2±0.7 1.1±0.0 16.8±1.16 1.16±0.08 
Equation 4.2: Single site binding 
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4.3.1.3  Lifetime 
The lifetime results for this concentration study are presented in Table 4.1. The lifetime 
could not be fitted accurately to a single exponential, so a bi-exponential model was 
used to fit this data.  The two lifetimes obtained are 3.3±0.1 ns and 1.1±0.0 ns.  The 
long time component is similar to the lifetime for 6-FAM in 1 % DMSO of 4.1 ns, 
suggesting that it is associated with those conformations of the MB where the dye and 
quencher are insufficiently close to quench the emission. When the target is absent, the 
majority of the lifetime contribution is from the shorter lifetime, at 57±1.3 %. As the 
target is added, the shorter lifetime intensity drops, reaching 16.8±1.16 % at 20 µM 
target. As target is introduced the percentage of MB in the open position increases, 
resulting in enhancement of the 3.3±0.1 ns lifetime. The shorter lifetime is most likely 
due to instrumental noise
16
, as it remains consistent throughout the experiment, with the 
apparent change in relative intensity caused by an increase in the intensity of 3.3±0.1 ns 
lifetime noise.  
Noise in TCSPC can occur due to electronic interference. If the different components of 
the TCSPC are powered by different power outlets, as was the case in these 
experiments, RF radiation from external sources to be introduced into the set-up. This 
can also occur if the computer attached to the TCSPC is connected to a wired network.
17
 
This noise in exceptionally difficult to present. In this system, the noise only appears to 
become a significant issue when the intensity of the dye is low.  
 
Figure 4.5 Change of 3.3±0.1 ns lifetime component of a 1 µM solution of the MB in 
PBS with  miR-132 target between 0.25 µM and 20 µM, after a hybridisation time of 10 
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minutes. 3 repeats were performed for each experiment, error bars are smaller than the 
size of icons. 
As illustrated in Figure 4.5, as the concentration of target is increased, a shorter lifetime 
contributed less to the signal, with the 3.3 ns lifetime becoming dominant contributing 
73.9±1.5 % of the intensity where the target concentration is 1.0 µM. This transition 
from a bi-exponential decay towards a single decay at 3.3 ns was consistent with 
opening of the MB and with the dye’s properties moving closer to those previously seen 
for free 6-FAM.  
4.3.2  RNA Extraction from SK-N-AS Cells  
As the MB had been successfully measured using a synthetic strand of miR-132 in 
solution, the next goal was to determine if detection was possible using a real sample 
containing miR-132. The SK-N-AS cell line was chosen as a source of   miR-132 as it 
has been shown to highly express this miRNA.
18
 
 
Figure 4.6: Emission spectra from the miRNA extracted from two independent batches 
of 10
7
 SK-N-AS cells following addition of the MB to give a concentration of 1 µM. 
Emission and excitation slits were 20 nm, excitation at 395 nm. 
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The total RNA present in a suspension of SH-N-AS cells (10 mL, 1.6 x 10
6
 cells per 
mL) was extracted, precipitated and taken up into 100  µL of buffer.  The MB complex 
was then added to give a final concentration of 1 µM and allowed to equilibrate for 30 
minutes.  Figure 4.6 shows the emission for two extracted samples using 395 nm 
excitation. The wavelength of maximum emission was shifted to shorter wavelengths by 
approximately 7 nm for the cell extract compared to the calibration solutions, most 
likely due to solvatochromic effects due to the more complex nature of the extracted 
cells compared to the clean buffer calibration solutions.   
Using the calibration data shown in Figure 4.4, the concentration of the miRNA target 
within the cell extract was approximately 0.45 µM. Given that the volume of a single 
SK-N-AS cell is approximately 20 pL, the concentration of an individual cell is 
approximately 0.14 µM.  This figure was strikingly high compared to miRNA 
concentrations found in other cells
19-21
, and suggests a high expression level in 
neuroblastoma cells. This higher than expected value may be due to the binding of the 
MB to the immature versions of miR-132, as these contain the same nucleic acid 
sequence.
22
 A number of studies have shown that the concentration of immature 
miRNAs can be equal to or higher than the concentration of mature miRNA.
23,24
 There 
are a number of possible errors in the calculation of this value. Cell counting was 
performed using a hemocytometer which has the potential to introduce error with regard 
to the total number of cells present in the sample. In addition, other RNA present in the 
sample may be capable of causing opening of the molecular beacon, which could cause 
higher than expected intensity. Further analysis would be required to achieve a definite 
conclusion on the cellular miRNA concentration. Significantly, the miR-132 
concentration for two independently analysed batches of cells, cultured separately, agree 
to within 10 %.  Overall, these in vitro experiments using lysed cells strongly suggest 
that the MB has attractive properties for live cell imaging which will be examined in a 
later section. 
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4.3.3  Base Mismatch 
4.3.3.1  Emission 
Beyond the issue of sensitivity, a key issue to be considered is the selectivity of the 
beacon:miR-132 interaction.  Therefore, the emission response where the target contains 
one, two and three mismatches, was investigated. A number of miRNA are present in 
cells which have some structural similarity to miR-132, including miR-212
25
 and        
let-7f
26
 which each share 9 base pairs. Figure 4.7 shows the emission spectra for a 1 µM 
solution of the MB in the absence of miR-132 target as well as in the presence of 1 µM 
of targets that differ from the fully complementary sequence by 1, 2 or 3 bases.  The 
signal due to one and two base mismatches was indistinguishable from that observed for 
the beacon in the absence of the target, i.e., even when the target contains only a single 
mismatch, no significant hybridization occurs and no increase in emission intensity was  
observed. The signal for 3 base mismatches was somewhat higher than that found for 
the 1-base mismatch but the response was  still three times lower than that found for the 
fully complementary which suggests good selectivity for this assay. 
 
 
Figure 4.7: Emission spectra of 1 µM MB in the presence of 1 µM of fully 
complementary target and 1 µM of 1, 2 and 3 base mismatch. Emission and excitation 
slits were 20 nm, excitation at 395 nm. 
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4.3.3.2  Absorption 
The absorption spectra for the MB with the fully complementary target and strands 
which contain mismatches are shown in Figure 4.8. As observed in the concentration 
study, the spectrum of the MB alone has a primary peak at 506 nm, with a secondary 
peak at 480 nm. The shape of the peak changes significantly upon the addition of target, 
with the 480 nm peak becoming less pronounced. This same trend is seen for the 
mismatched bases. Interestingly, the 1 base mismatch had the smallest 480 nm shoulder, 
and this increased in size for the 2 BMM, and larger again for the 3BMM. This 
represents further evidence that the binding of these additional strands is impacted by 
the number of mismatched bases present. 
 
 
 
Figure 4.8: Absorption spectra of 1 µM MB in the presence of 1 µM of fully 
complementary target and 1 µM of 1, 2 and 3 base mismatch. 
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4.3.3.3  Lifetime 
The TCSPC results for this experiment are shown in Table 4.2. As in the concentration 
study, two exponentials were required to fit this data. These two lifetimes were in the 
region of ~3 ns and ~1 ns. The MB only shows 45±1.74 % contribution from the longer 
lifetime, with the perfectly complementary  target at  74±4.00 %, and so based on the 
emission results obtained, it was expected that the contribution from the ~3 ns 
component would fall between these two values for the base mismatched RNA. The 
1BMM had a value of 63±5.1 % which while high, falls within the expected values. The 
2BMM however, was 98±09 %, and the 3BMM was 91±27 %. These values were 
exceptionally high compared to the concentration curve lifetimes previously seen where 
the maximum ~3ns contribution was 84±2.2 % for 20 µM of target with 1 µM of MB. 
This data suggests that the contribution of the longer and shorter lifetime signal may not 
be a useful measure of the opening of the MB.  
 
Table 4.2 Lifetime results of 3 repeats of 1 µM MB in PBS with 1 µM of fully 
complementary target and 1 µM of 1, 2 and 3 base mismatch. 
 τ1 (ns)  % τ2 (ns)  % 2 
MB 3.2 ± 0.25 45±1.7 0.8 ± 0.19 55 ± 1.7 1.20±0.01 
1 BMM 3.7±0.12 63±5.1 1.5±0.10 37±5.1 1.03±0.05 
2 BMM 3.9±0.02 98±0.9 1.1±0.01 2±0.9 1.12±0.05 
3 BMM 3.8±0.09 91±2.7 1.3±0.50 9±2.7 1.07±0.11 
Target 3.3±0.07 74±4.0 1.1±0.17 26±4.0 1.16±0.01 
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4.3.4  Alternate Conformers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Preferred and potential alternate conformations of the MB in the absence of 
target. 
 
Table 4.3 Calculated binding energies of preferred and possible alternate conformers of 
the MB in the absence of target. 
 ΔG (kcal.mole-1) Melting Temperature (°C) 
Preferred Conformer (A) -0.84 33.7 
Alternate (B) -0.45 27.9 
Alternate (C) -0.86 35.3 
Alternate (D) -1.18 39.0 
 
IDEAL CONFORMER 
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As mentioned previously, when the MB was measured in the absence of target, a 
measurable emission is observed. To determine the possible causes for this signal, 
molecular modelling was performed using UNAfold solfware. This analysis found that 
three alternate conformers exist when the dye and quencher are separated by a distance 
greater than the FRET distance, see Figure 4.9. This modelling treats every base in the 
MB as DNA, and does not take into account the additional stability granted due to the 
LNA. The most stable other confirmer, (D), shown above, has a predicted melting 
temperature of 39.0 °C, whereas the preferred conformer had a predicted melting 
temperature of only 33.7 °C.  
 
4.3.5  Temperature Study 
To test the impact of these additional conformers on the background signal intensity, a 
temperature study was undertaken. Other work with MBs has used thermal cycling, 
which involves increasing the temperature of the solution to melt all of the various 
forms, and then allowing the solution to cool.
27,28
 This should allow the most stable 
conformer to become the predominant form.   
Figure 4.10 shows the results of this experiment. The sample was measured before 
heating and brought to 70 °C for 1 hour to ensure complete melting of the beacon. The 
sample was then placed in a fluorimeter and measured at 1 minute intervals as it cooled. 
Initially, a large signal was observed, with the maximum intensity increasing four-fold 
suggesting successful opening of the MB. This is consistent with the enhancement in 
intensity observed for saturation of the MB with miR-132, see Figure 4.3, which 
resulted in a 4.5 fold increase in intensity. As the sample cooled to room temperature 
the signal intensity dropped significantly and within 7 minutes had reached the same 
intensity to within 6.6 % of that observed before heating. The sample was allowed to 
cool for 2 hours in total, but no further drop in intensity was observed. This experiment 
suggests that despite the previous modelling undertaken, that the predominant form is 
the “ideal conformer”, based on the 4-fold decrease in signal intensity upon cooling. 
The presence of a signal after heating, however, suggests that in order to further reduce 
this background intensity, design changes would need to be made to the beacon.  
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Figure 4.10 Emission spectra of 1 µM MB after being heated to 70 °C for 1 hour. 
Emission and excitation slits were 20 nm, excitation at 395 nm. 
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4.3.6  MB Version 2 (MB2) 
 
Figure 4.11 Scheme of MB version 2, with five bases in the stem section. 
When designing the second iteration of the MB (MB2), the primary focus was to 
decrease the background signal present in the absence of target. To achieve this, the 
number of bases in the “stem” of the MB was increased from four to five. Previous 
work has shown that this can further stabilise the self-bound form in the desired 
conformer
29,30
. While an increase in the stability of the self-bound form was desirable to 
reduce the background, it also had the potential to reduce the absolute sensitivity of the 
beacon, as the self-bound form was less likely to be opened by the target.
31,32
  
 
 
Figure 4.12 Preferred and potential alternate conformation of MB2 in the absence of 
target. 
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152 
 
Table 4.4 Calculated binding energies of preferred and possible alternate conformers of 
MB2 in the absence of target. 
 ΔG (kcal.mole-1) Melting Temperature (°C) 
Preferred Conformer (A) -1.87 40.5 
Alternate (B) -1.18 39.0 
 
Molecular modelling of the structure was performed before the synthesis of the new 
beacon, see Figure 4.12. The number of predicted alternate structures of significant 
stability was reduced to one with this new iteration. The melting temperature of the 
ideal form was predicted to increase to 40.5 °C, compared with 33.7 °C in the previous 
version. Importantly, the single predicted alternate conformer was predicted to occur at 
39.0 °C, which should favour the ideal form. 
Figure 4.13 shows the absorption matched emission spectra for the two versions of the 
MB in solution at 1 µM. The maximum emission intensity was reduced by 
approximately 20 % for the second iteration of the MB, suggesting that the preferred 
self-bound form of the beacon had become more favoured as a result of the stem length 
being increased. Based on the molecular modelling previously shown, it was expected 
that this decrease in signal in the absence of the miRNA target would be more 
significant due to the expected decrease in alternate conformers.  
 
 
Figure 4.13 Emission spectra for 1 µM of MB1 and MB2 in PBS after excitation at 
395 nm, absorbance matched. Emission and excitation slits were 20 nm. 
0
20
40
60
80
100
120
140
160
180
200
450 500 550 600 650 700
In
te
n
si
ty
 
Wavelength (nm) 
MB1
MB2
153 
 
The ability of the second MB (MB2) to detect the target miRNA, miR-132, in solution 
was investigated to allow comparison to the previous version. As before, the 
concentration of beacon was held constant at 1 µM, and the concentration of target was 
varied between 0.25 µM and 20 µM. 
4.3.6.1  Absorbance 
The absorbance spectra for MB2 is shown in Figure 4.14. Two peaks were observed at 
496 nm and 461 nm. This is shifted slightly from MB1, which show maximum 
absorbance at 506 nm and a secondary peak at 480 nm. As the concentration was 
increased, the 461 nm peak remained constant and the 496 nm peak increased in size, 
suggesting that the opening of the beacon increased the amount of 6-FAM available to 
give rise to this signal. Based on this data, it was decided to use an excitation 
wavelength of 395 nm as before, as this region of the curve is not affected by changes in 
the concentration which could distort the emission spectra. Overall the absorption 
spectra for MB2 was highly consistent with MB1, as was expected based on the high 
structural similarity between the two structures. 
 
 
Figure 4.14 Absorption spectra of 1 µM MB 2 in PBS with varying concentration of 
miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 10 minutes. 
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4.3.6.2  Emission 
The emission spectra for 1 µM of the MB2 with a range of miR-132 concentrations are 
shown in Figure 4.15. The signal increased significantly with the addition of target, with 
a linear increase being observed from 0.25 µM to 2 µM of target. After this point the 
intensity begins to level out, signifying that there is insufficient self-bound beacon, 
resulting in a constant emission intensity. This data was highly similar to the MB1, 
which showed a similar linear range of detection.  
 
Figure 4.15: Emission spectra of 1 µM MB2 in PBS with varying concentration of 
miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 10 minutes and 
after excitation at 395 nm with excitation slit 20 nm and emission slit 20 nm. 
 
Figure 4.16 shows the best-fit obtained which yields an association constant of 
1.34±0.4 x 10
6
, with a corresponding Gibbs free energy of -34.4 kJmol
-1
, indicating that 
the equilibrium strongly favours the formation of the hybridized product. The value 
observed is approximately double the 6.5±0.3 x 10
5
 achieved for the original version of 
the beacon, which suggest the binding affinity is even higher for MB2. Based on simple 
modeling of the two beacons which assumes that all the bases are DNA
33
, MB1 was 
calculated to have a Gibbs free energy of -33.39 kcal.mol
-1
, with MB2 at -
47.59 kcal.mol
-1
. This is an increase of approximately 21 %. While both calculations 
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increase is different between the two models. The calculated association value is 
believed to be more accurate, as it is based on experimental results.   
Overall, this increase in the association of MB2 and the target proves attractive for 
detection at lower concentrations, as this suggests that the MB will be more likely to 
open with lower amounts of miR-132. This may however, prove to have implications 
for the selectivity of the beacon.
34
  
The maximum intensity of the two beacons, normalized to remove the backroom signal, 
are shown in Figure 4.17. The two beacons were virtually indistinguishable at low 
concentrations from 0.25 µM to 2 µM, with very similar increases in intensity. The 
MB2 reached saturation at 2 µM, whereas the MB1 shows an increase up to 10 µM. 
This is consistent with the association constants previously discussed, with the MB2’s 
higher affinity resulting in saturation being reached at a lower target concentration. 
Overall from these results, the two MBs behave very similarly, with no major 
improvement for the MB 2 in terms of limit of detection or the background emission. 
 
Figure 4.16 Dependence of the emission intensity of a 1 µM solution of the MB2 in PBS 
on the concentration of the miR-132 target after a hybridization time of 10 minutes.  
The solid line is the least squares fit of Equation 1 to the experimental data. Emission 
and excitation slits were 20 nm, excitation at 395 nm. 
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Figure 4.17 Comparison of the emission intensity of a 1 µM solution of the MB1 and 
MB2 in PBS on the concentration of the miR-132 target after a hybridization time of 10 
minutes. Emission and excitation slits were 20 nm, excitation at 395 nm. 
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4.3.6.3  Lifetime 
The TCSPC results for the concentration range investigated are shown in Table 4.5. 
Two lifetimes were observed in the absence of target at 3.1±0.0 ns and 0.6±0.1 ns. 
These two lifetimes were similar to those observed for MB1 at 3.6±0.0 ns and 
1.1±0.0 ns. In MB1, the longer lifetime accounted for 43±1.1 % of the signal, whereas 
in MB2 this had increased to 72±0.9 % of the signal intensity. As the concentration was 
increased, the shorter lifetime contributed less to the signal and at 2 µM, where 
saturation of the MB2 was seen in the emission spectra previously, the lifetime decay 
became mono-exponential, with the shorter lifetime disappearing completely. In the 
MB1, the shorter lifetime also contributed less to the decay as the concentration 
increased, reaching 17±1.2 % at saturation. The MB2 did not show a residual short 
lifetime at saturation, which was consistent with the shorter lifetime arising from 
instrumental noise.  
Table 4.5 Lifetime results of 3 repeats of 1 µM MB2 in PBS with varying concentration 
of miRNA-132 between 0.25 µM and 20 µM, after a hybridisation time of 10 minutes 
when the emission is time independent. 
 
 
 
Concentration ( µM) τ1 (ns)  % τ2 (ns)  % 
2
 
0.00 3.1±0.0 72±0.9 0.59±0.1 28±0.8 1.12±0.03 
0.25 3.4±0.1 94±1.1 1.04±0.2 6±1.1 0.99±0.10 
0.50 3.3±0.0 93±3.5 1.03±0.3 7±3.5 0.97±0.04 
0.75 3.4±0.0 94±2.5 1.08±0.4 6±2.5 1.03±0.10 
1.00 3.4±0.0 83±1.1 1.15±0.2 17±1.1 1.30±0.38 
1.50 3.4±0.0 92±3.2 1.09±0.3 8±3.2 1.06±0.07 
2.00 3.3±0.0 100±0.0 N/A N/A 1.10±0.03 
10.00 3.3±0.0 100±0.0 N/A N/A 1.12±0.07 
20.00 3.3±0.0 100±0.0 N/A N/A 1.15±0.01 
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4.4  Conclusions 
The goal of this work was to study the localisation and concentration of miR-132 in live 
neuroblastoma cells. An importation step towards this goal was quatification of the MB 
in solution phase, as this allows the binding of the miR-132 to the MB to be studied 
outside of the complexity of a live cell. This can inform the interpretation of results 
from live cells, which is presented in a later section. 
The first objective of this chapter was to test the ability of the MB to detect its miRNA 
target in solution. The 1 µM MB was shown to be capable of detecting miR-132 with 
linear increase in the emission intensity as the target concentration is increased from 
0.25 µM to 2.0 µM. Above this point the increase in intensity with increasing 
concentration of the miR-132 target began to decrease. This is consistent with the 
solution containing insufficient quantity of the molecular beacon in the self-bound form. 
 The MB was shown to be high selective, with excellent discrimination for one, two and 
three base mismatches. The intensity from 1BMM and 2BMM was lower than that seen 
for 3BMM. The reason for this difference is not known, however the intensity is 
considerably lower for all of the mismatches studied. Within a live cell, no miRNA 
have been detected with such high similarity, so the insensitivity of the MB to 3BMM 
should insure high specificity in the cellular environment.  
 The MB was also capable of detecting miR-132 from a neuroblastoma cell line, SK-N-
AS, which gave a cellular concentration of miR-132 within the cell of approximately 
0.14 µM. This value is an approximation of the cellular miR-132 concentration. One 
major source of error for this measurement is the counting of the cells. Cell were 
counted with a haemocytometer, for a more accurate cell count flow cytometry would 
be required. This may improve the accuracy of this cellular concentration result.    
A significant signal was detected for the MB in the absence of target despite the use of a 
black hole quencher. Molecular modelling predicted the presence of three alternate 
conformers with similar association energies. The separation between the 6-FAM and 
the dabcyl quencher is larger in some of these conformers, which may explain this 
signal. Thermal cycling of the beacon resulted in no change in intensity, suggesting that 
the difference in energy between these conformers is either insufficiently large to drive 
the formation of a single conformer, or that a meta-stable state is formed kinetically. 
159 
 
In an attempt to reduce the background fluorescent from the beacon, a second iteration 
was designed. It was informed by molecular modelling which showed significantly 
higher stability of the self-bound form, and only a single alternate conformer. Testing of 
the MB2 showed a 20 % reduction in background fluorescence compared to the MB1. 
The linear detection range of the MB2 was found to be very similar to MB1, with no 
significant improvement in the signal to noise ratio. 
Overall the second iteration of the MB was shown to have no significant improvements 
over the first version, and at higher target concentrations was found to be even less 
effective. It was decided based on these results to perform live cellular imaging with the 
first version of the beacon. It was also decided to refrain from designing further 
iterations of the beacon, because the primary alternate conformer is based on similarity 
in the sensing region of the beacon where no changes can be made, and that further 
lengthening of the stem portion of the beacon would result in poorer target binding and 
detection limits based on molecular modelling.  
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5.1  Introduction 
miRNA has been shown to have an important role to play in a wide variety of biological 
pathways.
1
 Cells which have become cancerous tend to have differential expression of 
miRNA when compared with healthy cells.
2,3
 By analysing the miRNA concentration of 
a cellular population, it is possible to identify the presence of cancer, and potentially to 
determine the cancer subset.
4
 This can allow for earlier detection, since miRNA changes 
occur early in the disregulation of cells which leads to cancer.
5
 This can also inform 
treatment of the disease.
6
  
miR-132 has been shown to induce proliferation
7
, and is upregulated in chronic 
lymphoblastic leukaemias
8
, gastric cancer
9
, pancreatic cancer
10
 and neuroblastoma
11
. It 
has also been associated with neuronal differentiation
12,13
. miRNA primarily regulates 
cellular function by formation of the RNA induced silencing complex.
14
 The complex is 
formed after the export of the RNA from the nucleus.
15
 For this reason, the localisation 
of miRNA within the cell is an important indicator of cellular function, and disease 
state.  
 
Figure 5.1: Scheme for the live cell imaging of miR-132 using the MB. 
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This chapter reports on the use of the MB (MB) to probe where miR-132 is localised 
within live neuroblastoma cells and its concentration. It was shown in Chapter 3 that the 
dye, 6-FAM, is sensitive to changes in pH, whereby acidic pH caused the intensity of 
the dye to decrease significantly. The intensity of the dye was stable with increasing pH. 
In the cellular environment, the intercellular fluid, microchondria and nucleus are at pH 
of 7.4 or above, so no major impact on the intensity of the dye is expected. Lysosomes 
within the cell can reach  approximately pH 4, so it would be expected that fluorescence 
from these areas of the cell would be significantly reduced. The self-quenching of the 
dye was also examined, whereby significant quenching occurred at concentrations 
above 100µM. For this chapter, the concentration will be maintained below this level.  
In chapter 4, the ability of the dye to detect the miR-132 target was investigated. From 
this work, the MB reaches maximum emission intensity in approximately 10 minutes. 
This should allow for rapid detection of miR-132 within the cells.  The selectivity of the 
MB was also examined, where good discrimination was possible for a single 
mismatched base. Within the cell, no miRNA with this high degree of similarity have 
been identified, so the intensity received should be based solely on the presence of the 
miR-132 target. 
The first challenge was to introduce the MB to the cells. A number of approaches were 
examined for suitability, including passive uptake, the use of solvents to improve 
permeability, electroporation, peptide based transfection, and lipid based transfection.  
It was found that the MB was unable to passively enter the cell. The addition of 
permeabilizing agents such as 2 % DMSO, 2 % ethanol or 0.1 % triton-x also showed 
no measurable uptake of the beacon after 24 hours. Electroporation was investigated as 
a potential means of transferring the MB into cells. It was effective at introducing the 
MB; however the viability of the cell was very low, at approximately 5 %. The number 
of cells undergoing electroporation was increased to allow for a measurable population.  
The variability of the fluorescence intensity received from the cells was very high; with 
a relative standard deviation of approximately 56 %. Treatment of the cells with retinoic 
acid, which has been shown to upregulate the expression of miR-132, caused an 
increase in the overall intensity, however the high variability of the intensity within 
individual cells, combined with the low sample number, made measurement of a 
statistical difference challenging. 
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An alternative method was investigated to introduce the MB to the cells, without 
causing significant cell damage. A lipid based transfection showed good uptake of the 
MB, with a viability of approximately 60 %. Transfection with anti-miR-132, followed 
by transfection with the MB caused a decrease in average intensity, however a statistical 
difference could not be measured due to the variability between individual cells. 
Overall, this work suggests that single cell determination of miR-132 concentration may 
not be a useful diagnostic tool. 
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5.2  Experimental 
5.2.1  Materials  
DMSO, EtOH, Triton-X and retinoic acid were purchased from Sigma Aldrich. For 
DNA hybridisation, phosphate buffered saline (PBS) was prepared at a phosphate buffer 
concentration of 0.01 M and a sodium chloride concentration of 0.154 M using PBS 
tablets (Sigma Aldrich) in RNase free water. 
 
Nucleic acids were synthesised by Exiqon at 85 % purity. The following sequences 
were ordered: 
Molecular Bacon: 5’-6FAM-+CGA+CCA+TGG+CTG+TAG+ACT+GTT+AGT+CG-
DAB-3’ (where the + is a Locked Nucleic Acid)  
miR-132 Mimic: 5’- UAA-CAG-UCU-ACA-GCC-AUG-GUC-G-3’ 
anti-miR-132: 5’-CGA-CCA-TGG-CTG-TAG-ACT-GTT-A-3’ 
 
5.2.2  Cell Culture  
The adherent human neuroblastoma cell line, SK-N-AS, were obtained from the 
American Type Culture Collection (ATCC). The cells were cultured in Minimum 
Essential Media, with 10 % foetal bovine serum, 0.5 % L-glutamine and 0.5 % non-
essential amino acids, with 100 µg/mL Gentamicin at 37 ˚C and 5 % CO2. 
The cells were split at three day intervals, and seeded at a ratio of 1:3. Prior to splitting, 
the cells were rinsed with 5mL of PBS. 1 mL of trypsin was added for five minutes. 
Approximately 5mL of cell culture media was then added to neutralise the trypsin. 2 mL 
of this solution was then added to a new cell culture flask with 8 mL of media. The 
mixture was gently mixed by pipetting and then replaced in the incubator. 
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5.2.3  Electroporation  
Electroporation experiments were performed using the Bio-Rad GenePulser Xcell. Cells 
were incubated for 48 hours which achieved approximately 75 % confluency. Cells 
were then rinsed with PBS three times to remove the media, and trypsinized for 10 
minutes. Cells were resuspended in 1mL of media, and counted using a 
haemocytometer. Cells were diluted to achieve a cell density of 3 x 10
6
 cells per mL. 
400 µL of this suspension was loaded into an electroporation cuvette. MB or miR-132 
mimic was added to achieve a concentration of 5 µM. The cuvette was then placed in 
the Bio-Rad GenePulser Xcell and electroporated as previously described (see Section 
2.1.6). The cells were then immediately transferred to a cell culture dish, post 
electroporation, and media was added to bring the final volume to 2 mL. The cells were 
then incubated for 24 hours. This allowed the cells which survived the procedure to 
attach to the cell culture dish. Cells were then imaged by confocal microscopy to 
determine viability. 
5.2.4  N-TER Transfection  
20 µL of 50 µM MB was mixed with 80 µL of N-TER buffer. 100 µL of N-TER 
solution peptide (Sigma Aldrich) was then added to achieve a concentration of 5 µM 
MB. The mixture was incubated for 30 minutes at 37 °C, then added to 800 µL of media 
and added to cells. Cells were then incubated for 24 hours. 
5.2.5  Escort IV Transfection 
20 µL of 50 µM MB, miR-132 mimic or anti-miR-132, was added to 30 µL of media. 
5 µL of Escort IV transfection reagent (Sigma Aldrich) was added to 45 µL of media. 
The two solutions were mixed to give a nucleic acid concentration of 5 µM, and 
incubated for 20 minutes at 37 °C. The mixture was added to 900 µL of media and 
added to the cells. Cells were then incubated for 24 hours. 
5.2.6  Imaging 
Cellular imaging was performed using a Zeiss LSM 510 confocal microscope, which 
was used for dye visualisation, with an argon ion laser at 458 nm and with an LP560 
filter at 6 %. A 63x oil emersion objective lens (NA 1.4) was used, with a further 4x 
zoom obtained using the scanning software. Experiments were run for periods of up to 
60 minutes. 
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5.3  Results and Discussion 
This chapter describes the use of the MB to study the localisation and concentration of 
miR-132 within live cells. The first challenge was to deliver the MB into the cells. The 
first approach was passive uptake, whereby the cells were incubated with 5 µM MB in 
media. After 24 hours, the cells appeared to be healthy, with good attachment to the cell 
culture flask, normal morphology, and no significant cell debris visible. However, when 
the cells were imaged by confocal fluorescence microscopy, no signal was visible 
within the cells for the MB. This suggests that the MB is not capable of passive 
diffusion through the membrane. 
The two primary means of diffusion through a cell membrane are passive and 
facilitated.
16
 Only molecules which are small and non-polar are capable of passive 
diffusion through the lipid membrane.
17
 The MB is slightly negatively charged which 
makes passive diffusion unlikely.
18
 Facilitated diffusion proceeds via transmembrane 
proteins, however these channels require specific recognition or an external trigger, for 
example voltage-gated channels require a change in membrane potential.
19
 Overall this 
makes the passive transport of the MB through the cell membrane unlikely.   
Since passive uptake was unsuccessful, the use of agents to increase the permeability of 
the cells was then investigated. 2 % DMSO, 2 % EtOH and a surfactant, Triton-X, were 
investigated. Figure 5.2 shows the cells treated with 2 % DMSO after 4 hours and 24 
hours. The normal morphology and good attachment of the cells suggested low toxicity 
from the 2 % DMSO, however no uptake of the MB could be detected. 2 % EtOH and 
Triton-X showed similar results, with good viability of the cells, but no apparent uptake. 
The confocal settings were optimised so that the MB at 5 µM in the absence of the 
target was undetectable. It is possible that the lack of detectable signal was due to a low 
concentration of either the target miRNA or the MB, either of which could result in an 
undetectable intensity value.  
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Figure 5.2: Confocal fluorescence microscopy of SK-N-AS cells after incubation with 
5 µM MB in 2 % DMSO with media. Excitation with argon ion laser at 458 nm and with 
an LP560 filter at 6 %. 
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5.3.1  Electroporation 
The next method attempted was electroporation, which had previously been successful 
at introducing the 6-FAM dye to cells, see Section 3.3.6.2. Electroporation has been 
shown to be highly effective for the introduction of nucleic acids into mammalian 
cells.
20,21
 Initially 1 x 10
5
 cells were treated with 5 µM MB in media and electroporated 
with a square wave pulse of 200 V peak amplitude and 20 ms pulse width in a 0.2 cm 
gap electroporation cuvette. Figure 5.3 shows a batch of SK-N-AS cells which were 
electroporated 3 hours prior to being imaged. The cells were imaged in the media 
containing the MB, as this provided contrast for the image. A large amount of cell 
debris was visible, which suggested poor cell viability for the method. While a 
significant portion of the cells appeared to be dead, a number of viable cells were also 
observed. These live cells showed high emission intensity. However, the viability of the 
cells was estimated at below 2 % for this experiment. Based on these results, it was 
decided to increase the number of cells electroporated from 1 x 10
5
 to 3 x 10
6
, so that a 
sufficient number of viable cells would still remain to allow for analysis. 
Figure 5.4 shows a viable cell which was electroporated 24 hours prior to imaging. As 
in the previous experiment, a large amount of cell debris is viable in the media, which 
was due to the large number of cells destroyed during the electroporation procedure. 
Interestingly, these cells showed an area of very high intensity within the nucleus, with 
much lower intensity in the surrounding cytoplasm (500x difference). This was in 
contrast to the electroporation with 6-FAM seen previously, which showed that even in 
cells with ruptured cell membranes, the dye was still highly excluded from the nucleus.  
There are a number of possible explanations for this higher intensity within the nucleus. 
One is that the MB is preferentially transported to the nucleus by an intercellular 
process, however access to the nucleus is tightly controlled by the nuclear pore 
complex
22
. This makes it highly unlikely for a given nucleic acid sequence to be 
actively transported into the nucleus.
23
 Another possibility is that the beacon is 
electroporated into the entire cell and the portion in the cytoplasm is broken down or 
excluded, causing a reduction in signal intensity, however if the beacon was broken 
down, this would increase the separation between the 6-FAM and the quencher, which 
would cause an increase in signal. The third possibility is that the concentration of the 
beacon is consistent across the cytoplasm and nucleus, and that a higher concentration 
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of miR-132 within the nucleus is causing the beacon to open, resulting in a higher 
intensity signal.  
The localisation of miR-132 within cells is not well understood, with different 
experiments resulting in different expression. A recent study examined the relative 
concentration of miR-132 in the nucleus and cytoplasm using a variety of methods 
including microarray, northern blotting and deep sequencing.
24
 Cells were separated by 
centrifugation into a nucleus and cytoplasm fraction. The results varied depending on 
the measurement technique used, with deep sequencing showing a very high expression 
level in the nucleus compared to the cytoplasm, whereas northern blotting showed a 
slightly lower relative signal from the nucleus.  
These published results broadly agree with the nuclear localisation observed in this 
experiment. Even if the number of miR-132 in the cytoplasm is slightly lower than in 
the nucleus; the volume of the nucleus is considerably smaller, which would result in a 
higher effective concentration.  
Interestingly, miR-132 has been linked to neuronal cell survival, with miR-132 being 
upregulated in response to damage to the cell.
24
 The electroporation procedure causes 
damage to the cell membrane which much be repaired by the cell, and so it is plausible 
that electroporation is activating this stress response, causing the miR-132 expression 
level to be increased.
21
  This upregulation would involve production of miR-132 in the 
nucleus of the cell, which would explain the high signal observed.  
Since the localisation of miR-132 in live cells had been achieved, the next objective was 
to determine the concentration within the cells.  
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Figure 5.3: Confocal fluorescence microscopy of SK-N-AS cells 3 hours after 
electroporation with 5 µM MB. Excitation with argon ion laser at 458 nm and with an 
LP560 filter at 6 %. 
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Figure 5.4: Confocal fluorescence microscopy of SK-N-AS cells 24 hours after 
electroporation with 5 µM MB. Excitation with argon ion laser at 458 nm and with an 
LP560 filter at 6 %. 
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5.3.2  Concentration of miR-132  
The next objective was measurement of the concentration of miR-132 within the cell. 
When cells are electroporated, the cell works to actively repair the pores which form in 
the membrane. These pores can remain open for up to 9 minutes.
25
 During this period of 
time, the concentration of MB should fully equilibrate between the solution and interior 
of the cell. This means that the concentration of MB within the cells should be 
approximately 5 µM. The confocal microscopy settings were optimised so that the 
background signal which was measured for the MB in the absence of target would not 
produce a measurable fluorescence. Thus, any signal detected in the confocal 
microscopy images should be due to opening of the MB.   
The intensity values of the MB with a range of miR-132 conentrations were recorded in 
solution using the confocal microscope. When the settings in Figure 5.4  were used, the 
intensity received was very low. This resulted in significant noise, and made 
determination of an absolute intensity difficult. In an attempt to overcome this issue, the 
gain settings were increased so that the intensity of the MB with miR-132 gave a very 
high intensity, which had the effect of significantly reducing the noise associated with 
the measurement. The full concentration range was then performed at these increased 
gain settings. A single point calibration was then performed using the higher gain 
setting, and then with the lower gain setting used in Figure 5.4. This single point 
calibration was then used to numerically adjust the calibration curve down, by assuming 
a linear dependence of the intensity on gain, see Figure 5.6 
As can be seen in Figure 5.5, the intensity increased steadily as the MB was added, 
giving similar relative intensities to the solution phase experiments in Chapter 2. As 
illustrated in Figure 5.6, when the intensity values were adjusted, the minimum 
detectable value was approximately 4.6 µM with the settings used to record the confocal 
images. The average intensity of the nucleus seen in Figure 5.4 corresponds to a 
concentration value of approximately 5.8 µM according to this calibration. 
This value is significantly higher than expected based on the previous value achieved 
for lysed cells, which gave a concentration for the entire cell of 0.14 µM. Assuming that 
all of the miR-132 present within the cell is localised in the nucleus and the volume of 
the cell is taken as being approximately 20 pL, and the volume of the nucleus as being 
2.3 pL, then the concentration within the nucleus would be approximately 1.2 µM. As 
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reported by other researchers, these data speak to the difficulties of precisely defining 
the absolute miRNA concentration in different regions of the cells. But the results 
strongly suggest that following electroporation the miR-132 concentration is in the 
micromolar range. 
As previously discussed, miR-132 has been linked to the survival response of the cell, 
so it is possible that the miR-132 concentration for this experiment was higher than that 
in the lysed cells experiment, however the magnitude of the increase in the measured 
intensity was unexpected. It is also unlikely that all of the miR-132 was in fact located 
within the nucleus.  
The cause for this increase in intensity value within the nucleus of the cell is not well 
understood. 6-FAM was shown in Chapter 2 to be sensitive to changes in pH, however 
the pH value in the nucleus is approximately 7.2, which is very similar to the pH 7.4 for 
the PBS used for the calibration, so this is not expected to cause any significant 
difference.  
 
 
Figure 5.5: Average intensity measured by confocal microscopy for 5 µM MB with a 
range of miR-132 concentration from 0.25 µM to 10 µM in PBS. Gain increased to give 
maximum possible signal. 3 repeats of the experiment were performed. 
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Figure 5.6: Average intensity measured by confocal microscopy for a 5 µM solution of 
the MB with a range of miR-132 concentration from 0.25 µM to 10 µM in PBS. Intensity 
numerically adjusted based on a single point calibration to match gain settings used in 
Figure 5.4. 3 repeats of the experiment were performed. 
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5.3.3  Electroporation of Target into Cells 
Since delivery of the MB had been successfully achieved, the next objective was to 
examine the ability of the MB to monitor changes in the intercellular miRNA 
concentration. The goal was to introduce a miR-132 mimic to the cell, and then 
introduce the MB.  
As a control experiment, 3 x 10
6
 cells were initially electroporated in fresh media, and 
then incubated for 8 hours. The cells were then electroporated a second time with 5 µM 
of the MB and incubated for a further 12 hours.  
Figure 5.7 shows the results for this experiment. The viability of the cells was very 
poor, with a large amount of cell debris visible in solution, and very few cells adhering 
to the glass slide. While it was technically possible to further increase the number of 
cells used in the experiment, the viability was so low that an acceptable sample size 
would have been unachievable. This experiment suggested that electroporation is too 
damaging to the cells for consecutive cycles to be performed. 
This low viability was somewhat expected based on the mechanism of electroporation. 
Sealing of pores formed during electroporation requires active repair by the cell. This 
process involves the removal of water, reordering of membrane lipids, and use of ion 
pumps to restore ion gradients.
26,27
 This is a time consuming and energy intensive 
process. In the case of even larger membrane defects, cytoplasmic transport vesicles 
must be actively transferred to the defect site.
28
 It is probable that even after 12 hours, 
the resources used to repair the membrane are still depleted, and so the resealing of 
defects becomes more difficult, resulting in apoptosis.
29
  
Since addition of miR-132 to the cells using electroporation was not a viable approach, 
alternate methods of modulating the cellular miR-132 concentration were then 
examined.  
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Figure 5.7: Confocal fluorescence microscopy of SK-N-AS cells after two 
electroporation cycles with 5 µM MB. Excitation with argon ion laser at 458 nm and 
with an LP560 filter at 6 %. 
20µm 
20µm 
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5.3.4  Retinoic acid Treatment 
Retinoic acid had been show previously to upregulate the production of miR-132 in 
neuroblastoma cell lines.
29
 It was hoped that by treating cells with retinoic acid for 24 
hours, a measurable increase in the intensity would be observed, corresponding to 
upregulation of miR-132. 
The retinoic acid was not soluble in water, or in a DMSO:water solvent system, and so a 
5 % solution of ethanol was investigated. SK-N-AS cells were treated with 1 µM 
retinoic acid for 24 hours. Cells were then electroporated with 5 µM MB, and incubated 
for a further 12 hours. The results for this experiment are shown in Figure 5.8, alongside 
a 5 % ethanol only control. The viability of the retinoic acid treated cells was 
approximately 5 %, which was similar to the control population.  
As illustrated in Figure 5.9, the average intensity in the retinoic acid treated cells is 
higher than the control population. Unfortunately, the intensity values for individual 
cells can vary significantly. For the control cells, the average intensity value was 
73.13±41.10 A.U., (n=22), i.e., the relative standard deviation is approximately 56 %. 
This large variation between cells makes it challenging to confirm a statistically 
significant difference between populations of control and retinoic acid treated cells.  
One possible cause for this large deviation seen between individual cells is that the 
natural expression level of miR-132 is significantly different. A recent study, which 
examined the miRNA concentration of individual cells, found that distribution among 
individual cells varied greatly depending on the miRNA measured and the cell line 
tested. For example, in the K652 cell line, miR-223 expression had a standard deviation 
of 79 % and the distribution was not log-normal, whereas miR-16 gave a standard 
deviation of 30 % with log normal expression.
30
  
The distribution of the control population is shown in Figure 5.10. Unfortunately, the 
poor viability of the cells resulted in a relatively small number live of cells, which 
further complicated the analysis.  In both the cytoplasm and nucleus, the distribution 
appears to be non-normal, however this may be due to the intensity threshold of the 
experiment, whereby low intensity signals corresponding to cells with a lower 
concentration of target are not detectable.  This suggests a high level of difference 
between the expression of miR-132 in individual cells. As previously discussed, 
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miR-132 has been linked to the stress response of neuronal cells.
24
 In this experiment, 
cells were electroporated and treated with 5 % ethanol, both of which are capable of 
activating a stress response. It is possible that the distribution of miR-132 may be 
different in a normal population of cells.  
The next objective was to deliver the MB to the cells without causing significant 
disruption to the cells. A number of different transfection reagents were examined for 
suitability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Confocal fluorescence microscopy of SK-N-AS cells treated with 1 µM 
retinoic acid for 24 hours (left), and 1 µM ethanol (right). Electroporated with 5 µM 
MB, and incubated for 12 hours before confocal microscopy. Excitation with argon ion 
laser at 458 nm and with an LP560 filter at 6 %. 
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Figure 5.9: Average fluorescence intensity in the nucleus and cytoplasm of SK-N-AS 
cells treated with 1 µM retinoic acid for 24 hours, and 1 µM ethanol. Electroporated 
with 5 µM MB, and incubated for 12 hours before confocal microscopy.  
 
       
Figure 5.10: Fluorescence intensity in the nucleus (left) and cytoplasm (right) of 
SK-N-AS cells in 5 % EtOH. Electroporated with 5 µM MB, and incubated for 12 hours 
before confocal microscopy. 
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5.3.5  Transfection with N-TER 
In an attempt to deliver nucleic acid to cells without causing the poor viability 
previously seen for electroporation, a peptide based delivery system called N-TER was 
examined. This transfection reagent had previously proved successful for delivery of 
nucleic acids to neuronal cell lines.
31 
Cell-penetrating peptides are a class of short 
peptides which enable the uptake of molecules through the cell membrane.
32
 The 
transfected molecule can be held by covalent bond or by non-covalent interactions. The 
peptides tend to gain access to the cell by direct translocation and endocytosis.
33
   
The MB was mixed with N-TER, as previously described in Section 5.2.4, and added to 
the SK-N-AS cells. Figure 5.11 shows the results of the transfection after 4 hours. A 
significant amount of cell debris is visible; however the majority of the cells appeared to 
be healthy, with good attachment to the surface and normal morphology. A number of 
the cells showed high intensity in the nucleus, as previously seen with electroporation; 
however for the majority of the cells no significant fluorescence emission was detected.  
24 hours after transfection, the cells were washed to remove dead cell debris and the 
cells were visualised under confocal, see Figure 5.12. The vast majority of the cells 
showed no emission, with a small number showing very low intensity emission. This 
suggests that the N-TER may be toxic to the cells which it efficiently transfects, as the 
percentage of cells with emission decreased from the 4 hour time point to the 24 hour 
time point. It is also possible that the cells had excluded the beacon over the 24 hour 
period, however no evidence of this was seen in the electroporation experiments 
previously performed.  
Based on the poor uptake of the MB shown in this experiment, alternate transfection 
reagents were then investigated. 
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Figure 5.11: Confocal microscopy of SK-N-AS cells treated with 5 µM MB and N-TER 
transfection reagent for 4 hours in media. Excitation with argon ion laser at 458 nm 
and with an LP560 filter at 6 %. 
20µm 
20µm 20µm 
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Figure 5.12: Confocal microscopy of SK-N-AS cells treated with 5 µM MB with N-TER 
transfection reagent for 24 hours in fresh media. Excitation with argon ion laser at 458 
nm and with an LP560 filter at 6 %. 
20µm 
20µm 20µm 
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5.3.6  Transfection with Escort IV 
Since the peptide based transfection was unsuccessful in delivering the MB into the 
cells, a lipid based transfection, Escort IV, was investigated. Lipid transfections involve 
the encapsulation of a negatively charged species, in this case DNA / LNA, to form 
micelles with a positively charged outer membrane.
34
 These positively charged micelles 
are capable of passing through the negatively charged cell membrane.
35
 Liposome 
transfections have been shown to have high efficiency and reproducibility with low 
toxicity.
36
 
The MB was combined with Escort IV, as previously described in Section 5.2.5, and 
added to the SK-N-AS cells. After 4 hours the uptake was observed by confocal 
microscopy. As seen in Figure 5.13, a number of cells show a weak emission suggesting 
that a small amount of the MB has been uptaken. Also visible are a number of smaller 
areas showing a high intensity fluorescence signal. These are believed to be MB 
containing micelles that have not yet been uptaken into the cells. 
After 24 hours the cells were visualised again, as seen in Figure 5.14. The number of 
micelles which were visible at the 4 hour time point was significantly reduced. The 
number of cells showing uptake of the MB was also significantly increased. As 
previously seen for electroporated cells, the area of the cell showing highest intensity is 
the nucleus. This is very promising, as it suggests this signal is not as a result to damage 
of the cell caused by electroporation. A weaker signal is also present in the cytoplasm, 
suggesting that miR-132 is predominantly nuclear localised.   
The viability of the cells was approximately 65 %, which was a significant 
improvement over the 5 % viability achieved with electroporation.  
Since a method of delivering nucleic acid to the cells without causing significant 
reduction in cell viability had been identified, modulation of the cellular miR-132 
concentration was again attempted. 
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Figure 5.13: Confocal microscopy of SK-N-AS cells treated with 5 µM MB with Escort 
IV transfection reagent for 4 hours. Excitation with argon ion laser at 458 nm and with 
an LP560 filter at 6 %. 
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Figure 5.14: Confocal microscopy of SK-N-AS cells treated with 5 µM MB with Escort 
IV transfection reagent for 24 hours in fresh media. Excitation with argon ion laser at 
458 nm and with an LP560 filter at 6 %. 
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5.3.7  Mimic and anti-miR 
SK-N-AS cells were treated with either a miR-132 mimic, or anti-miR-132 using Escort 
IV for 24 hours. Cells were then treated with 5 µM MB for a further 24 hours, and the 
results were visualised by confocal microscopy. 
Cells which were treated with the miR-132 mimic reacted poorly. No cells were 
attached to the surface of the cell culture dish, with only cells in suspension visible. 
Figure 5.15 shows a selection of these cells. The cell membrane is damaged for most of 
the cells, with death vacuoles visible. These images suggest that the cells transfected 
with miR-132 underwent apoptosis. While analysis of these cells is not possible, since 
the conditions within dead cells can be significantly different to live cells
37
, these data 
suggest that the transfection was successful, and the miR-132 is toxic to the cells at high 
concentrations. Since no cells were found attached to the surface it also suggests that the 
transfection was successful at introducing miR-132 to a significant fraction of the entire 
population. 
 
 
Figure 5.15: Confocal microscopy of SK-N-AS cells treated with 5 µM miR-132 mimic 
with Escort IV transfection reagent for 24 hours, followed by 5 µM MB with Escort IV 
for 24 hours. Excitation with argon ion laser at 458 nm and with an LP560 filter at 6 %. 
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Figure 5.16: Confocal microscopy of SK-N-AS cells treated with Escort IV for 24 hours, 
followed by 5 µM MB with Escort IV for 24 hours. Excitation with argon ion laser at 
458 nm and with an LP560 filter at 6 %. 
 
 
Figure 5.17: Confocal microscopy of SK-N-AS cells treated with 5 µM anti-miR-132 
with Escort IV for 24 hours, followed by 5 µM MB with Escort IV for 24 hours. 
Excitation with argon ion laser at 458 nm and with an LP560 filter at 6 %. 
 
Figure 5.16 shows the control population of cells for this experiment. These cells were 
treated with Escort IV for only 24 hours, and then with MB. The viability of the cells 
was very high, at approximately 80 %, with the majority of the cells showing normal 
morphology, with good attachment to the surface. The relative intensities of the various 
cells is significantly different, with some cells showing an intensity in the nucleus of 7 
20µm 20µm 
20µm 20µm 
 191 
 
A.U., whereas others were as high as 123 A.U. Figure 5.18 shows the distribution of 
miR-132 within the nucleus of 307 cells. The average intensity was 20.5±13.3 A.U., 
which is a relative standard deviation of 163 %.  
On possible reason for the high variability of these cells is the passage number. Cells 
were passaged a maximum of 25 times from the frozen stock, which may allow for 
significant divergence from the parent line. This could cause the cells examined to have 
the higher than expected variance in intensity shown in Figure 5.18.  
Figure 5.17 shows images of cells transfected with anti-miR-132. As seen in the control 
population there is a large variation in the intensity from the cells. The viability of these 
cells was high at approximately 80 %, with cells showing good attachment and normal 
morphology. These cells were seeded at approximately 60 % confluency, and were 
highly confluent at the end of the experiment which suggests that the cells were capable 
of growing normally despite the addition of anti-miR-132.  Figure 5.19 shows the 
distribution of the intensity in the nucleus of these cells. The average intensity was 
16.8±7.0 A.U. which is a relative standard deviation of 41 %. It was expected that the 
addition of the anti-miR-132 would result in a significantly lower signal than that found 
for the control population. While the intensity is lower for these cells, the standard 
deviation makes it difficult to confirm a statistically significant difference.  
The Shapiro-Wiki normality test
38
 was used to analyse the distribution of the two 
populations. This is considered the most powerful normality test for all sample sizes and 
distributions
39,40
, and is suitable for a sample size from 3 to 5000
41
. The control 
population had a calculated P value of 0.0871, assuming a significance interval of 95 %, 
this distribution is Gaussian. The anti-miR-132 treated cells however had a calculated P 
value of 0.0123, and as such is considered non Gaussian. This analysis suggests that the 
transfection of the anti-miR-132 did have a measurable impact on the cells, causing the 
loss of a normal distribution, but that the natural variation between the miR-132 
concentration in individual cells makes direct comparison of the intensities difficult. 
The sample sizes used for this analysis are 238 for the control population and 307 for 
the anti-miR-132 treated cells.  
The death of cells transfected with miR-132 mimic suggests that the transfections 
performed in this experiment were successful. While the change in the shape of this 
distribution suggests that the cells were impacted by the addition of the anti-miR-132, 
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no definitive conclusions can be drawn from this data. As previously mentioned, the 
passage number of the cells may be impact the variability of the population, so the wide 
distribution of miR-132 seen here may be as a result of this population drift. 
Alternatively, this distribution could be linked to the cell cycle or some other cellular 
process.  
 
Figure 5.18: Fluorescence intensity in the nucleus of SK-N-AS cells treated with Escort 
IV for 24 hours, followed by 5 µM MB with Escort IV for 24 hours. 
 
Figure 5.19: Fluorescence intensity in the nucleus of SK-N-AS cells treated with 5 µM 
anti-miR-132 with Escort IV for 24 hours, followed by 5 µM MB with Escort IV for 24 
hours. 
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5.4  Conclusions 
The objective of this chapter was to use the MB to study the localisation and 
concentration of miR-132 in a neuroblastoma cell line. The MB was successfully 
introduced to the cells by electroporation. The area of highest intensity was in the 
nucleus of the cell, suggesting a high nuclear concentration of miR-132. These high 
intensities are potentially as a result of a cellular survival mechanism which upregulate 
the production of miR-132.  
The intensity values achieved by confocal microscopy were used to estimate the 
concentration of miR-132. The concentration within the nucleus was calculated as 
approximately 5.8 µM. Based on the lysed cell experiment from Chapter 2, the 
maximum concentration of miR-132 within the nucleus was 1.2 µM. The reason for the 
considerably higher value under confocal microscopy is not known but variations of this 
kind have been reported previously.   
The ability of retinoic acid to modulate the intercellular miR-132 concentration was also 
investigated. Unfortunately, the poor viability of the cells after retinoic acid treatment 
and electroporation resulted in a small sample size, so a statistically significant 
difference could not be confirmed. 
Modulation of the intercellular miR-132 concentration was then attempted by 
electroporation a miR-132 mimic into the cell, followed by the MB. Again, the poor 
viability caused by electroporation caused all of the treated cells to undergo apoptosis. 
Alternate methods of delivering the MB to the cells were investigated. A peptide based 
transfection system resulted in poor uptake, however a lipid based transfection allowed 
for highly efficient transfection with viability of above 60 %. The MB was introduced to 
the cells via this method and, as with electroporation, the area of highest intensity was 
within the nucleus of the cell. This agreement between the two transfection approaches 
suggests that this is a real result. 
The lipid based transfection was used in an attempt to vary the intercellular miR-132 
concentration. Transfection of a miR-132 mimic resulted in 100 % cell death, which 
suggests that miR-132 is toxic to cells at high concentrations. Analysis of the control 
population showed the high variability in miR-132 between individual cells, which 
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fitted to a Gaussian distribution. This high variability may be due to the high passage 
number of the cells, which can allow the characteristics of the cells to drift, giving rise 
to a number of distinct cell populations with differing characteristics. This issue could 
be avoided by more frequent restoration of cells from frozen stocks.    
Transfection with anti-miR-132 resulted in similar viability to the control population, 
however the large variability between cells made confirmation of a statistically 
significant difference impossible. However, the distribution of miR-132 became less 
Gaussian compared to the control population, which suggests the transfection was 
successful. 
Overall this chapter highlights the challenges that arise from the large variability that 
can occur in intercellular miR-132, which in turn make measurement of the absolute 
concentration problematic.  Currently, without the ability to overcome these challenges, 
live cell imaging of miR-132 is not currently able to provide deep insights into 
neuroblastoma detection or progression. 
The results contained in this chapter are currently awaiting publication.  
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CHAPTER 6 
 Detection of miR-132 by Displacement Assay 
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6.1  Introduction 
The detection of short nucleic acids, specifically miRNAs, is important for the detection 
and diagnosis of a number in diseases, including cancer.
1-3
 The early detection of cancer 
has been shown to improve survival rates for a number of cancers. 
7-9
 To achieve 
detection before the onset of clinical symptoms, a method of detection which is highly 
sensitive and suitable for wide scale screening is required.  
Detection of miRNA in solution is challenging due to the short nature of the nucleic 
acid strand, typically 17-25 nucleotides or 5-9 nm in length.
1
 Also, for physiological 
samples, the concentration of miRNA can be extremely low, often in the sub picomolar 
range.
2
 The current state of the art, PCR, requires amplification of the initial quantity of 
miRNA to achieve measurable levels.
3-5
  
According to  survey findings from ‘Testing Sites Holding a Certificate of Waiver under 
the Clinical Laboratory Improvement Amendments of 1988” (USA) point of care 
devices use “waived” testing which requires “simple tests with a low risk for an 
incorrect result”.6 While PCR allows for ultra-sensitive detection7-9, the equipment and 
personnel required mean that this technology is not currently applicable to a point of 
care setting
10-12
. While other methods of detecting miRNA are currently possible, these 
suffer from poor sensitivity, in the case of optical devices, or high complexity, as shown 
in Chapter 1 for electrochemical detection. The objective of this research is to achieve 
the amplification free detection of ultra-low concentration of miR-132 through a novel 
displacement assay in which a single binding event can produce a measureable signal, 
i.e., sensitivity towards the single molecule level.   
This technology is well suited for use in a flow based system, and is therefore suitable 
for a point of care setting. This can aid in wide scale screening of disease by improving 
the availability and reducing the time taken to achieve a measurement. Future work will 
focus on optimising the sensitivity of the assay, and integration into a flow chip, to 
allow for high speed, sensitive miRNA detection.   
Figure 6.1 shows the scheme used in this assay, which utilises the strong recognition of 
nucleic acids for complementary strands.
13-15
 In this prototype nucleic acid assay, a 
capture strand of DNA, complementary to miR-132, was bound to a surface. A carboxy 
functionalised probe strand of DNA, partially complementary (11 out of 22 bases) to 
this capture, was then attached to an amino functionalised 3µm radius microsphere 
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using 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) coupling. These 
microspheres where then allowed to hybridise with the surface immobilised capture 
strands. When the fully complementary miRNA target was added, it should displace the 
probe strand, freeing the microsphere into the contacting liquid. Unlike the initial target 
miRNA, the displaced sphere can be visualised using conventional microscopy. The 
microsphere can also be labelled with a fluorescent dye, allowing it to be quantified 
using fluorescence.   
The major benefit of this approach is that the detection surface can be prepared in 
advance as part of a disposable microfluidic chip. When a detection is performed,  a 
small volume of blood or plasma can be added to the device, with no other reagents 
required. This system should be able to produce a result within minutes, allowing for 
rapid diagnosis and treatment. Since a single displacement even releases a large 
microsphere, this generates a large easily measurable signal, either using a simple 
fluorescence reader, or alternatively by the generation of an electrical current as the 
large magnetic microspheres moves through an inductive coil. This assay has the 
potential for single molecule detection of miRNA, as a single hybridisation event results 
in a measurable signal. 
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Figure 6.1: Scheme of displacement assay showing, (A) a 3µm microsphere,(B) EDC 
coupling of probe DNA and Cy5 Dye, (C) attachment of a microsphere to Au surface 
via thiolated capture strand, (D) displacement of microsphere upon addition of target 
miRNA. 
(A) 
 
 
 
(B) 
 
 
 
 
(C) 
 
 
 
 
 
(D) 
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6.2  Experimental 
6.2.1  Materials 
Cyanine5 amine dye was purchased from Lumiprobe at 95% purity. 3 µm ProMag 3 
Series COOH microspheres were purchased from Polyscience. [Ru(bpy)2PIC-COOH]
2+
 
was synthesised by Dr. Kellie Adamson and was fully characterised using NMR, HPLC, 
voltammetry and elemental analysis. DNA and RNA were purchased from Exiqon at 
≥80 % purity. The following sequences were ordered for the detection of miR-132:  
Capture: 5’–CGA-CCA-TGG-CTG-TAG-ACT-GTT-A–3’-SH 
Probe: 5’–AGC-CAT-GGT-CG-3’-NH2 
miR-132 Target: 5’-UAA-CAG-UCU-ACA-GCC-AUG-GUC-G-3’ 
All other reagents were purchased from Sigma Aldrich. Gold coated silicon wafer, 
99.999% Au, 100 nm thick, was used for images. For DNA hybridization, phosphate 
buffered saline (PBS) was prepared at a phosphate buffer concentration of 0.01 M and a 
sodium chloride concentration of 0.154 M using PBS tablets (Sigma Aldrich) in RNase 
free water. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was purchased at 
≥99.0 % purity.  
 
6.2.2  Emission Spectroscopy 
Emission spectra were obtained using a Jasco V-670. Emission and excitation slits were 
typically 2.5 nm. Solvents used were PBS unless otherwise stated. 
 
6.2.3  Imaging 
Imaging was performed using a Zeiss LSM 510 confocal microscope, which was used 
for particle visualisation, with a HeNe laser at 633 nm and with an LP650 filter at 10% 
for Cy5 labelled microspheres, and excitation with argon ion laser at 458 nm and with 
an LP615 filter at 4.1% for [Ru(bpy)2PIC-COOH]
2+
 dye. A 63x oil emersion objective 
lens (NA 1.4) was used, with a further 4x zoom obtained using the scanning software.  
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6.2.4  Electrochemical Set-Up 
Measurements were performed using a CH Instruments Model 660. A three-electrode 
electrochemical cell was used for electrochemical measurements. The working electrode 
was a 100 nm thick Au coated silicon wafer (Sigma Aldrich), the reference electrode 
was silver/silver chloride (Ag/AgCl in 3 M KCl), and the counter electrode was a 
platinum wire. Solutions were deoxygenated before use with nitrogen. Experiments 
were carried out at room temperature (~20 °C). All glassware was cleaned in an acidic 
solution comprised of three parts H2O, one part HNO3. 
 
6.2.5  DNA Immobilisation 
Au wafer electrodes were immersed in a 10 µM solution of thiolated probe DNA in PBS 
buffer for 14 hours. Electrodes were then rinsed in deionised water to remove loosely 
attached oligos.  
 
6.2.6  EDC Coupling 
For EDC coupling a buffer was prepared with 0.01 M K2HPO4 and 0.15M NaCl and 
was pH adjusted with NaOH to pH 5.5. 10 µL (1.27 x 10
7
) of the microspheres were 
washed twice with 100 µL of the coupling buffer and then re-suspended in 100 µL of 
coupling buffer. Cy5 dye and probe DNA was added at the required concentration. 
100 µL of 5 mg ml
-1
 EDC in coupling buffer was then prepared, and 20 µL of the EDC 
solution was further added. All of the work with EDC was performed as quickly as 
possible, since EDC is highly reactive in aqueous environments. The solution was 
mixed by pipetting and subsequently incubated for 2 hours at room temperature. 
Following the reaction, the reaction vessel was placed close to a magnet to coalesce the 
particles and the supernatant was removed. The particles were then washed 5 times with 
200 µL of PBS, with magnetic separation of the particles. The functionalized 
microspheres where then resuspended in 100 µL of PBS. 
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6.3  Results and Discussion 
6.3.1  Capture Deposition on Au 
The objective to this work was the displacement of large particles to produce a 
significant measurable signal. The first element of this was the functionalization of a Au 
surface with the capture DNA. The capture strand was designed with a thiol bond which 
spontaneously forms a strong bond with Au.
16
 To probe the binding of the thiolated 
DNA to the Au, a 100 nm thick Au coated silicon wafer was immersed in 1 µM capture 
solution for 14 hours. A voltammogram was recorded in 0.1 M H2SO4 before and after 
the deposition of the DNA. The results for this experiment are shown in Figure 6.2. 
Before DNA deposition, a Au oxide reduction peak is visible at approximately +0.8 V. 
This peak gave a microscopic electrode area of 0.221 cm
2 
using Equation 2.2. After 
deposition of DNA this active area was reduced to 0.095 cm
2
, which represents a 
reduction of 57 % due to DNA adsorption. The shape of the voltammogram also 
changed, becoming sloped due to an increase in the resistance. This provides excellent 
evidence for the blocking of the surface by the thiolated DNA and suggests an 
appropriate coverage of the electrode surface, ie., the capture DNA strands are 
sufficiently far apart that they can hybridise with the target strands on the particle but 
are not so dense that the particle is essentially irreversibly bound due to the formation of 
many linakages.
17
  
Since the capture DNA had been successfully bound to the Au surface, the next 
objective was to assess the ability of the probe strand to hybridise with the capture 
DNA. 
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Figure 6.2: Cyclic voltammograms in 0.1 M H2SO4 of a Au wafer electrode, before and 
after the deposition of 1 µM capture DNA in PBS for 14 hours. The reference electrode 
was silver/silver chloride. 
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6.3.2  Capture / Probe Hybridization  
 
Figure 6.3: Scheme for the attachment of the capture DNA to Au, followed by 
hybridization of the [Ru(bpy)2PIC-COOH]
2+
 labelled probe strand (left). Displacement 
of probe after the addition of the miRNA target (right). 
To visualise the hybridisation of the probe strand to the capture, an EDC coupling was 
performed between an amine functionalised DNA and a carboxy functionalised 
[Ru(bpy)2PIC-COOH]
2+
 dye. This dye was chosen as it emits at 610 nm and its lifetime 
depends on the local microenvironment. The coupling was performed with 5 µM DNA 
and 40 µM dye in coupling buffer with 5 mg EDC for 12 hours to ensure high labelling 
efficiency of the probe strand. A Au wafer, modified with capture DNA, was then 
immersed in the reaction mixture for 12 hours at room temperature. The Au wafer was 
rinsed 5 times with PBS to remove any non-specifically attached dye. The capture-
probe-[Ru(bpy)2PIC-COOH]
2+
 wafer was then imaged under a confocal microscope to 
visualise the dye.  
Figure 6.4 (A) shows the signal received after modification of the surface with capture 
DNA. No measurable fluorescent signal was detected. Figure 6.4(B) shows the Au 
surface after hybridisation of the [Ru(bpy)2PIC-COOH]
2+
 labelled probe DNA. A 
uniform signal was detected across the Au surface. To ensure that the signal was not 
due to backscatter from the Au, a small area was imaged intensively for 10 minutes. 
After scanning, the fluorescence intensity in this region significantly reduced; this is 
consistent with bleaching of the dye in this area. This experiment suggested that the 
probe strand had successfully hybridised to the capture modified Au surface.  
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The next objective was to determine if the dye labelled probe could be displaced with 
miR-132. The Au wafer was placed in a 1 µM solution of the target for 3 hours. It was 
then removed from the solution and rinsed with PBS.  The Au wafer was reimaged by 
confocal microscopy, see Figure 6.4(C). The intensity before the RNA target was added 
was 496±8 A.U., which then dropped to 211±10 A.U.. This represents a reduction of 
57 % in intensity and provides good evidence for the effective displacement of the 
[Ru(bpy)2PIC-COOH]
2+
 labelled probe by the target miRNA.  
Based on this experiment, it was decided that the underlying displacement mechanism 
was working as expected, and so the next objective was the preparation and 
displacement of the microspheres with the intention that a small number, ideally one, 
binding event could be detected on the basis of displacing the luminescent microsphere. 
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Figure 6.4: Confocal fluorescence microscopy of bare Au wafer with (A) capture DNA, 
(B) [Ru(bpy)2PIC-COOH]
2+
 labelled probe DNA, and (C) 1 µM target. Excitation with 
an argon ion laser at 458 nm and with a LP615 filter at 4.1 %. 
 
20µm 
20µm 
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Average Intensity: 496 ± 8 A.U.  
Average Intensity: 211 ± 10 A.U.  
Average Intensity: 2 ± 0 A.U.  (A) 
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6.3.3  Cy5 Amine 
 
Figure 6.5: Structure of Cyanine 5 Amine. 
 
In order to aid the visualisation of the microspheres, the decision was made to co-
immobilise a dye along with the probe DNA strand. The photophysics of the Cyanine-5 
amine (Cy5) dye were investigated to determine its suitability for use as part of the 
displacement assay. This dye had a number of attractive properties for integration into 
the displacement assay. The dye is water soluble, which is essential as the microspheres 
are not stable in most organic solvents.
18
 It contains an amine group which allows for 
convenient coupling to the microsphere. Cy5 has a reasonable quantum yield
19
 at 0.2 
and acceptable photostability
20
. 
Figure 6.6 shows the absorption and emission spectra for 10 µM Cy5 in PBS. The 
maximum emission was found at 662 nm, which closely matches the literature value of 
670 nm
21
. A broad absorption peak is seen from approximately 500 nm to 700 nm, with 
maximum absorbance at 640 nm, which is close to the 650 nm value previously 
reported.
22
 These spectra show a very small stokes shift for Cy5, with significant 
overlap between the emission and absorption spectra. This suggests that self-quenching 
of the dye is likely to occur at high concentrations.  
To further probe the photophysical properties of the dye, its lifetime in aqueous solution 
was examined. 
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Figure 6.6: Absorbance and emission spectra of 10 µM Cy5 in PBS. Excitation at 
600 nm with excitation and emission slits at 2.5. 
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The photophysics of Cy5 has been shown to be highly oxygen dependent. 
23-25
. For this 
experiment, working in deoxygenated solutions was not practical, so the lifetime was 
measured in a normal PBS solution. The lifetime of the dye was examined using time 
correlated single photon counting. Figure 6.7 shows the fit to the TCSPC data for the 
lifetime measurement. The decay could not be accurately fitted using a single 
exponential, so a bi-exponential model was used. The residual plot shows an even 
distribution over the analysed range which suggests a bi-exponential model is sufficient 
to describe this decay.  A shorter lifetime at 0.5±0.0 ns accounted for 88 % of the signal, 
with a longer component at 1.6±0.0 ns contributing 12 % of the signal. The shorter 
lifetime is believed to be due to instrument noise, as previously observed in Section 
3.3.5. The longer lifetime of 1.6±0.0 ns is similar to the literature values of 1.8 ns.
26,27
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Figure 6.7: Time correlated single photon counting lifetime for 10 µM Cy5 in PBS with 
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A concentration curve for the Cy5 dye was prepared to examine the effect of 
concentration on the fluorescent intensity of the dye, based on the spectral overlap 
observed in Figure 6.6.  The concentration was varied between 1 µM and 1000 µM. The 
results for this experiment are shown in Figure 6.8 and Figure 6.9. From 1 µM to 50 µM 
the emission intensity increased, reaching a maximum of 19±1 A.U. At higher 
concentrations, the intensity began to fall. At 100 µM the intensity was 14±1 A.U., 
decreasing to 4±0 A.U. at 500 µM. As the concentration further increased, the intensity 
approached 0, reaching 2±0 A.U. at 1 mM. The shape of the emission spectra also 
changed significantly over the concentration range. At 10 µM and below, the spectra 
contains only a single peak. As the concentration was increased, a second peak becomes 
visible at approximately 716 nm. The position of maximum intensity also changes, 
increasing linearity with the log of concentration as shown in Figure 6.10. The 
photophysics of Cy5 have been analysed in a number of studies, with self-quenching 
indicated due to cis-trans isomerisation
28,29
, reverse intersystem crossing
30,31
, 
phosphorescence
32,33
 and millisecond blinking
23,34,35
.  
 
Figure 6.8: Emission spectra for a range of Cy5 concentrations from 10 µM to 1 mM in 
PBS. Excitation at 600 nm with excitation and emission slits at 2.5. 
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Figure 6.9: Maximum emission intensity for a range of Cy5 concentrations from 10 µM 
to 1 mM in PBS. Excitation at 600 nm with excitation and emission slits at 2.5. Results 
for 3 repeats are shown. Where error bars are not visible, they are smaller than the 
icon. 
 
Figure 6.10: Position of maximum emission intensity for a range of Cy5 concentrations 
from 10 µM to 1 mM in PBS. Excitation at 600 nm with excitation and emission slits at 
2.5. Results for 3 repeats are shown. Where error bars are not visible, they are smaller 
than the icon. 
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Based on the reduction in intensity observed at high dye concentration, the close 
overlap observed between the absorption and emission spectra, and previous reports of 
self-quenching at high concentration
36,37
, the energy transfer between Cy5 molecules 
was calculated since this will help identify the optimum separation/loading of the dye 
on the microsphere surface. 
 
Table 6.1:  Calculated values for Förster energy transfer for self-quenching of Cy5. 
Forster Distance (Å) 89.331 
Rate of Electron Transfer (1/s) 2.342 x 1026 
Dexter Value (1/eV) 1.114 
J value (cm
6
) 1.370 x 10-11 
 
The distance between two molecules of Cy5 at which energy transfer is 50 % efficient 
(R0) can be represented as: 
 
Where  K
2
 = Orientation factor 
 ϕD = Fluorescence quantum yield 
 n = Refractive index  
 J = Spectral overlap integral   
 
The orientation factor was assumed to be 2/3 for rapidly rotating randomly orientated 
donor and acceptor molecules.
38
 The refractive index was 1.333 for water.
39
 The 
quantum yield was 0.2, as previously reported.
40
 The spectral overlap was calculated 
based on the spectra shown in Figure 6.6. Based on this calculation, the critical Förster 
energy distance was calculated as 89 Å. This is a short distance, so a high degree of 
self-quenching is expected for high concentrations of the dye. At a concentration of 
approximately 0.56 µM quenching is expected to be 50 % efficient.  
Equation 6.1: Critical Förster energy distance 
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The photophysics of the Cy5 had been characterised, so the next objective was coupling 
of the dye to the microspheres. 
 
6.3.4   Microspheres with Cy5 
The Cy5 dye was attached to the microspheres by EDC coupling. EDC allows for the 
efficient coupling of primary amines to carboxylic acid groups.
41-43
 It is also water 
soluble, which is necessary for working with the microspheres due to poor stability in 
organic solvent.
44,45
 The microspheres are uniformly modified with carboxy groups 
which act as the attachment site for the coupling reaction. Based on the manufacturer’s 
specifications, each microsphere contains 4.44 x 10
9
 carboxy groups. The coupling was 
performed with 1.27 x 10
7
 microspheres, so the reaction mixture contained 5.64 x 10
16
 
carboxy groups. This gives an effective concentration of 0.45 µM during the coupling. 
500 µM Cy5 was added to ensure complete coverage of the microspheres.   
The results of this experiment are shown in Figure 6.11. The brightness of the dye was 
sufficient to allow for visualisation of the microspheres. The cross section shows that 
the dye is localised to the outside of the microsphere as expected. To analyse the effect 
of bleaching on the brightness of the particles, a small area was scanned intensively for 
5 minutes. After scanning, the brightness of the particles increased from 1603±42 A.U. 
to ≥4095 A.U. According to the manufacturer’s specification, the area of occupation for  
a single carboxylic acid group on the surface is 0.7 Å
2
. Assuming complete coverage of 
a microsphere with Cy5 and 0.7 Å separation between the microspheres, Forester 
energy transfer would be 100 % efficient.   This significant increase in fluorescence 
intensity is constant with bleaching of the Cy5 dye, which lowers the local 
concentration, resulting in an increase in the observed intensity. 
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Figure 6.11: Confocal fluorescence microscopy of 1.27 x 10
7
 3µm microspheres after 
EDC coupling of with 0.5 mM Cy5. Excitation at 633 nm with LP165 filter at 10 %. 
20µm 
20µm 
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6.3.5  Microspheres with Cy5 and Probe 
 
 
Figure 6.12: Scheme showing the two approaches for the modification of microspheres 
with Cy5 and probe DNA. 
For the attachment of the probe strand to the microsphere two approaches were 
examined. The first approach was to simultaneously attach the probe strand and dye (1 
Step). This coupling was performed with 1 mM Cy5 and 5 µM probe DNA. The 
objective of this experiment was to achieve a microsphere with a moderately low 
surface coverage of DNA so that it does not bind too strongly to the capture strand 
modified surface. The second approach was to first react the microspheres with probe 
DNA and then fill the vacant sites with Cy5 (2 Steps). This approach could give a much 
higher surface coverage of probe DNA, and a lower coverage of Cy5. In this experiment 
the concentration of carboxy groups was approximately 0.45 µM. 10 µM of probe DNA 
was coupled with the microspheres, which was expected to result in a high surface 
coverage of DNA. This was then followed with 1 mM Cy5.    
The results for this experiment are shown in Figure 6.13. The intensity of the 1 Step 
reaction was 862±155 A.U., which is considerably higher than the 1558±455 A.U. 
observed for the particles modified in two discrete steps. This is consistent with a higher 
dye coverage for the 1 Step reaction resulting in a higher local dye concentration, 
leading to increased trivial quenching due to the small Stokes shift. The difference in 
intensity between the two reactions suggests that the probe DNA was successfully 
attached to the microspheres. The goal of this work was the displacement of the 
microsphere from a capture functionalised Au surface. Preferably, only a single probe 
strand would link the microsphere to the surface. For this reason the 1 Step 
1 Step  
 
2 Steps 
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microspheres were considered to be the most appropriate, as the surface coverage of 
probe DNA should be considerably lower.  
 
Figure 6.13: Confocal fluorescence microscopy of 1.27 x 10
7
 3 µm microspheres after 
(A) EDC coupling of with 1 mM Cy5 and 5 µM probe, and (B) EDC coupling of 10 µM 
probe followed by EDC coupling with 1 mM Cy5. Excitation at 633 nm with LP165 
filter at 10 %.  
20µm 
20µm 
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6.3.6  Attachment of Microspheres with Probe to Capture  
Modified Au 
 
 
Figure 6.14: Scheme showing deposition of capture DNA onto Au (top), and co-
deposition of capture DNA with dodecanethiol (bottom). 
 
The next objective was the attachment of the microspheres to the Au surface via 
hybridisation of the probe DNA to the capture strand. As previously discussed, ideally 
the microsphere would be attached to the surface by a single probe/ capture 
hybridisation, so that a single miRNA binding event would result in displacement of the 
microsphere. The 1 Step microspheres were preferred, due to the lower surface coverage 
of probe strand, however as previously shown in Figure 6.4, the deposition of capture 
onto the Au surface would result in very high coverage of capture DNA. In order to 
examine the effect of surface coverage of capture DNA on the binding of the probe, 
1 µM of capture was co-deposited with 10 µm of dodecanethiol. It was hoped that this 
would result in lower surface coverage of the capture strand, while simultaneously 
improving the orientation of the capture DNA on the surface to improve the availability 
of the capture to the probe.  
Au wafer was modified with capture DNA. Microspheres where then deposited onto the 
surface, in solution, and allowed to hybridize for 14 hours. The surface was then rinsed 
with PBS to remove loosely bound microspheres. The microspheres were 3 µm in size, 
so were visible to the naked eye in bulk. During the washing phase of the experiment it 
was noted that the majority of the microspheres were liberated from the surface. The Au 
wafer was then imaged by confocal microscopy. The results of this experiment are 
Capture DNA only 
 
 
 
Capture DNA: Dodecanethiol (1:20) 
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shown in Figure 6.15. The surface coverage was much lower than expected (given the 
long hybridisation time one would anticipate the spheres to be close packed), with some 
areas of the Au wafer showing no microspheres present. 
Figure 6.16 shows the results for the Au wafer with capture and dodecanethiol co-
deposited on the surface. As in the previous experiment, the majority of the microsphere 
appears to be removed during the washing phase of this experiment. The confocal 
images show very low surface coverage, similar to that seen for the previous 
experiment.  
To test if the microspheres, which were visible on the surface, were attached via the 
probe capture hybridisation, or due to non-specific interactions, the Au wafer was 
immersed in 10 µM target miRNA for 3 hours. The Au wafer was then gently rinsed to 
remove any displaced microspheres and imaged again under confocal. No difference in 
the surface coverage was observed, which suggests that the microspheres were adhered 
by non-specific interactions or the probe could not access the capture strands underneath 
the bound microspheres. 
Repeats of this experiment showed similar results, with no displacement of the 
microspheres upon the addition of miR-132 target. These results suggested that either 
the capture probe hybridisation was not occurring, or alternatively, that the strength of 
this interaction was not sufficient to hold the microsphere at the surface.  
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Figure 6.15: Confocal fluorescence microscopy of 1.27 x 10
7
 3 µm microspheres after 
EDC coupling of 5 µM probe DNA with 1 mM Cy5 after 4 hours deposition on Au wafer 
functionalised with 1 µM capture for 14 hours. Excitation at 633 nm with LP165 filter 
at 10 %. 
 
 
 
20µm 20µm 
20µm 20µm 
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Figure 6.16: Confocal fluorescence microscopy of 1.27 x 10
7
 3µm microspheres after 
EDC coupling of 5 µM probe DNA with 1 mM Cy5 after 4 hours deposition on Au wafer 
functionalised with 10 µM dodecanethiol and 1 µM capture for 14 hours. Excitation at 
633 nm with LP165 filter at 10 %. 
 
 
 
 
 
 
 
20µm 20µm 
20µm 20µm 
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6.3.7  Potential Controlled Deposition 
Previous experiments had demonstrated that the probe strand was capable of hybridising 
to the capture DNA, and that it had been successfully displaced by the addition of 
miR-132 target, which suggested that there was no issue with the quality of the nucleic 
acid used.  One possible explanation for this is electrostatic repulsion of the negatively 
charged spheres (due to deprotonation of the carboxy groups) by the negatively charged 
DNA capture strands. Based on the manufacturer’s specification, a single unmodified 
microsphere has a surface charge of 0.078 aC. This charge could be the cause of 
repulsion between the negatively charged capture DNA on the Au surface and the probe 
strand.  
To investigate this issue, Au wafer was functionalised with capture DNA.   A potential 
of +0.3 V was applied for 2 hours during the deposition of the probe and Cy5 
functionalised microspheres. This potential is positive of the potential of zero charge for 
clean Au but is not expected to change the DNA capture layer structure.  The objective 
was to attract the microspheres to the surface where they could then hybridise. The 
surface was then gently rinsed to remove non-specifically bound microspheres. Figure 
6.18 shows the results for this experiment. A large number of microspheres were visible 
on the surface of the Au. While the microspheres were visible using the backscattered 
light, no fluorescent signal was visible. This result was unexpected, and was also very 
different to the confocal images previously seen.  
The next objective was to test the microsphere’s ability to be displaced by the target 
miRNA. To measure the displacement of microspheres, the system was set up as shown 
in Figure 6.17. The confocal system available uses an inverted microscope and an oil 
immersion lens. Images were collected by placing a thin glass cover slide over the lens, 
and placing the Au wafer with the Au side down onto the glass. When PBS was added 
between the glass and Au wafer, the Au wafer rose in height away from the lens. This 
placed the Au surface outside the maximum confocal distance of the system. The 
microspheres are heavier than water, and so they would sink to the glass surface if 
displaced from the Au. In this experiment, PBS was added and the surface of the glass 
was imaged after 15 minutes. As can be seen in Figure 6.18(B), very few particles were 
detected after this time. This suggested that the microspheres were well attached to the 
Au surface, either by capture / probe hybridisation or by non-specific interactions.  
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miR-132 target was then added to bring the concentration in the PBS to 10 µM. The 
glass surface was imaged again after another 15 minutes. A significant number of 
microspheres were present on the surface of the glass. This experiment indicates that 
these microspheres were successfully displaced from the surface of the Au.  
Of interest in this experiment is the loss of fluorescence by the dyes when bound to the 
surface of the Au, which was reversed upon release onto the glass. This suggests that 
the loss of fluorescence was not as a direct result of the potential controlled deposition. 
One explanation for this is quenching of the dye excited state by the Au surface. This 
would provide further evidence for the successful attachment of the microspheres to the 
Au surface in this experiment. If this is the case, then this could potentially act has a 
highly sensitive method for the detection of analyte binding. If displacement of the 
microsphere causes “switching on” of the dye, then this would provide a large easily 
measurable signal, with very low background.   
226 
 
 
 
Figure 6.17: Scheme showing detection of microspheres using inverted confocal 
microscope, whereby displaced microspheres are released from the Au surface and fall 
onto the underlying glass, where they are detected.  
Confocal Volume 
Gold Surface 
Glass Slide 
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Figure 6.18: Confocal fluorescence microscopy of 1.27 x 10
7
  1-Step microspheres after 
4 hours deposition with applied potential of +0.3 V in PBS on Au wafer functionalised 
with 1 µM capture for 14 hours. Excitation at 633 nm with LP165 filter at 10%. (A) 
microspheres on Au wafer surface, (B) glass surface 15 minutes after addition PBS and 
(C) glass surface 15 minutes after the addition of 10 µM target miRNA.  
20µm 20µm 
20µm 20µm 
20µm 20µm 
(A) 
(B) 
(C) 
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This experiment appeared to be successful in the displacement of the microspheres by 
addition of target miRNA. The next objective was to determine the concentration 
dependence of the displacement of the microspheres. Unfortunately, repeats of this 
experiment produced highly inconsistent results. The primary issue was the capturing of 
the microspheres on the Au surface. In follow up experiments, this surface coverage 
varied from no microspheres present, to a similar surface coverage as that seen in Figure 
6.18. The reasons for this inconsistency are not known and further investigations are 
justified. 
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6.4  Conclusions 
The objective of this work was the detection of miR-132 by displacement assay. The 
displacement assay was shown to work using a Au surface modified with capture DNA, 
and probe functionalised with a [Ru(bpy)2PIC-COOH]
2+
 dye. When the miR-132 target 
was added, the intensity of the [Ru(bpy)2PIC-COOH]
2+
 dye was reduced, which 
suggests that the displacement had successfully taken place.  
To generate a large analytical signal for the displacement of a single probe strand by the 
target, a 3µm microsphere was prepared with a probe strand and a dye, Cy5 to aid in the 
visualisation of the probe by fluorescent microscopy. The surface coverage of the probe 
on the surface could be controlled by the order in which the DNA and dye were 
attached, or by the relative concentration of the two.  
Immobilisation of the microsphere onto capture functionalised Au was initially 
unsuccessful, with very low surface coverage and no displacement with the addition of 
miR-132. This was believed to be due to electrostatic repulsion between the negatively 
charged microsphere, and the negatively charged capture surface. To overcome this 
issue, a positive potential was applied to the surface. Microspheres appeared to adhere 
to the surface after this process, with the fluorescence of the dye not visible, possibly 
due to transfer of the excited state into the Au mediated by the DNA duplex. 
However, repeats of this experiment gave highly inconsistent results, with very low 
surface coverage for some experiments, and no apparent displacement of the 
microspheres with the addition of target in others. A number of factors may explain this 
result. In this experiment the capture/ probe hybrid has an associated association and 
disassociation rate, as does the capture/ target hybrid. In order for the assay to perform 
as expected, the association of the microspheres must be sufficient to anchor the particle 
to the surface. The disassociation rate must be high enough to facilitate the preferential 
binding of the target, which allows the displacement to occur. The design of the DNA 
strands was optimised so that the association of the target with the capture strand would 
be considerably more energetically favourable than the capture/ probe hybrid, based on 
the number of matching bases. 
Negative charging of the microspheres caused the dissociation of the capture/ probe 
hybrid to become more favoured, which while beneficial for displacement, caused 
issues for the immobilisation of the microspheres. This issue appears to have been 
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solved by the potential controlled deposition; however other approaches are also 
considered possible. The addition of charged moieties to the microsphere could be 
adjusted to make the net charge neutral or slightly positive. This should remove the 
need for an applied potential.  
Another potential issue is the transport of the target past the microsphere. These large 
particles may slow the diffusion of the target miRNA to the surface. This means that the 
effective concentration at the surface is considerably lower than in solution. This factor 
could be mitigated by controlling the dispersion of capture DNA on the surface so that 
microspheres have greater separation or by tuning the capture strand length. This should 
be controllable by co-deposition with an alkane thiol monolayer as previously 
discussed.  This would also improve the sensitivity of the assay, since capture DNA 
present on the surface, which is not bound to a microsphere, competes for miRNA 
target added, further lowering the effective concentration available to displace the 
microspheres.  
For the microsphere to be successfully displaced, the association of the target/ capture 
needs to be high, as does the disassociation of the capture/ probe.  The design of the 
DNA strands is sufficient to allow this to occur for a single linkage from the probe to 
the surface as illustrated by the successful displacement of the [Ru(bpy)2PIC-COOH]
2+
 
probe. However, for the microspheres, the number of linkages to the surface is 
potentially much higher. A single microsphere could have multiple probe/ capture 
hybrids immobilising the particle to the surface. This means that even though 
disassociation of the probe/ capture hybrid is favourable, the high number of linkages 
makes displacement highly unlikely.  
This issue could be resolved by reducing the surface coverage of capture, as discussed 
previously, and of the probe strand. For the probe strand this should be achievable by 
varying the concentration of the probe with respect to the Cy5 dye or another blocking 
group. Ideally, only a single capture and probe strand would then be available. This 
should allow for a single target binding event to cause the release of the microsphere. 
Overall a number of issues remain with this assay, with further optimisation required to 
achieve the determination of ultra-low concentrations.  
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7.1  Conclusions and Future Work 
The ability to detect short strands of nucleic acids, including micro RNA (miRNA),  has 
a range of implications for the detection of diseases such as cancer, and can inform the 
staging and treatment of these conditions as explored in Chapter 1. The current state of 
the art, polymerase chain reaction (PCR), is capable of detecting ultralow 
concentrations of nucleic acids, however the equipment, skilled personnel and time 
required for measurements limits this approach to centralised labs. miRNA have the 
potential to detect the presence of disease before the onset of visible symptoms, and this 
early detection can improve patient outcomes, especially in the case of cancer.  In order 
to realise this potential, methods of miRNA detection which are fast, affordable, 
accurate and highly sensitive are required. To achieve wide scale screening, the device 
should ideally be available in a point of care setting. 
Points of care devices are required to be simple, accurate and to have no reasonable 
expectation of failure. PCR is currently not able to achieve this standard, and so 
alternate methods of miRNA detection have been widely explored. Electrochemical 
detection of miRNA has the potential to fulfil these criteria. A single electrochemical 
event can generate a large, easily measurable signal. This allows the amplification free 
detection of miRNA. By integrating an electrochemical detection strategy into a 
microfluidic device, ultrasensitive point of care detection is possible.  
The highly sensitive strategies developed here, electrocatalytic nanoparticles, molecular 
beacons (MB) and displaceable microspheres, for the detection of nucleic acids 
represents a powerful, versatile platform technology. The systems have been 
demonstrated for single targets but multiplexed detection of several nucleic acid targets 
should be possible by varying the size and metal composition of the regioselectively 
modified nanoparticles or the dye emission wavelength in the MB/labelled spheres. 
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With further development, the particle based assays should be suitable for point of care 
detection of nucleic acid disease biomarkers, potentially as part of a flow based system. 
Moreover, the regioselective platinum nanoparticles should be capable of the reduction 
of water which would allow the production of a reagent free device. Beyond 
electroanalytical applications, regioselective nanoparticles have significant potential for 
the creation of nanoscale structures. The dual functionality of these particles allows for 
the potential attachment of different probes, which facilitates the creation of 3D 
nanostructures. The use of conductive linkers would enable the production of size 
tuneable nanowires, see Figure 7.1, which have wide ranging applications.  
 
Figure 7.1: Potential size tuneable nanowires using PtNPs functionalised on either end 
with a conductive linker.  
 
In this work, the expression of miR-132 in live neuroblastoma cells was examined. The 
high variability and nuclear localisation of miR-132 within individual cells provides a 
valuable insight into the role of miR-132 in neuroblastoma. While the high variability of 
the results reported may be impacted by the passage number of the cultured cells, 
analysis of primary tumour cells using this MB system may be able to provide 
information on the functional role of miR-132 in neuroblastoma at the single cell level. 
The MB unexpectedly emitted even in the absence of the target which increases the 
limit of detection. The number of self-binding bases was adjusted in an effort to reduce 
this background but no significant improvement was achieved. Further optimisation of 
the number of bases in the stem region, and adjustment of the dye and quencher used 
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may allow for an improved limit of detection. Integration of quantum dots could also 
potentially aid in detection by improving the emission intensity and sharpen the 
emission profile which is useful for multiplexing. Quantum dots can have issues with 
toxicity and in efficient quenching, so integration into a MB may prove challenging. In 
this work, electroporation and lipid based transfection was used for the transport of the 
molecular bacon into the cell. Modification with cell penetrating peptides could allow 
for transport of the beacon into the cell without the use of additional reagents, which is 
desirable for use in a clinical setting. The attachment of a charged species to the MB 
may also improve the uptake of the MB. 
A displacement assay for the detection of miR-132 was also reported. This assay has 
significant potential for point of care detection based on the large signal produced from 
the binding of a single particle. At present, issues remain with the density of capture and 
target DNA which allows for linkage of the beacon to the surface via multiple 
hybridisations. This significantly reduces the potential limit of detection. Further 
optimisation is required to overcome this issue.  
Another issue was the negative charge of the microsphere, which caused repulsion 
between the capture and probe strands. While this is attractive for easy displacement of 
the particles, it also caused issues with the attachment of the microsphere to the surface. 
This could be overcome by the addition of positively charged groups, which could be 
modulated to achieve a neutral or slightly positive charge. In this work, binding of the 
microsphere to the gold surface caused quenching to the attached dye. This is highly 
attractive for the detection of miRNA, since this provides a large, easily measurable 
signal upon displacement. This has the potential for to provide a simple point of care 
detection strategy, whereby whole blood is added to a displacement array, and 
displacement of the microspheres causes switching on of a significant fluorescent 
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signal. This detection could also be mediated by a flow based system, or using magnetic 
separation.   
This displacement assay should be capable of the release of any particle. This could 
allow for an assay using nanoparticles as the sensing elements, or a species which 
exhibits electrochemiluminescence (ECL). This could allow for simple multiplexing, 
where a different species is released in response to different miRNA target binding. This 
could allow for sensitive, selective detection of multiple miRNA on a single 
microfluidic chip.  
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Dual  function  platinum nanoparticles  (PtNPs) incorporating  two  functions,  i.e.,  DNA  capture  and  elec-
trocatalysis that are physically separated, are  described.  The physical separation  of the  two  functions
signiﬁcantly  enhances  the  sensitivity of DNA detection  giving  attomolar  limits of detection.  The regio-
selective functionalisation  has  been  achieved using defects within  a dodecanethiol  (C12)  monolayer
deposited  on a gold  electrode.  These defects–nucleation  sites allow  for  the  electrodeposition  of electrocat-
alytic, mushroom  shaped PtNPs. The monolayer  allows one  side of the nanoparticle  to be  functionalised
with  a 20-base  oligonucleotide  with a C3  spacer  thiol (probe)  that  selectively  captures  a sequence  specif-
ically  associated  with  the strain of Staphylococcus  aureus  associated  with  mastitis.  Once  functionalised
with  capture strand  DNA,  the  particles  are  released by  sonication  which  maintains  the structural  integrity
of the  DNA.  Thus, the  desorbed  nanoparticles  are capable of biorecognition  on  the  top  curved  side  and
electrocatalytic  reduction  of hydrogen  peroxide  on the non-functionalised  lower surface. A  second gold
disc  electrode  was modiﬁed  with  a  15-base  oligonucleotide  with  a C3 spacer  thiol (capture). The presence
of a 41-base  target  oligonucleotide,  S. Aureus, which  hybridized  with both  capture  and  probe  oligonu-
cleotides, brings  the  PtNP close to the  electrode  surface  facilitating  the  electrocatalytic reduction  of
hydrogen peroxide  generating  a signiﬁcant current  for  each hybridisation  event.  This  highly sensitive
detection approach  opens  up  the  possibility  of avoiding  polymerase  chain  reaction  (PCR) or  nucleic acid
ation  sequence-based  ampliﬁc
. Introduction
Platinum nanoparticles (PtNPs), have attractive properties for
nalytical applications including electrocatalysis which can dra-
atically enhance the sensitivity of detection [1], photophysical
roperties that can enhance energy harvesting [2–5],  as well as
nergy storage and conversion [6–10].
We previously described the regio-selective functionalisation
f metal nanoparticles that were functionalised on one side with
NA while the opposite side was electrocatalytically active [11,12].
articles functionalized in  a regio speciﬁc manner also allows
or different linkers, e.g., assorted DNA sequences or antibod-
es and nucleic acids, to be co-immobilized in  distinct areas
iving superior control over the direction of assembly and facil-
tating multianalyte detection using a  single nanoparticle. The
egio-selective hemi-spherical PtNPs were obtained by deposit-
ng a  thiolated self-assembled monolayer onto the gold electrode
urface before electrodeposition. The top surface of these PtNPs
as then functionalised with thiolated terminated probe strand
∗ Corresponding authors. Tel.: +353 861273781.
E-mail address: elainespain@gmail.com (E. Spain).
013-4686/$ – see front matter © 2013 Elsevier Ltd. All  rights reserved.
ttp://dx.doi.org/10.1016/j.electacta.2013.10.025(NASBA)  based  ampliﬁcation  of the  target.
© 2013  Elsevier  Ltd. All  rights  reserved.
DNA, and a short current pulse at a  current density of approx-
imately 100 mA  cm−2 was applied to the nanoparticle modiﬁed
electrode with the objective of melting the nanowire connect-
ing the hemispherical nanoparticle to the electrode. These rather
aggressive conditions were used to  rapidly desorb the function-
alised nanoparticles, which, once in  solution would diffuse away
from the electrode surface thus retaining their functionality of  the
bound nucleic acid without causing any damage to the bound DNA.
However, the aggressive current step not only removed the PtNPs
but also the templating alkane thiol monolayer, and results sug-
gested that induced additional surface roughening of the gold disc
electrode also took place [12].
Sonication is frequently used to break up  aggregates during
puriﬁcation [13], mixing of two or more nanomaterials [14] and
many other types of solution processing techniques [15–18]. It  can
also be  used to  remove nanospheres masks and release surfaced
conﬁned nanoparticles [19,20]. Therefore, sonication represents an
attractive approach for the release of regio-selectively function-
alised metal nanoparticles in  a  manner that causes minimal damage
to the underlying electrode and perhaps allowing the monolayer
template to be reused.
In this contribution, we  describe a  simple sonication-assisted
desorption route for the production of highly dispersed and
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GScheme 1. Platinum nanoparticle format
niform PtNPs. Using this method, DNA functionalized PtNPs
ere easily isolated from the monolayer templated electrode and
emained separated after sonication. As illustrated in Scheme 1, our
pproach is  based on PtNPs that have been electrodeposited onto an
lectrode functionalised with a  dodecanethiol monolayer in  which
efects template the nanoparticle electrodeposition. The top sur-
ace of these PtNPs is functionalized with thiol terminated probe
trand DNA. Then the electrode is sonicated to  break the nanowire
onnecting the hemispherical nanoparticle to the electrode causing
isconnection of the DNA functionalized PtNPs. These DNA labelled
lectrocatalytic particles are then used in  a hybridization assay
o determine low concentrations of the target by measuring the
aradaic current associated with reduction of peroxide in  solution.
he target is  a  DNA sequence from the speciﬁc bacteria that causes
astitis (mammary gland inﬂammation). This nucleic acid detec-
ion strategy represents a  signiﬁcant advance over current practice
here mastitis is  detected based purely on clinical signs e.g. udder
welling and irritation (i.e., tender to the touch), fever as well as
educed milk production.
. Experimental
.1. Materials
Dodecanethiol was obtained from Sigma–Aldrich. The buffer,
enoted as 1 M  NaCl-TE, contained 1.0 M  NaCl, 10 mM  Tris–HCl,
nd 1 mM ethylenediaminetetraacetic acid (adjusted to pH 7.0
y adding 1.0 M  NaOH) and was used for DNA hybridization.
latinum nanoparticles (diameter 50–70 nm)  that were used for
niform functionalization with a  probe strand DNA were pur-
hased from Particular GmbH. All aqueous solutions were prepared
sing Milli-Q water. The oligonucleotides were purchased from
urogentec©TM and their purity was >98%. The base sequences are
s follows:Capture: 5′-CGG-CAG-TGT-TTA-TCA-3′-SH
Target: 5′-TGA-TAA-ACA-CTG-CCG-TTT-GAA-GTC-TGT-TTA-
AA-GAA-ACT-TA-3′
Probe: SH-5′-TA-AGT-TTC-TTC-TAA-ACA-GAC- -3′d regio-selective DNA functionalization.
Base mismatch: 5′-TGC-TAA-ACA-CTG-CCG-TTT-GAA-GTC-
TGT-TTA-AAA-GAA-ACT-TA-3′
3 Base mismatch: 5′-TGC-TAA-ACA-CTG-CCG-CTT-GAA-GTC-
TGT-TTA-GAT-GAA-ATA-TA-3′
2.2. Instrumentation
A  three-electrode electrochemical cell was used at a tempera-
ture of 22 ± 2 ◦C. The working electrode was a 2 mm radius planar
gold disc. It was  polished with a nylon cloth with 1 m diamond
polish and thoroughly rinsed with Milli-Q water and ethanol before
sonication in  Milli-Q water for 5 min. Voltammetry in acid was used
to determine the surface roughness factor by scanning the elec-
trode between +1.500 and −0.300 V. The counter electrode was  a
large area coiled platinum wire and a  silver/silver chloride (Ag/AgCl
in 3 M  KCl) acted as reference. SEM images were taken using a
Hitachi S3000N scanning electron microscope at an accelerating
voltage of 5 kV. Dynamic Light Scattering (DLS) experiments were
performed at 25 ◦C on a Nanosizer NanoZS (Malvern Instruments,
Malvern, U.K.) using a detection angle of 173◦ and a  3 mW  He-Ne
laser was operating at a  wavelength of 633 nm.  The polydisper-
sity indices were calculated from the cumulants analysis as deﬁned
in  ISO13321 [21].  The intensity size distributions were obtained
from analysis of the correlation functions using the Multiple Nar-
row Modes algorithm based upon a  non-negative least-squares ﬁt
[22] using Dispersion Technology software (v. 5.3, Malvern Instru-
ments; Worcestershire, U.K.). The values used for the viscosity of
platinum in  0.01 M H2SO4 were 26.7 cPa s at 298 K.
2.3. Monolayer self assembly
The gold electrodes were cleaned by placing them in  piranha
solution (3:1 mixture of sulphuric acid and 30% hydrogen perox-
ide. CAUTION: This mixture reacts violently with organic material!)
for 20 min, followed by thorough rinsing with ultra-pure water.
The electrode was  then scanned between +1.500 and −0.300 V in
0.01 M H2SO4 to measure the surface roughness of the gold elec-
trode, and to ensure that the electrode is electrochemically clean.
Afterwards, the gold disk electrode was  washed with ethanol and
imica Acta 128 (2014) 61–66 63
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Fig. 1. Cyclic voltammograms of (A) 2 mm  unmodiﬁed gold electrode, (B) after depo-
sition of a defective C12 monolayer, (C) following electrodeposition of PtNPs into the
monolayer defects (D)  after the PtNPs have been desorbed via sonication. The scale
bar  for (A) and (B) are 10 A while for (C) and (D) it is 40 A.  The  supporting elec-E. Spain et al. / Electroch
hen placed in a 1 mM  solution of dodecanethiol in ethanol and
onolayer self-assembly allowed to proceed for 7 h.  After the for-
ation of the monolayer, the substrate was rinsed four to ﬁve times
ith ethanol and dried under a  N2 stream.
.4. DNA probe immobilization and hybridization
.4.1. Step 1: Fabrication of regio-selectively DNA functionalized
latinum nanoparticles
Platinum nanoparticles were electrodeposited from 1 mM
ydrogen hexachlorideplatinate(IV) hydrate (H2PtCl6) in  0.5 M
2SO4 using the defects within the self-assembled monolayer as
emplates. Subsequently, in Step 1B, the PtNPs were functional-
zed with probe oligo (5′ thiolate) by  immersing the nanoparticle
unctionalized electrode in a  10 M  solution of the probe DNA
trand dissolved in  1 M NaCl-TE Buffer for 2 h. The modiﬁed elec-
rodes were then washed with deionized water for 15 s to remove
oosely bound oligo and immersed in 0.01 M H2SO4. The oligo func-
ionalized PtNPs were then removed via sonication for 1 h and
e-dispersed in  0.01 M  H2SO4.
.4.2. Step 2A: Monolayer of capture strand DNA
A monolayer of capture strand DNA was prepared on a freshly
olished and electrochemically cleaned gold disk electrode by
mmersing it in  a 10 M solution of the capture strand DNA dis-
olved in  1 M NaCl-TE Buffer. After 5 h,  the electrode was rinsed
ith deionized water for 15 s to remove loosely bound oligo.
.4.3. Step 2B: Hybridization of target oligo to the capture surface
Hybridization of the target at concentrations between 10 pM
nd 1 M to the immobilized capture strand was performed at
7 ◦C in  1 M  NaCl-TE Buffer for 90 min. Following hybridization, the
odiﬁed electrode was rinsed thoroughly with buffer.
.4.4. Step 2C: Probe hybridization
The nanoparticle labelled probe DNA was then hybridized to the
omplementary section of the target not used for binding to  the
apture strand for 2 h at 37 ◦C in  1 M NaCl-TE Buffer. Finally, before
uantitation, it was thoroughly washed with deionized water.
.5. Electrochemical detection of Staphylococcus Aureus ss-DNA
arget
Following assembly of the capture-target-nanoparticle labelled
robe DNA sequence, the modiﬁed electrode was placed in an aque-
us solution of 0.01 M H2SO4 and the current measured at −0.250 V
fter equilibration for 10 min. Then, sufﬁcient hydrogen peroxide
as added to give a  ﬁnal concentration of 200 M,  and the reduc-
ion current associated with peroxide reduction at the bound PtNPs
as measured at −0.250 V after 10 min. The analytical response is
aken as the difference in current, i,  measured before and after
eroxide addition.
. Results and discussion
.1. Cyclic voltammetry
Self assembled monolayers, SAMs, of alkane thiols on gold allow
he interfacial properties to  be tuned for particular applications.
hey adsorb rapidly to give ﬁlms that initially have a  high defect
ensity which slowly anneal to give well-ordered ﬁlms [23]. Here,
efective monolayers are deliberately created by using a  rela-
ively short monolayer deposition time. Fig. 1(A) and (B) illustrate
yclic voltammograms for the 2 mm  radius gold electrodes before
nd after deposition of the defective monolayer, respectively. The
ctive surface area can be determined using voltammetry in 0.01 Mtrolyte is  0.1 M H2SO4. The  counter electrode was  a large area platinum wire, and
the reference electrode was saturated Ag/AgCl (3 M KCl).
H2SO4 as the supporting electrolyte by creating and subsequently
reducing a  gold oxide monolayer on the unmodiﬁed fraction of
the electrode. By comparing the charge passed before and after
monolayer deposition, the area available for platinum nanoparticle,
PtNP, electrodeposition can be determined. Monolayer deposition
decreases the area under the gold oxide reduction peak cur-
rent at approximately +0.87 V from 0.034 cm2 for the unmodiﬁed
electrode (roughness factor of 1.08) to  0.028 cm2 following mono-
layer deposition. This result conﬁrms that there are a  substantial
number of sites for metal deposition at the partially blocked sur-
face. PtNPs were deposited into the defects within the monolayer
from a 0.5 M sulphuric acid solution containing 1 mM  hydrogen
hexachlorideplatinate(IV) hydrate (H2PtCl6). Fig. 1(C) illustrates
the cyclic voltammogram following nanoparticle deposition at an
applied potential of −0.250 V for 180 s. After the electrochemically
deposition of PtNPs, the area under the platinum oxide reduc-
tion peak [24,25] (between 0.05 and 0.3 V  vs.  Ag/AgCl) increased
while the area associated with gold oxide formation and reduc-
tion decreased signiﬁcantly. Signiﬁcantly, the microscopic area
following deposition of the PtNPs is 0.296 cm2, i.e., nanoparticle
deposition increases the area available for DNA deposition by a
factor of approximately 11 when compared to dodecanethiol tem-
plated electrode, i.e., the radius of the electrodeposited PtNPs is
signiﬁcantly larger than that of the templating defects leading to
mushroom shaped particles. Following binding of the probe oligo,
the nanoparticle modiﬁed electrode was removed via sonication
for 1 h at 90 sonics min with the objective of disconnecting the
64 E. Spain et al. / Electrochimica Acta 128 (2014) 61–66
Fig. 2. SEM images of (A) a gold electrode following deposition of the templating monolayer following, (B) electrodeposition of PtNPs for 180 s,  (C) after the PtNPs have
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Feen  desorbed via sonication and (D) drop cast ﬁlm of desorbed nanoparticles from
uspension). The acceleration voltage is  5 kV.
anowire linking the hemispherical nanoparticle to the electrode.
his method successfully desorbed the nanoparticles. Fig. 1(D)
hows that the peak heights associated with both platinum oxide
eduction and hydrogen adsorption–desorption are dramatically
ower after desorption of the PtNPs. Signiﬁcantly, the area under
he gold oxide peak, reduction peak centreed at approximately
0.8 V increases after nanoparticle desorption to 0.030 cm2,  which
s indistinguishable from that found for the defective templating
onolayer before deposition 0.028 cm2. Signiﬁcantly, in contrast
o the previously reported current jump approach [11,12],  son-
cation successfully removes the PtNPs with minimal alkane thiol
onolayer desorption.
.2. SEM
Fig. 2(A) shows an SEM image of the gold electrode following
eposition of the defective alkane thiol template for 7 h and elec-
rodeposition of the PtNPs (Fig. 2(B)) using a  deposition time of
80 s. It is  challenging to  accurately determine the size distribution
f the templating defects in the monolayer using SEM. However, it is
lear that with an electrodeposition time of 180 s that the radius of
he nanoparticles typically exceeds the size of the defects by  at least
0%, i.e., the electrodeposited nanoparticles are mushroom shaped.
he image reveals a  relatively high surface coverage of nanoparti-
les with a  radius of 70 ± 30 nm.  This particle shape will result in
pproximately two thirds of the total nanoparticle surface (hemi-
phere) being modiﬁed by  probe strand DNA with approximately
ne third (disk) being unmodiﬁed and available for electrocatalysis.
ig. 2(C) displays an SEM of a sonicated gold electrode; where, the
lectrodeposited PtNPs within a  defective C12 monolayer have been
emoved. The SEM demonstrates that the sonication step success-
ully removes the majority of the PtNPs from the electrode surface.
ig. 2(D) shows an image for a gold substrate onto which a dropletension (inset: particle size distribution measured using DLS for desorbed PtNPs in
of the suspended nanoparticles has been drop cast and allowed to
dry. This image reveals that desorption does not change the aver-
age particle size signiﬁcantly and a relatively high concentration
of nanoparticles in the suspension can be achieved. In addition to
the SEM characterization, the radius of the suspended nanoparti-
cles was obtained by DLS, (inset Fig. 2(D)), as 70 ± 30 nm,  which is
consistent with the SEM data.
3.3. Binding of regio-selectively decorated nanoparticles
In  order to  successfully detect DNA, the desorbed nanoparticles
must be  both electrocatalytically active and be capable of binding
the target DNA. As  illustrated in Scheme 1,  an electrode modiﬁed
with DNA capture strands was  ﬁrst allowed to hybridize with
the target strand, part of which is complementary to the capture
strand. This electrode was then placed into the NP suspension for
90 min  during which time the non-hybridized section of the target
hybridizes with the oligo bound to the metal nanoparticle. Fig. 3(A)
illustrates the voltammogram obtained for an electrode in  0.01  M
H2SO4 after electrodeposition of the PtNPs and functionalisation
with the probe strand DNA. Fig.  3(B) shows the response obtained
for a pristine gold electrode modiﬁed with the capture strand
DNA after both the target and the nanoparticle functionalized
probe strand hybridization steps have occurred. Both of  these
ﬁgures show well deﬁned peaks for Pt oxide formation in the
0.6 to 1.2 V  range, reduction of Pt oxide at approximately +0.3 V,
as well as peaks in  the range of −0.05 V to  −0.3 V associated
hydrogen adsorption–desorption, respectively. These observations
indicate successful binding of the nanoparticles suggesting that the
DNA functionalized PtNPs can be  removed into suspension using
sonication. Control experiments in  which the target is  not added or
where the nanoparticles are either not  functionalized with DNA, or
are functionalized with non-complementary DNA, do  not  exhibit
E. Spain et al. / Electrochimica Acta 128 (2014) 61–66 65
Fig. 3. (A) Cyclic voltammogram of a  2  mm radius gold disc  electrode after electrode-
position of the PtNPs and functionalization with probe DNA (step 3 of Scheme 1),
(B) cyclic voltammogram of a 2 mm radius gold disc electrode after modiﬁcation
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Fig. 4. Calibration plots for the electrochemical detection of S. Aureus mastitis DNA
on  a  2 mm diameter bare electrode following hybridization with probe DNA immo-
bilize regio-selectively on  PtNPs () and where the probe is unlabelled (). A control
experiment showing the response of the electrode with uniform PtNPs functional-
ized with a homogenous full DNA monolayer is also illustrated (). In all cases, a  ﬁnal
concentration of a 200 M solution of H2O2 in aqueous 0.01 M H2SO4 was  added.
i  represents the difference in current before and after addition of the H2O2 at  an
applied potential of −0.250 V following approximately 10 min equilibration time.
Where error bars are not visible, they are smaller than, or comparable to, the size ofith the capture strand DNA and hybridization with the target and the nanopar-
icle labelled probe sequence where the target strand concentration is  1 M. The
upporting electrolyte is  0.01 M H2SO4,  and the scan rate is 100 mV  s−1.
eatures associated with platinum oxide or  hydrogen adsorption,
.e., the extent of non-speciﬁc adsorption of the functionalised
anoparticles is very low.
.4. Electrochemical detection of S. Aureus DNA
Platinum nanoparticles are  well known to catalyze the reduction
f hydrogen peroxide. The probe-modiﬁed PtNPs were hybridized
ith the modiﬁed electrode containing the DNA sequence com-
lementary to the probe ssDNA to form a  surface-bound duplex
dsDNA). The analytical performance of the DNA sensor using
he regio-selectively modiﬁed nanoparticles was  investigated and
ompared with that observed for nanoparticles that are uniformly
unctionalized with the probe DNA. The catalytic activity of the
tNPs bound through DNA hybridization (Step 2-C in  scheme) was
ssessed by  applying ﬁxed potential of −0.2500 V to the work-
ng electrode and the difference in  current, i,  observed before
nd after the addition of 200 M  H2O2,  measured. Fig. 4 shows
he dependence of i on the log [DNA] for detection of pathogen
NA where the probe strand is either unlabelled or  is labelled with
egio-selectively modiﬁed PtNPs. In each case, an acceptably linear
esponse is observed for concentrations of sequence-speciﬁc DNA
rom S. Aureus from 10 pM to  1 M.  The sensitivity of the 2 mm
old disc electrode () following hybridisation of the DNA where
he probe DNA strand is unlabelled is 0.0314 A−1,  reﬂecting the
oor electrocatalytic properties of the DNA modiﬁed gold electrode.
hese low currents in the absence of PtNP labels indicate that the
ackground current associated with direct reduction of hydrogen
eroxide at the underlying electrode is low. This result is signiﬁcant
s the magnitude of this background current will directly inﬂuence
he limit of detection. In contrast, the sensitivity of the assay involv-
ng regio-selectively modiﬁed PtNPs labelled with probe strands
) is approximately 28 times larger, 8.8 ×  10−2A−1, than thatthe symbols.
found in the label free assay, indicating that a signiﬁcant popula-
tion of the nanoparticles are desorbed by the sonication–desorption
technique. This result clearly indicates that physically separat-
ing the two  functions of the nanoparticles, i.e., electrocatalysis
and molecular recognition, leads to a  signiﬁcant improvement in
assay performance. The dramatically higher sensitivity and wide
linear dynamic range indicates that the desorbed nanoparticles
retain both their electrocatalytic and DNA binding capabilities. Also,
the high current density observed suggests that heterogeneous
electron transfer from the PtNPs, through the DNA  linker, to the
underlying electrode is  relatively facile.
Fig. 4 also highlights a control experiment (); where, com-
mercially bought PtNPs in  suspension were homogenously labelled
with probe DNA and then investigated for the catalytic activity
for the H2O2 oxidation–reduction reaction. An acceptably linear
response is observed for concentrations of sequence-speciﬁc DNA
from S. Aureus from 10 pM to 1 M.  However, the sensitivity of
the uniform PtNP electrode is 4.9 ×  10−2A−1,  reﬂecting the poor
electrocatalytic properties of the round PtNPs with a full DNA
monolayer compared to  the regio-selective decorated PtNPs. The
current associated with direct reduction of hydrogen peroxide at
the metal centre is  low as for electrocatalysis to  occur, electrons
need to run through the DNA monolayer before it reaches the PtNP
surface. These low currents indicate that the regio-selective deco-
rated PtNPs provides a surface that is  covered in  DNA to give you
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olecular recognition with another uncoated side to  give a  clean
urface for catalysis.
The selectivity of the sensor was also investigated using a  tar-
et DNA sequence that contained a single mismatch. Signiﬁcantly,
he differential current observed for this one base mismatch DNA
equence was a factor of four smaller than that found for the fully
omplementary sequence suggesting high discrimination ability.
oreover, S. epidermis which has 3 base mismatches, gives no mea-
ureable current response demonstrating the system is robust with
espect to  false positives. This result is  particularly important as
. epidermis can often be mistaken for S.  Aureus and its presence
ncorrectly associated with mastitis. It  also further conﬁrms that the
ound DNA has not been denatured as the particles are desorbed
ff the electrode surface.
. Conclusion
It was demonstrated that PtNPs could be regio-selectively func-
ionalized (upper surface only) with DNA while the remainder of
he particles surface is  unmodiﬁed allowing efﬁcient electrocatal-
sis to occur. An efﬁcient strategy for desorbing regio-selective
lectrocatalytic PtNPs via sonication is  presented. The key advan-
age of this simple sonication-assisted desorption route is  the
solation of highly dispersed and uniform PtNPs nanoparticles with-
ut any damage to  the bound DNA or underlying gold electrode.
hese desorbed particles can then quickly sample the solution and
an selectively detect target strand DNA at attomolar concentra-
ions by stirring rather than waiting for target strands to arrive
t the electrode interface. This is  particularly important for detec-
ion of sub-femtomolar DNA where diffusion is  too slow to allow
he surface coverage of the target to approach equilibrium on a
eaningful timescale. The assay is characterized by  a  wide dynamic
ange, high sensitivity, a  low detection limit and an excellent ability
o discriminate against interferences.
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